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Abstract  
 
Propolis is a sticky resin produced worldwide by honeybees (Apis mellifera). It is used to seal 
off holes in the hive from intruders, prevent putrefaction and thus prevent infections of the 
colony. The use of propolis as a natural or traditional product which dates as far back as 300 
B.C. Globally, research has been extensively dedicated to studying the antimicrobial 
properties of propolis from various geographical and climatic regions.  Brazilian propolis has, 
however, become a subject of increasing interest due to its characteristic favourable 
biological activities and is thus considered the “gold standard” of all propolis. This has 
resulted in the increased global demand for propolis. Despite this global outlook, research on 
the antimicrobial and chemical properties of propolis specifically from South Africa (SA) has 
been sorely neglected. 
 
The aim of this study was to evaluate the antimicrobial activity of 39 SA ethanolic extracts of 
propolis (EEP) and three Brazilian EEP’s(used as controls). The antimicrobial activities of 
EEP samples were evaluated using the minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) assays against two yeasts, two Gram-positive 
and two Gram-negative bacteria. Interactive efficacies of the ten most active propolis 
samples, combined with conventional antimicrobials and honey, were evaluated using the 
fractional inhibitory concentration (ΣFIC) assessment. The chemical profile and composition 
of propolis was determined using high performance thin layer chromatography (HPTLC) and 
ultra-performance liquid chromatography coupled to photodiode array detector-
quadrupole/time-of-flight mass spectrometry (UPLC-PDA-qTOF-MS/MS) analysis. 
 
All strains of bacteria and yeasts tested showed susceptibility to the 39South African EEP 
samples. Some noteworthy activities were observed with some samples (GP9, GP11 and 
WC8) displaying an MIC and MBC value as low as 6 µg/ml against Staphylococcus aureus. 
In this study it was found that the majority (56%) of South African EEP samples displayed 
average antimicrobial activity better than that of the Brazilian control samples; 71% of 
samples displayed noteworthy activity against S. aureus and 79% against Cryptococcus 
neoformans. Notable interactions were identified, such as the combination of EEP’s with 
gentamicin where synergistic profiles were most often observed against Pseudomonas 
aeruginosa with ΣFIC ranging from 0.19 to 0.37. The Brazilian EEP sample was the only 
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sample found to display antagonism when combined with the antifungals; amphotericin B 
and nystatin.  
 
Chemical analysis led to the identification six compounds namely; quercetin, galangin-5-
methyl ether, pinobanksin-3-O-propionate, pinobanksin-3-O-butyrate or isobutyrate, 
pinobankin-3-O-pentanoate or 2-methylbutyrate and pinobanksin-3-O-hexanoatewhich were 
identified for the first time in SA propolis in this study. Chemometric analysis of LC-MS data 
revealed two distinct clusters and confirmed that the South African propolis is chemically 
distinct from Brazilian propolis. Furthermore, chemometric analysis was used to compare 
chemical data to antimicrobial activity. Orthogonal projections to latent structures (OPLS) 
models were created for the two Gram-positive bacteria (Enterococcus faecalis and S. 
aureus) and Candida albicans. Using the S-plot function, it was possible to identify the 
bioactive constituents in propolis as chrysin, pinocembrin, galangin and pinobanksin-3-O-
acetate. 
 
South African propolis displayed noteworthy antimicrobial activity, favourably comparable 
to that of the Brazilian control and global “gold standard”. Interactive efficacy studies 
demonstrated notable synergistic profiles when combined with ciprofloxacin and gentamicin 
against Gram-negative bacteria. This could possibly have an impact on the future use of 
conventional antimicrobials with alternative therapies including propolis. Furthermore, SA 
propolis displayed not only superior activity in comparison to the Brazilian propolis but also 
exhibited superior antimicrobial activity in comparison to other extensively studied propolis 
from South America, Europe and Asia.  
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Chapter 1: Introduction 
 
1.1. What is propolis? 
Propolis is a resin produced worldwide by honeybees (Apis mellifera)(Figure 1.1).It varies in 
texture from sticky or mouldable to hard or friable and differs in colour, from light yellow to 
green and dark brown(Figure 1.2), according to the botanical source from which it is derived 
(Salatino et al., 2011; Maraschin et al., 2012). Once resin is collected from the buds of the 
various flora, it is masticated and mixed with the salivary enzymes. Propolis is hard and 
brittle at temperatures below 0°C and becomes sticky and soft once warm (Lofty, 2006). The 
word propolis simply put means “the defence system of the city”, derived from the Greek 
words “pro” meaning “in front of” and polis meaning “the city”.  
 
 
 
Figure 1.1:Production of propolis by honeybees Apis mellifera(www.biobees.com; 
www.foodwarriornetwork.com; mlmpropolis.com; www.fortunehoneyproducts.com) 
 
Resin produced by plants 
Propolis produced by honeybees (Apis mellifera) 
Resin collected by honeybees 
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Figure 1.2:Crude propolis illustrating different colours and textures. 
 
  
Therefore, propolis maintains the homeostasis of the hive as well as provides protection to 
the bee colony (Fokt et al., 2010; Simone-Finstrom and Spivak, 2010; Miguel and Antunes, 
2011). It is used as a disinfectant and antibiotic within the hive whereby infections within the 
colony are prevented (Castaldo and Capasso, 2002; Miguel and Antunes, 2011). Propolis 
extracts are known to be highly active against honeybee parasites such as Paenibacillus 
larvae and the wax moth Galleria mellonella (Bastos et al., 2008). 
 
1.2. Historical uses 
The use of propolis, as a natural or traditional product for medicinal use dates back to 300 
B.C (Burdock et al., 1998; Melliou and Chinou, 2004; Ramos and Miranda, 2007; El Ashry 
and Ahmad, 2012). Egyptians used propolis for its antiputrefactive properties to embalm the 
deceased (Castaldo and Capasso, 2002; de Groot, 2013). Propolis has been used extensively 
since archaic times and holds many pharmacological uses. It was recognized by numerous 
physicians such as the Greek and Romans, Aristotle and Dioscorides for its vast amount of 
medicinal uses. During the Middle Ages and among the Arab physicians, propolis was used 
as an antiseptic, mouth disinfectant and cicatrizant in wound healing. The Incas used propolis 
as an anti-pyretic, and between the 17
th
 and 20
th
 centuries, propolis became increasingly 
popular in Europe due to its reported antibacterial activities, leading to its incorporation as an 
official drug in the British pharmacopoeias (Castaldo and Capasso, 2002; de Groot, 2013; 
Wagh, 2013). Propolis is mentioned in Herst, Berlin and ancient Egyptian papyri as an 
effective treatment for sores and ulcers (El Ashry and Ahmad, 2012).More than 90 years ago, 
propolis was mixed with petroleum jelly and used during the Anglo-Boer war in South Africa 
(SA) for wound healing as well as tissue regeneration (Ghisalberti, 1979; Han et al., 2005; 
Ramos and Miranda, 2007; de Moura et al., 2011; El Ashry and Ahmad, 2012). 
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1.3. Pharmacological uses 
Propolis has been shown to exhibit immunomodulatory and immunostimulatory effects 
(Castaldo and Capasso, 2002). Also reported are its antioxidant, anti-tumor, anti-
inflammatory, antimicrobial, antiviral, antiparasitic, anti-carcinogenic, anti-diabetic 
properties, cholesterol lowering effects, as well the treatment of duodenal and gastric ulcers; 
it is for these purposes that modern day herbalists have been prescribing propolis (Banskota 
et al., 2001;Borrelli et al., 2002; Ramos and Miranda, 2007; Viuda-Martos et al., 2008; du 
Toit et al., 2009; Abu-Mellal et al., 2012; El Ashry and Ahmad, 2012; da Silva Frozza et al., 
2013; Król et al., 2013; Kuropatnicki et al., 2013; Wagh, 2013). Other studies have reported 
on its strong hepatoprotective and antioxidant properties (Banskota et al., 2001; Sforcin, 
2007; Viuda-Martos et al., 2008). Propolis has been reportedly used for the treatment of 
various ailments such as influenza and upper respiratory tract infections (Rahman et al., 
2010). Numerous studies have been conducted on propolis worldwide, both in vitro and in 
vivo, through clinical studies, either alone or in combinations with calcium hydroxide, 
detailing the beneficial effects of propolis in dental health and in the reduction of dental 
caries (de Rezende et al., 2008; Awawdeh et al., 2009; Bertolini et al., 2010; Arslan et al., 
2011; Madhubala et al., 2011; Kousedghi et al., 2012; Mattigatti et al., 2012;Bezerra et al., 
2015; Pimenta et al., 2015). Lu et al. (2005) documented the use of propolis in the prevention 
of gingivitis among other oral infections and also confirmed the usefulness of propolis in the 
treatment of allergies and different pathological conditions such as tumours and diabetes. 
 
In Japan, propolis is believed to be beneficial to health and is used in numerous health 
products found on the market (Nagai et al., 2003).Propolis has also been used increasingly as 
a preservative in various food substances (Tosi et al., 2007), as well as in veterinary medicine 
for the treatment of various ailments such as mastitis in cows, canine otitis and Salmonella 
infections (Cardoso et al., 2010;Al-safi, 2013; Aamer et al., 2015).The properties of propolis 
are now being scrutinized in greater detail with various studies reporting on the broad-
spectrum antimicrobial activity, anti-inflammatory and anticarcinogenic and 
immunomodulatory effects (Banskota et al., 2002; Simone-Finstrom and Spivak, 
2010).Miguel and Antunes (2011) reported that propolis has become a substance of increased 
importance used therapeutically either alone or in combination therapy with a variety of 
medicines and homeopathic products. Salatino et al. (2011) reported that propolis is gaining a 
wide acceptance in popular medicine in various parts of the globe. Brazilian propolis in 
particular has become a subject of increasing interest due to its characteristic favourable 
biological activities. The main Brazilian plant sources are Araucaria spp., Baccharis spp. and 
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Eucalyptus spp. (Bankova et al., 2000; Kumazawa et al., 2003). This has resulted in the 
increased global demand for Brazilian propolis, with the State of Paraná producing over 36 
tons of propolis annually (de Castro, 2001).  
 
1.4. Antimicrobial studies 
Globally, research has been dedicated to studying the antimicrobial properties of propolis 
from various geographical and climatic regions especially Brazil, Turkey, Argentina and 
Italy, as well as Colombia, Ethiopia, Russia, Bulgaria, Greece, India, Slovenia, Portugal and 
Thailand (Garedew et al., 2004; Boyanova et al., 2006; Kalogeropoulos et al., 2009; Righi et 
al., 2011; Choudhari et al., 2012; Mavri et al., 2012; Silva et al., 2012; Siripatrawan et al., 
2013) to name a few.  
 
Appendix G provides an overview of the antimicrobial studies undertaken on propolis 
worldwide. An in-depth review of these studies conducted on the antimicrobial properties of 
propolis clearly showed that propolis; irrespective of the country of origin has remarkable 
antimicrobial properties when compared to other natural products. Furthermore, it was noted 
that in these studies, propolis was most frequently tested against micro-organisms such as; S. 
aureus, P. aeruginosa, C. albicans, E.coli, E. faecalis, various Streptococcus spp. as well as 
some resistant microbial strains such as methicillin-resistant S. aureus. It is, however, 
important to note that whilst propolis worldwide has been rather extensively studied, the 
antimicrobial efficacies of African, specifically South African propolis in particular have 
been poorly investigated. Figure 1.3 further supports this observation in the lack of 
investigations, as it illustrates the scarcity of studies conducted within the African continent 
in comparison to South America (i.e. Brazil and Argentina), Europe (i.e. Turkey and Italy) 
and Asia (i.e. India and Iran).  
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Figure 1.3: Studies conducted worldwide on the antimicrobial properties of propolis in 
comparison to Africa. 
  
 
Although research may be lacking in other continents, such as Australia and North America, 
Africa is still poorly studied in comparison to South America, Europe and Asia (Figure 1.3), 
with less than 15 studies being conducted on African propolis. From a SA perspective, the 
antimicrobial investigation of propolis has been somewhat neglected, with only three studies 
by other authors investigating the properties of SA propolis and only one of these on its 
antimicrobial property. A study conducted by du Toit et al. (2009), investigated the 
antimicrobial properties of SA propolis, however, the study was more focused on the 
chemical and anti-inflammatory properties, rather than the antimicrobial properties. 
Kumazawa et al. (2004) studied the anti-oxidant and free-radical scavenging properties of SA 
propolis. Seidal et al. (2008) reported on the antimicrobial activity of propolis from different 
geographical and climatic zones, which included only one sample from SA. Considering that 
the antimicrobial efficacy of SA plants has demonstrated a number of promising anti-
infective properties (van Vuuren, 2008), the probability that propolis derived from the unique 
SA flora could potentially be an effective antimicrobial is high. Clearly, an in-depth 
investigation involving propolis from all geographical areas within SA warranted attention.  
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1.5. Chemical composition 
The chemical composition of propolis is extremely complex with more than 300 constituents 
having already been identified to date  (Bosio et al., 2000; Sawaya et al., 2004; Koru et al., 
2007; du Toit et al., 2009; Kalogeropoulos et al., 2009; Petrova et al., 2010; Dias et al., 2012; 
Mavri et al., 2012; Siripatrawan et al., 2013, Zhang et al., 2014). Composition is largely 
dependent on the climate, bee species and local flora available (Markham et al., 1996; Righi 
et al., 2011; Salatino et al., 2011). Amongst the constituents contained in propolis are wax, 
resins, balsams, essential oils, amino acids, sugars, polyphenols, esters of phenolic acids, 
flavonoids, sesquiterpenes, diterpenes, triterpenes, lignans, prenylated benzophenones, 
aldehydes, steroids and coumarins (de Castro, 2001; Mohammadzadeh et al., 2007; 
Hernández et al., 2005; Farooqui and Farooqui, 2012; Mavri et al., 2012). Phenolics (mostly 
flavonoids) are reported as constituting over 50% of the total weight of a given propolis 
sample (Bankova et al., 1996). 
 
Different chemotypes of propolis have been reported. The most common types of propolis 
reported are Temperate -produced from the bud exudates of Populus trees, Birch, Tropical, 
Mediterranean and Pacific (Popova et al., 2004; Bankova, 2005b). In Europe and the more 
temperate zones, propolis is found to contain more flavonoids and phenolic acid esters as 
opposed to propolis found in Cuba and Venezuela. The main constituents found in Cuban red 
propolis are prenylated benzophenones. Furthermore, red Mexican propolis is found to 
contain a vast amount of flavones, isoflavans and pterocarpans (Hernández et al., 2005; Lotti 
et al., 2010; Righi et al., 2011). Poplar-derived propolis has been found to be rich in 
flavonoids and aromatic acids (Sawaya et al., 2010). Birch propolis is found more 
specifically in Russia and is chemically distinct from Poplar propolis (Christov et al., 1999). 
Pacific propolis is characteristically rich in prenylated flavanones (Popova et al., 2010). 
Propolis obtained from the tropical regions mainly contains prenylated p-coumaric acid 
derivatives, flavonoids, benzophenones, lignans and terpenes (Popova et al., 2009). Brazilian 
propolis is a highly valued propolis and has gained tremendous commercial importance due 
to its wide range of health benefits (Salatino et al., 2011). The green and brown Brazilian 
propolis samples are the most common types. Green propolis is rich in prenylated phenyl 
propanoids, triterpenoids, chlorogenic and benzoic acids, whilst the brown propolis contains 
mainly flavonoids and terpenes (Sawaya et al., 2006; Righi et al., 2011). Propolis has 
repeatedly been reported to be rich in flavonoids, in particular, pinocembrin, galangin and 
chrysin (Markham et al., 1996; Melliou and Chinou, 2004; Valencia et al., 2012).  
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Figure 1.4 provides a summary of the most frequently identified compounds present in 
propolis (i.e. pinocembrin, galangin and chrysin), based on studies conducted globally 
(Appendix H). In addition to these aforementioned compounds it can be seen that caffeic 
acid, kaempferol, quercetin, p-coumaric acid, ferulic acid, pinobanksin and apigenin are also 
compounds often reported by other studies as major constituents of propolis. From Figure 1.4 
it can further be seen that pinocembrin and chrysin are the compounds most commonly found 
and reported in propolis. The only factor that may vary is the concentration in which these 
compounds are found. 
 
 
 
Figure 1.4: Compounds most commonly identified in propolis, globally. 
 
 
A study conducted by Maraschin et al. (2012) utilized Fourier transform infrared 
spectroscopy (FTIR) and UV-visible spectroscopies coupled with chemometrics to 
differentiate between samples produced in southern Brazil, a region known to be rich and 
diverse in botany. Poplar propolis has been identified using UV-visible spectrophotometry by 
Popova et al. (2004) and other chromatographic methods such as high-performance liquid 
chromatography (HPLC), thin layer chromatography (TLC) and gas chromatography (GC) 
(Sârbu and Mot, 2011). Bankova et al. (2000), argues that there are some constraints with 
such an analytical approach. Therefore, a need arises for a faster screening method that can 
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characterize propolis by chemical composition from different geographical regions. This led 
scientists to the discovery of a novel and faster method of analysis known as direct insertion 
mass spectrometric fingerprinting technique. This technique has proven to be a robust 
propolis characterization method (Sawaya et al., 2011). Chemometric methods are currently 
being considered in order to analyse the huge data sets resulting from non-selective analytical 
techniques (Maraschin et al., 2012). It is due to this information that this study resolved to 
conduct chemical analysis on SA propolis using HPTLC, UPLC-PDA-qTOF-MS/MS and 
chemometric analysis. 
 
Propolis samples from SA have previously been documented to contain different types of 
phenolic compounds and reported as possibly displaying some similarities with poplar 
propolis found in temperate regions (Kumazawa et al., 2004). However, limited research has 
been conducted on the chemical properties of SA propolis. Studies conducted by du Toit et 
al. (2009), reported on the flavonoids as well as a non-flavonoid caffeic acid phenethyl esters 
(CAPE). Zhang et al. (2014) reported on the chemical profiles of a limited number of 
samples (i.e. five samples) obtained from the KwaZulu-Natal province of SA. Of the five 
samples tested by the study, three samples displayed chemical profiles similar to that of 
temperate region poplar propolis whilst the other two samples were found to be rich in 
diterpene acids, characteristic of propolis originating from the eastern Mediterranean regions. 
Although SA has a very active bee-keeping community, there is a lack of scientific research 
on both the biological properties (i.e. antimicrobial) and chemical composition of locally 
produced propolis from all provinces.  
 
1.6. Combination studies 
Resistance to antimicrobials is a growing concern in the industry of medical health and 
scientists are constantly looking for an alternative means of inhibiting microbial growth as 
well as enhancing the potencies of the current available antimicrobials. The use of propolis in 
combination with other natural products has shown a dramatic increase in popularity (Miguel 
and Antunes, 2011).  Studies have been conducted in specific countries such as China, Brazil, 
Cuba, Bulgaria and Russia introducing propolis as a vaccine adjuvant, demonstrating the 
positive effects of the combined use of propolis with other therapeutic regimens (El Ashry 
and Ahmad, 2012). Propolis has also been reported to display synergism with conventional 
antimicrobials (Fernandes et al., 2005; Orsi et al., 2006; Rahman et al., 2010; Helaly et al., 
2011; Naher et al., 2011; Orsi et al., 2012). Some examples include the combination with 
clarithromycin for the treatment of Helicobacter pylori infections, implicated in the 
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development of peptic ulcers (Nostro et al., 2006) and with gels used for wound healing 
(Berretta et al., 2012) as well as muco-adhesive gels in the treatment of vulvovaginal 
candidiasis (Berretta et al., 2013). Propolis has been proven to enhance the activity of some 
antibiotics against the Staphylococcus species (Rahman et al., 2010).  
 
Propolis has been tested against Salmonella typhimurium in combination with gentamicin and 
ampicillin. The study reported synergism when EEP was combined with ampicillin, whilst 
combinations with gentamicin produced only additive interactions (Al-Safi, 2013). 
Synergistic interactions were also found with gentamicin and amoxicillin against S. aureus 
(de Lima Silva et al., 2015). Wojtyczka et al. (2013a) tested the interactive efficacy of Polish 
EEP samples against a multitude of antibiotics; cefoxitin, clindamycin, tetracycline, 
tobramycin, penicillin, ciprofloxacin and more. Synergistic activity was reported with 
chloramphenicol against S. aureus (Araújo et al., 2015). Speciale et al. (2006), tested 
propolis in combination with beta-lactams, macrolides and fluoroquinolones, however, no 
synergism was reported.  
 
Mantovani et al. (2008) reported synergism between EEP from the south of Brazil and six out 
of the seven antibiotics tested in the study against coagulase-negative Staphylococcus strains. 
These included; cephalotin, netilmicin, clindamycin, vancomycin, oxacillin and tetracycline. 
In a study conducted by Scheller et al. (1999), synergistic interactions were reported between 
EEP and anti-tuberculosis drugs; rifampicin, streptomycin, ethambutol and isoniazid. The 
study argues one antagonistic interaction between EEP and ethambutol, the study reasoned 
that this antagonism may be due to the development of a chemical bond between ethambutol 
and one of the active constituents in propolis. 
 
Studies conducted on Serbian propolis by Stepanović et al. (2003) reported synergism 
between ethanolic extracts of propolis (EEP) and ampicillin, ceftriaxone, doxycycline, 
amikacin, nalidixic acid, trimethoprim/sulfamethoxazole and nystatin. Helaly et al. (2011) 
investigated the interactive efficacies of propolis when combined with polymyxin B, colistin 
sulphate, vancomycin, sulphamethoxazole-trimethoprim, erythromycin, tetracycline, 
chloramphenicol, bacitracin, fusidic acid, ampicillin-sulbactam, amoxicillin-clavulanic acid, 
methicillin, cefaclor, cefoperazone, cefipime, imipenem, ciprofloxacin, ofloxacin, 
levofloxacin, gentamicin, neomycin and tobramycin. The study reported synergistic effects 
for most of the antibiotics tested against S. aureus and the organism which was resistant to 
fluoroquinolones, cephalosporins and imipenem became sensitive to these antibiotics in the 
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presence of EEP compared to when these antibiotics were tested alone. Naher et al. (2011) 
tested the interactive efficacy of propolis originating from Iraq and established that the 
following combinations displayed synergy; propolis with amoxicillin displayed synergy 
against P. aeruginosa, H. pylori, E. coli and Klebsiella pneumoniae; clindamycin with 
propolis displayed synergy against P. aeruginosa, H. pylori, K. pneumoniae, and 
Enterococcus aerogenes; rifampicin with propolis displayed synergy against P. aeruginosa, 
E. coli, K. pneumoniae, S. pyogenes, and E. aerogenes; and nystatin with propolis was 
reported to display additive activity against C. albicans. Stepanović et al. (2003) investigated 
the synergism of ethanolic extracts of propolis (EEP) with the antibiotics ampicillin, 
ceftriaxone, doxycycline, amikacin, nalidixic acid, trimethoprim/sulfamethoxazole and 
nystatin against S. aureus, K. pneumoniae and C. albicans.  
 
In vivo studies conducted by Onlen et al. (2007), evaluated the effects of antibacterial 
combinations of propolis and ciprofloxacin tested in rabbits for the treatment of P. 
aeruginosa keratitis. Using 3% propolis drops, instilled into both eyes of the infected rabbits, 
did not cause a noteworthy or desirable effect, however, when combined with various 
concentrations of ciprofloxacin the study yielded synergistic results. A similar study 
conducted by Oksuz et al. (2005) also tested the interactive efficacy of ciprofloxacin and EEP 
on rabbits infected with S. aureus keratitis. A bacterial count was conducted on the corneas of 
treated rabbits. The study reported lower levels of bacteria in the eyes of rabbits treated with 
ciprofloxacin and propolis than those treated with ciprofloxacin or propolis independently, 
thereby suggesting synergism between ciprofloxacin and propolis. Sforcin and Bankova 
(2011) postulated that propolis may hold the potential for novel drug developments, as in 
vitro studies pave the way to the understanding of the mechanism of action of propolis. 
 
A clinical study conducted by Adewumi and Ogunjinmi (2011) in Nigeria, combined propolis 
with another natural product of the hive, honey. The honey and propolis were combined in a 
lotion and applied to the septic wounds of 50 patients, three times a day. The study reported 
that 60% of wounds were completely healed by the end on the 10
th
 day and the remaining 
40% completely healed by the end of the 15
th
 day, all wounds were reported to have healed 
without any remnants of scars or blisters. Propolis has been reported to be combined in other 
formulations such as toothpastes (Groppo et al., 2008; Palombo, 2011; Skaba et al., 2013) 
and in collagen-based dressings used in the treatment of burns (de Almeida et al., 2013). 
The activity of 10% w/v propolis in combination with fennel honey was tested against 
various strains of Staphylococcus sp. implicated in bovine mastitis. The study reported that 
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although all pathogens displayed antimicrobial sensitivity to the samples of honey tested 
individually, the combination of 10% propolis and fennel honey displayed the best 
synergistic interactive efficacy with MICs and MBCs of 13.96% and 28.26% v/v, 
respectively. The study further concluded that the incorporation of propolis into the tested 
honey patch would potentiate the antimicrobial activity of the honey (Aamer et al., 2015). 
Furthermore, in dentistry, Pimenta et al. (2015) tested the interactive efficacy of brown 
Brazilian propolis at a concentration of 20% with calcium hydroxide in the treatment of oral 
E. faecalis infections. The study reported good interactive efficacy with a percentage 
inhibition of 41% compared to 21% inhibition when calcium hydroxide was used alone. Al-
Waili et al. (2012) reported a synergistic interaction between honey and propolis against 
multi-drug resistant S. aureus, E. coli and C. albicans. In spite of the number of studies 
conducted on propolis in various combinations, studies on SA propolis, in particular, in 
combination with antimicrobials and other natural products such as honey have been 
neglected. 
 
1.7. Aim and objectives 
The overall aim of this study was to investigate the antimicrobial efficacy and chemical 
composition of SA propolis by undertaking the following objectives; 
 Source and prepare propolis extracts using absolute ethanol as the solvent of choice.  
 Determine the antimicrobial activity of the varied propolis samples (n=42) using the 
micro-titre plate serial dilution minimum inhibitory concentration (MIC) method against 
relevant pathogens. 
 Determine the minimum bactericidal concentration (MBC) using Tryptone Soya agar 
(TSA). 
 Determine the chemical composition and structure activity relationship of propolis using 
high performance thin layer chromatography (HPTLC) and Ultra-performance liquid 
chromatography coupled to photodiode array detector-quadrupole/time-of flight mass 
spectrometry (UPLC-PDA-qTOF-MS/MS). 
 Investigate antimicrobial interactions of propolis with ciprofloxacin, gentamicin, nystatin, 
amphotericin B and honey by determination of the fractional inhibitory concentration 
index (ΣFIC) of 1:1 combinations.  
 Correlate chemical composition with geographical variance and the observed 
antimicrobial activity of propolis using chemometric analysis.  
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Chapter 2: South African propolis: Chemical profiles 
and chemometric analysis 
 
2.1. Introduction 
The progress of chemical studies conducted on propolis samples from SA thus far, has been 
outlined in Chapter 1, Section 1.5.Only three studies were found to discuss the composition 
of SA propolis. Two focused on chemical composition, however, the number of samples 
tested from such a diverse country with diverse flora was limited, with the majority number 
of samples being five; of which all five were collected from the same province in SA 
(Kumazawa et al., 2004; Zhang et al., 2014). The third study conducted by du Toit et al., 
(2009) focused mainly on the anti-inflammatory properties of SA propolis rather than its 
chemical composition. 
 
The objective of this Chapter was to develop fingerprinting and metabolite profiles of 39 SA 
propolis samples obtained from the different provinces of SA using high performance thin 
layer chromatography (HPTLC), ultra-performance liquid chromatography-photodiode array 
detector-quadrupole-time-of-flight mass spectrometry (UPLC-PDA-qTOF-MS). 
Chemometric modelling was also used in order to observe possible chemo-geographical 
patterns. 
 
2.2. Materials and methods 
2.2.1. Sourcing of propolis samples 
Propolis samples (n=42) were sourced from different provinces of SA in collaboration with 
the SA Bee Industry Organisation (SABIO). Of these samples, 39 (i.e. samples 4-42) were 
from SA and three control samples (i.e. samples 1-3) from Brazil. Brazilian samples were 
included for comparative purposes as they are generally considered superior in activity due to 
the junction of two factors; genetics of Brazilian bees with the diversity of the regional flora. 
Samples were kept in a freezer at -4°C to ensure ease of working due to the nature of propolis 
becoming sticky and difficult to work with when warm. Table 2.1 lists samples used for 
chemical characterization, with their corresponding locations and extract yields. Figure 2.1 
serves as an illustration of the specific sample locations across the various provinces of SA. 
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Table 2.1: Propolis samples: extract yields and localities. 
No. Location CODE 
Weight of 
sample used (g) 
Weight of 
extract (g) 
% yield 
1 Orange River NC1 11 1.84 16.76 
2 Northern Pretoria GP1 17.3 2.72 15.75 
3 North West NW1 15.7 2.49 15.87 
4 Christiana- North West NW2 16.7 5.85 35.01 
5 Christiana- North West NW3 17.4 5.66 32.56 
6 Outeniqua Mountains, Oudtshoorn WC1 5.7 2.57 45.12 
7 Brazil BR1 21.2 5.99 28.24 
8 Brazil BR2 17.8 7.19 40.39 
9 Walkerville (Vereeniging) GP2 9.2 3.76 40.87 
10 Springs GP3 10 3.70 37.00 
11 Johannesburg  GP5 10 5.95 59.50 
12 Johannesburg  GP6 9 4.45 49.44 
13 Johannesburg GP7 9 5.26 58.44 
14 Lakeside/Westlake GP8 21 5.68 27.05 
15 Northern Cape NC2 10 3.70 37.00 
16 Western Cape WC2 7 5.21 74.43 
17 Somerset West WC3 13 5.12 39.38 
18 Botrivier WC4 12 6.19 51.58 
19 Graafwater WC5 7 2.02 28.86 
20 Brazil BR3 10 4.65 46.50 
21 Douglas- Northern Cape NC3 6 2.35 39.17 
22 Bloemfontein FS1 18 10.02 55.67 
23 Honeydew GP9 12 6.13 51.08 
24 Edenvale GP10 9.3 5.25 56.45 
25 Edenvale GP11 4.8 3.42 71.25 
26 Baviaanskloof – PE EC1 6.7 1.12 16.72 
27 Pretoria GP12 7.3 2.71 37.12 
28 Pretoria GP13 7.3 3.42 46.85 
29 Beaufort West WC6 14.1 2.5 17.73 
30 Lydiana Gardens- Pretoria GP14 8.8 2.92 33.18 
31 Lydiana Gardens- Pretoria GP15 14.4 4.37 30.35 
32 Northern Cape NC4 5.5 1.08 19.64 
33 Western Cape WC7 3.3 0.24 7.27 
34 KwaZulu-Natal KZN1 3.8 1.07 28.16 
35 Southern Suburbs - Cape Town WC8 7.3 2.22 30.41 
36 Southern Suburbs - Cape Town WC9 4.1 1.97 48.05 
37 Southern Suburbs - Cape Town WC10 7.9 3.38 42.78 
38 Wilgerivier – Bronkhorstspruit GP16 7.6 2.05 27.01 
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No. Location CODE 
Weight of 
sample used (g) 
Weight of 
extract (g) 
% yield 
39 Beaulieu – Midrand GP17 12.1 4.02 33.31 
40 President Park – Midrand GP18 12.0 5.94 49.67 
41 Devon - Sedibeng area (Gauteng) GP19 4.2 1.47 35.08 
42 Mooinooi - North West NW4 7.3 3.05 41.67 
GP=Gauteng; NW=North West; WC=Western Cape; NC=Northern Cape; EC=Eastern Cape; KZN=KwaZulu-
Natal; FS= Free State; BR = Brazil 
 
 
Figure 2.1: Geographical locations of propolis samples used in this study. 
 
 
2.2.2. Preparation of extracts for chemical studies 
Preliminary studies were conducted using various solvents in order to investigate which 
solvent system extracted the most compounds out of samples. It was proven that 80% 
aqueous ethanol effectively extracted compounds and produced the best HPTLC plate with 
clear separation of compounds, unlike other solvents tested that led to the “bleeding” or 
rather “merging” of compounds. Therefore, a 100 mg of each sample was submerged in 10 
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ml of 80% aqueous ethanol and placed in an orbital shaker incubator for a period of 24 hours 
at 27°C.  After 24 hours the final suspension was filtered through a 0.22-μm Clarinert™ 
syringe filter for chemical profiling. The standards were prepared in ethanol. 
2.2.3. HPTLC fingerprinting and profiling 
HPTLC analysis of SA propolis samples and Brazilian control samples was carried out using 
the CAMAG semi-automated HPTLC instrument, which consisted of an automatic sampler 4 
(connected to a nitrogen tank), an automatic developing chamber (ADC2), a chromatogram 
immersion device and a documentation device Reprostar 3 all of which utilize winCATS 
version 1.4.4.6337 planar chromatography manager software (Figure 2.2).  HPTLC pre-
coated silica gel 60F254 (MERCK, Germany) glass plates were used for the HPTLC analysis. 
By means of a 25 μl Hamilton micro-syringe in the automatic TLC sampler 4.A volume of 5 
μl (0.05 mg/µl) of each propolis extract was applied onto the plates as an 8 mm band, 5 mm 
from the bottom edge of the plate.  
The separation was then carried out by using a solvent system of chloroform: methanol: 
formic acid (38: 2.8: 2; v/v). The chromatogram was developed in a glass twin-trough 
chamber in ADC2 which was automatically saturated with the prepared mobile phase vapour 
for 20 minutes. The ascending development was carried up to a distance of 70 mm. Once 
developed, the plate was dried using a dryer and resulting images were captured under 
ultraviolet (UV) light at 254 and 365 nm. Hereafter derivatization was carried out with 
natural product reagent (1% methanolic diphenylboric acid-β-ethyl amino ester: 5% ethanolic 
polyethylene glycol - 9000) and 85 ml methanol, 10ml glacial acetic acid, 5ml of 
concentrated sulphuric acid added very slowly and 0.5 ml of anisaldehyde. The HPTLC plate 
was placed in a dipping tank in the aforementioned solution and ascending development was 
carried up to a distance of 70 mm as done previously.  This was done in order to permanently 
stain the plate, capture chromatographic fingerprinting profiles and record their profiles.  
The retention factor (Rf) was calculated as follows:  
 
Rf = 
distance travelled by sample 
distance to solvent front  
 
 
Hereafter, plates were further analyzed, dominant bands were identified and new HPTLC 
plates were prepared containing each of the chosen SA propolis samples and Brazilian 
control samples. All SA samples displayed the same dominant band and all Brazilian controls 
displayed the same dominant band (Figure 2.3). 
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Figure 2.2: HPTLC process using A: automatic TLC sampler 4; B: Automatic developing 
chamber 2 and; C: Reprostar 3 documentation system (Camag). 
 
 
Figure 2.3: a- HPTLC plate at 254 nm indicating dominant bands in all SA samples and 
Brazilian control samples; b- HPTLC plates at 366 nm indicating dominant bands in all SA 
samples and Brazilian control samples. 
A B C 
Brazilian samples South African samples 
South African samples 
a 
b 
Brazilian samples 
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A volume of 3 μl (0.03 mg/µl) of the chosen propolis extract was applied onto the plates in 
the same manner as elaborated previously. Separation was carried out using the same solvent 
system of chloroform: methanol: formic acid (38: 2.8: 2; v/v). However, no derivatization of 
plates was done. Four pre-coated silica gel 60F254 (MERCK, Germany) glass plates were 
prepared for each of the samples, dominant bands were then carefully scratched off, placed 
into sample bottles and 3 ml of HPLC grade methanol was added. These samples were then 
used for UPLC-PDA-qTOF-MS analysis in order to identify these prominent compounds.  
 
2.2.4. UPLC-PDA-qTOF-MS chemical profiling 
Ultra-performance liquid chromatography-photodiode array detector-quadrupole-time-of-
flight mass spectrometry (UPLC-PDA-qTOF-MS) for chemical profiling analysis of SA and 
Brazilian propolis samples was performed using a Waters ACQUITY™ UPLC™ system 
obtained from Waters Corp., Milford, MA, USA. The UPLC system was equipped with a 
PDA detector and quadrupole-TOF mass spectrometer. A volume of 1 µl (0.01 mg/µl) of 
each sample was injected into the system, and separation was then achieved on a BEH C18 
(2.1 x 150 mm, 1.7 µm) column. The binary mobile phase contained 0.1% formic acid in 
water (phase A) and acetonitrile (phase B) (phase A and B were obtained from ROMIL-
SpS™, Cambridge, United Kingdom).  
 
The following gradient programme was used; 
 10 to 40% of phase B within 2.5 minutes 
 40 to 45% of phase B for the next 8.5 min 
 45 to 80% of phase B over a further 0.5 min, then returned to the initial conditions (10 
to 40% of phase B) and conditioning at 10% B over 1 min, finished at 14 min.  
 
The flow rate was set at 0.45 ml/min and the temperature of the column was kept constant, at 
35°C. The UV spectrum of each sample was recorded within range of 200 to 400 nm using 
the PDA detector. The acquisition of mass spectra was performed at negative mode by 
electrospray ionisation (ESI). The conditions for the ESI source were; a capillary voltage of 
34.0 kV; sampling cone at 40 V; source temperature set at 100°C; and desolvation 
temperature set at 500°C. Nitrogen was used as a desolvation gas at a flow rate of 600 L/h. 
The prominent ions were further selected for MS/MS fragmentation analysis, in which the 
collision energy was ramped from 6 to 40 V. MassLynx software version 4.0 (Waters) was 
used for instrument control and data acquisition (i.e. chemical profiling).  
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2.2.5. Chemometric analysis 
The UPLC-ESI-MS data of all samples was analysed using chemometric methods. The 
chromatograms were first pre-processed using the MarkerLynx 4.1 system in which Apex 
Track
TM 
detected the chromatographic peaks and assigned retention times accordingly across 
the entire data set attained. The ions which were associated with these peaks were identified, 
and their corresponding ion intensities, retention times and masses (m/z) were then captured 
and aligned accordingly (Stumpf and Goshawk, 2004). This aligned data was then further 
assembled in a single matrix, imported into SIMCA-P+ 12.0 and analysed firstly using 
principal component analysis (PCA). This is a mathematical algorithm that reduces 
multidimensional data, to a co-ordinate system which then allows for a graphical 
interpretation of the data. The spatial distribution of the samples can also be observed on a 
score plot where samples with a similar chemical nature will then cluster close together and 
dissimilar samples will fall further apart. Secondly, classification and discriminant analysis of 
these propolis samples was performed using orthogonal projections to latent structure-
discriminant analysis (OPLS-DA). A loadings plot was used in order to describe the 
relationships amongst the measured variables. Those samples furthest from the origin of the 
plot were then regarded as the highest contributors to variance within the chemical space.  
 
2.3. Results 
2.3.1. HPTLC fingerprinting of South African propolis 
In this study, a novel HPTLC chromatographic fingerprinting method was developed for the 
characterization and authenticity of SA propolis samples in comparison to the control 
Brazilian propolis samples, this study (Appendix A) is the first to report on this fingerprinting 
technique unused by other studies (Kasote et al., 2014a). Figures 2.4a and 2.4b show the 
HPTLC fingerprinting images of 39 SA propolis samples under the wavelengths 254 and 366 
nm before derivatization with a natural product reagent in comparison to the three control 
Brazilian propolis samples. These HPTLC fingerprinting profiles of SA propolis samples 
were notably different from the three control Brazilian propolis samples. Most of the SA 
samples displayed distinctive greenish yellow florescent bands under a wavelength of 366 nm 
(Figure 2.4b).This may be attributed to the presence of flavonoids and phenolic acids.  
 
Figures 2.4c and 2.4d show images of SA samples in comparison tithe control Brazilian 
propolis samples under wavelengths 254 and 366 nm after derivatization with a natural 
product reagent. Primarily, all propolis samples look alike and no distinct chemical difference 
may be seen between Brazilian and SA propolis. However, with further investigation and 
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after derivatization of HPTLC plates with a natural product reagent some clear distinctions 
may be seen at this point. Moreover, some chemical variations were apparent within SA 
samples themselves (Figure 2.4a, b, c and d.). Most SA propolis samples tested displayed 
distinctive greenish-yellow florescent bands under wavelength 366 nm before as well as after 
derivatization with the natural product reagent (Figures 2.4c and 2.4d).This may possibly 
confirm the presence of chemical compounds such as flavonoids and phenolic acids as 
observed in other studies (Appendix H). 
 
2.3.2. UPLC-PDA-qTOF-MS chemical profiling 
Preparative UPLC-PDA-qTOF-MS/MS analysis in negative mode was used to identify and 
confirm the phenolic and flavonoid compounds from SA propolis samples seen in HPTLC. 
UPLC-ESI-MS Total ion chromatogram (TIC) of representative SA propolis samples in 
comparison with Brazilian propolis is shown in Figure 2.5. From this chromatographic 
fingerprint it can be seen that the SA propolis sample was different in comparison to the 
control Brazilian propolis samples. Both the HPTLC and UPLC-ESI-MS chromatographic 
fingerprints therefore confirmed that SA propolis is different from Brazilian propolis.  
 
The identification of these compounds was done by matching their retention times (Rt), 
maximum UV absorptions, pseudomolecular ion mass values and MS/MS fragmentation 
patterns with authentic compounds, confirmed from a standard when available or confirmed 
with data previously reported in literature. Fifteen phenolic and flavonoid compounds, 
reported in Table 2.2, were identified in the SA propolis samples. Figure 2.6 is a UPLC-ESI-
MS total ion chromatogram (TIC) of SA propolis displaying the peak numbers of compounds 
as reported Table 2.2. Peak 8 had a UVmax of 288 nm and was found to be the compound 
most prominent in SA propolis and was identified by the study as being the marker 
compound for SA propolis samples tested. Peak 8 was identified as pinocembrin (Pellati et 
al., 2011).  
 
Furthermore, this analysis of SA propolis samples resulted in the identification of six new 
additional compounds unidentified in SA propolis. These included quercetin, galangin-5-
methyl ether, pinobanksin-3-O-propionate, pinobanksin-3-O-butyrate or isobutyrate, 
pinobankin-3-O-pentanoate or 2-methylbutyrate and pinobanksin-3-O-hexanoate (Figure 
2.7). Among the compounds identified, pinocembrin was found to be the major constituent in 
the SA propolis samples. In addition, artepillin C and cinnamyl acetate were identified as the 
marker compounds for the Brazilian propolis samples.  
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Figure 2.4: a-HPTLC plates at 254 nm before derivatization (samples 1-3 = Brazilian; samples 4-42 = SA); b- HPTLC plates at 366 nm before 
derivatization (samples 1-3 = Brazilian; samples 4-42 = SA). 
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Figure 2.4: c- HPTLC plates of samples 1-21 after derivatization (samples 1-3 = Brazilian; samples 4-42 = SA) with natural product reagent at 254; d-
HPTLC plates of samples 22-42 after derivatization (samples 1-3 = Brazilian; samples 4-42 = SA) with natural product reagent at 366 nm.
c c 
d d 
Rf 
Rf 
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7
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Figure 2.5: UPLC-ESI-MS total ion chromatogram (TIC) of one SA propolis sample in comparison with one control Brazilian propolis sample.
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Figure 2.6: UPLC-ESI-MS total ion chromatogram (TIC) of SA propolis displaying the peak 
numbers of compounds. 
 
 
Table 2.2: Identification of phenolic and flavonoid compounds from SA propolis by UPLC-
PDA-qTOF-MS/MS. 
Peak 
No. 
Rt 
(min) 
UVmax 
Pseudomolecular 
ion [M-H]
-  
(m/z) 
MS/MS 
fragmentation 
of [M-H]- 
Fragment 
Identification 
Compound 
1 1.91 
238,285,
291,308 
179 177, (133) 
[M-H-2H]
-
,[M-H-
2H-CO2]
-
 
Caffeic acid
a
 
2 2.29 
229,262,
277,306 
163 163, (117) 
[M-H]
-
,[M-H-H2O-
CO]
-
 
p-Coumaric acid
a
 
3 3.26 291 301 -301 [M-H]
-
 Quercitin
a
 
4 3.43 284 285 
283,265,(250),
237 
[M-H-2H]
-
,[M-H-
2H-H2O]
-
, [M-H-
2H-H2O-CH3]
-
, [M-
H-2H-H2O-CO]
-
 
Pinobanksin-5-
methyl ether
b
 
5 3.86 289 271 (269),251,223, [M-H-2H]
-
,[M-H- Pinobanksin
b
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Peak 
No. 
Rt 
(min) 
UVmax 
Pseudomolecular 
ion [M-H]
-  
(m/z) 
MS/MS 
fragmentation 
of [M-H]- 
Fragment 
Identification 
Compound 
195,149, 105 2H-H2O]
-
, [M-H-
2H-H2O-CO]
-
,[M-
H-2H-H2O-2CO]
-
, 
[
1,3
A-2H], [
1,3
A-2H-
CO2] 
6 4.53 259,350 283 
281,266,(237),
209 
[M-H-2H]
-
,[M-H-
2H-CH3]
-
, [M-H-
2H-CO2]
-
, [M-H-
2H-CO2-CO]
-
 
Galangin-5-
methyl ether
b
 
7 5.92 266, 313 253 
(251),207,179,
149,105 
[M-H-2H]
-
,[M-H-
2H-CO2]
-
, [M-H-
2H-CO2-CO]
-
, 
[
1,3
A-2H], [
1,3
A-2H-
CO2] 
Chrysin
b
 
8 6.27 288 255 
(253),211,185,
169,149,105 
[M-H-2H]
-
,[M-H-
2H-C2H2O]
-
, [M-H-
2H-C3O3]
-
, [M-H-
2H-2C2H2O]
-
, [
1,3
A-
2H], [
1,3
A-2H-CO2] 
Pinocembrin
b
 
9 6.44 264,357 269 
(267),211,195, 
167 
[M-H-2H]
-
,[M-H-
2H-2CO]
-
, [M-H-
2H-CO-CO2]
-
, [M-
H-2H-2CO-CO2]
-
 
Galangin
b
 
10 6.72 291 313 313,269,(251) 
[M-H-2H]
-
,[M-H-
2H- acetate]
-
, [M-
H-2H-acetate-H2O]
-
 
Pinobanksin-3-
O-acetate
b
 
11 7.32 264 283 
281,266,(237),
209 
[M-H-2H]
-
,[M-H-
2H-CH3]
-
, [M-H-
2H-CO2]
-
, [M-H-
2H-CO2-CO]
-
 
Tectochrysin
b
 
12 9.37 291 327 325,269,(251) 
[M-H-2H]
-
,[M-H-
2H- propionate]
-
, 
[M-H-2H- 
propionate -H2O]
-
 
Pinobanksin-3-
O-propionate
b
 
13 12.42 291 341 339,269,(251) 
[M-H-2H]
-
,[M-H-
2H- 
butyrate/isobutyrate
]
-
, [M-H-2H-
butyrate/isobutyrate 
-H2O]
-
 
Pinobanksin-3-
O-butyrate or 
isobutyrate
b
 
14 13.07 290 355 251 
[M-H-2H-
pentanoate/2-
methylbutyrate-
Pinobankin-3-O-
pentanoate or 2-
methylbutyrate
b
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Peak 
No. 
Rt 
(min) 
UVmax 
Pseudomolecular 
ion [M-H]
-  
(m/z) 
MS/MS 
fragmentation 
of [M-H]- 
Fragment 
Identification 
Compound 
H2O]
-
 
15 13.42 290 369 269,(251) 
[M-H-2H- 
hexanate]
-
, [M-H-
2H- hexanoate -
H2O]
-
 
Pinobanksin-3-
O-hexanoate
b
 
a 
Confirmed from standard.
b 
Confirmed from literature (Pellati et al., 2011; Falcão et al., 2013) 
 
 
 
Figure 2.7: Structures of identified phenolic and flavonoid compounds from SA propolis. 
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Pinobanksin-3-O-pentanoate - R1 = OH, R2 = 
OCOC4H9 
Pinobanksin-3-O-hexanoate - R1 = OH, R2 = 
OCOC5H11 
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2.3.3. Chemometric analysis of UPLC-ESI-MS data of propolis samples 
Chemometric studies were undertaken in order to investigate the possibilities of regional 
variations among SA propolis samples. Figure 2.8a shows a scatter plot of PCA scores for the 
42 (39 SA and three Brazilian controls) propolis samples. These plots were constructed using 
UPLC-ESI-MS data which was pre-treated with MarkerLynx. The PCA plot displayed three 
distinct clusters with the Brazilian samples (red cluster) falling outside the Hotelling’s T2 
(95% CI) in the 2nd quadrant. Few samples from both the Gauteng (GP) and Western Cape 
(WC) provinces of SA occupy a separate cluster in the first quadrant (green cluster).These are 
separated from the majority of SA samples which lie within the blue cluster. Samples present 
in the green cluster demonstrated a chemical variation which resulted in the spatial 
distribution of these samples within the first quadrant. The majority of SA propolis samples 
(i.e. blue cluster) exhibit similar chemical profiles, and they are therefore seen to be tightly 
clustered. The chemical variation within the dataset which was responsible for the formation 
of these three clusters along PC1 and PC2 was estimated to be 49% (R2Xcum (PC1+2)). Figure 
2.8b, a corresponding dendrogram shows the three distinct clusters identified with the green 
cluster showing more variation as compared to the blue cluster. 
 
 
Figure 2.8: A PCA score scatter plot (a) showing separation of propolis extracts into three 
clusters and (b) the corresponding dendrogram showing the linkages of the three clusters. 
 
 
  
a b 
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Assigning of classes to the three clusters in Figure 2.8a, allowed for the construction of an 
OPLS-DA model. Figure 2.9a is an OPLS-DA scores plot, this plot demonstrates a similar 
pattern of chemical variability as seen in the PCA plot however, tighter clustering of the 
propolis samples can be seen. The chemical variation observed within the propolis samples 
related to the differentiation of the clusters (predictive) was estimated at 31% (R2X = 0.31). 
An orthogonal variation of 16% is what separated the Brazilian propolis from both SA 
propolis clusters along PC2, this resulted in the red cluster falling outside of the Hotelling’s 
T
2
 in the 4
th
 quadrant. This observation demonstrated and confirmed what was seen during 
HPTLC analysis, UPLC-PDA-qTOF-MS analysis as well as on the UPLC-ESI-MS TIC 
(Figure 2.5), that is that SA propolis is chemically distinct from Brazilian propolis. The SA 
propolis samples tested also displayed variable chemical profiles, which resulted in two 
chemotypes being identified in OPLS-DA. The possibility of the presence of more than two 
chemotypes in the SA propolis cannot be ignored, as PCA demonstrated in this study that 
some chemical differences between propolis samples in the green cluster is apparent.  
In order to further investigate the chemical differences between the three clusters, a loadings 
scatter plot (Figure 2.9b) of the X-variables was constructed. This loadings plot displays the 
relationship between variables and aims to correlate X-variables to patterns that were 
observed in the scores plot. Based on the position of the observation in question on the scores 
plot, the X-variables, in a similar position to these, in the loadings plot can be reported to be 
noteworthyly influential in distinguishing or identifying these observations. Figure 2.9 shows 
the variables that may be used as markers to differentiate the propolis chemotypes.  
 
Figure 2.10 is an illustration of the LC-MS chromatographs representing each of the three 
clusters (chemotypes) seen in the PCA and OPLS-DA graphs. In Figure 2.10 each major peak 
represents a compound that is eluted at that specific retention time and their corresponding 
abundance; these compounds are reported in Table 2.3. Figure 2.10a shows specifically that 
the compound displaying a retention time of 12.64 minutes occurs more abundantly in 
Brazilian propolis than in the SA propolis samples. The green cluster in Figure 2.10a is 
characterised by high levels of compounds found at 10.96, 12.18 and 13.55 minutes 
respectively (Figure 2.10b). However, the majority of the SA samples found in the blue 
cluster, hereby referred to as common SA propolis, showed a more consistent profile which 
was characterised by compounds eluting at 3.89, 5.86, 6.19, 6.38, 12.37 and 13.41 minutes 
(Figure 2.10c).  
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Figure 2.9: An OPLS-DA score scatter plot (a) showing separation of propolis extracts into 
three clusters and the corresponding loadings scatter plot showing the X-variables that are 
correlated to the three clusters (b) are shown.  
 
 
Figure 2.10: LC-MS fingerprint chromatograms representing each of the three chemotypes. 
a)red cluster, b) blue cluster and c) green clusters. 
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Table 2.3 shows the marker compounds identified within the three identified clusters, these 
compounds were identified using chemometric methods and available literature in order to 
confirm the identities of the molecules. On inspection of the UPLC-ESI-MS chromatograms 
of three representative samples from the three clusters clear differences in the chemical 
profiles were observed (Figure 2.10). Ultimately, the chemical profiling of propolis samples 
has demonstrated clear chemical differences between Brazilian propolis and SA propolis.  
 
 
Table 2.3: List of marker compounds identified for the three propolis clusters. 
Cluster Retention time(Rt) m/z ratio Compound 
Red cluster 12.64 299 Artepillin C
b
 
Green cluster 10.96 317 Myricetin
b
 
12.18 325 n.i. 
13.55 371 Pentamethoxyflavone
b
 
Blue cluster 3.89 271 Pinobanksin
b
 
 5.86 253 Chrysin
b
 
 6.19 255 Pinocembrin
b
 
 6.38 269 Galangin
b
 
 12.37 341 Pinobanksin-3-O-butyrate or isobutyrate
b
 
 13.41 369 Pinobanksin-3-O-hexanoate
b
 
n.i.: not identified.
b 
Confirmed from literature (Hegazi and Abd El Hady, 2002; Gardana et al., 2007; Pellati et 
al., 2011; Falcão et al., 2013). 
 
 
2.4. Discussion  
Chromatographic fingerprinting techniques such as HPTLC have been established as very 
promising tools for the standardization of crude drugs, particularly when authentic standards 
or marker compounds are not available for comparison. HPTLC is a rapid, sensitive, 
reproducible and low cost fingerprinting technique (Chen et al., 2006). UPLC-PDA-qTOF-
MS is a powerful tool that has increasingly been used in the fingerprinting and chemical 
profiling of herbal drugs due to its sensitivity, resolution and throughput capacity (Grata et 
al., 2008; Li et al., 2010). This technique provides accurate MS data and UV spectra for the 
identification of unknown compounds (Li et al., 2010). Mass spectroscopic analysis in 
negative mode was found to be the most sensitive in the determination of flavonoid structures 
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(Cuyckens and Claeys, 2004). Hence, UPLC-PDA-qTOF-MS/MS in negative mode was used 
to identify phenolic and flavonoid compounds from SA propolis samples. 
 
The chemical composition of propolis is known to be extremely complex with a vast number 
of constituents having already been identified (Appendix H). Amongst the constituents found 
in propolis phenolic compounds (mostly flavonoids) are reported as constituting over 50% of 
the total weight of any propolis sample (Bankova et al., 1996). An earlier study conducted by 
Kumazawa et al. (2004) also reported the presence of pinobanksin, pinobanksin 5-methyl 
ether, chrysin, pinocembrin, galangin and pinobanksin-3-O-acetate in a SA propolis sample 
tested by the study, however, the presence of quercetin was not reported by Kumazawa et al. 
(2004). As mentioned in Chapter 1, Section 1.5, Zhang et al. (2014) reported on a limited 
number of SA propolis samples obtained from one region of SA, namely KwaZulu-Natal. The 
study concluded that a majority of SA samples tested displayed chemical profiles similar to 
temperate region poplar propolis. The overall chemical pattern observed in this study was in 
alignment with reports by Zhang et al. (2014) and led to the conclusion that the majority of 
SA propolis samples tested in this study displayed a similar profile to that of the common 
temperate poplar (i.e. European) propolis samples.  
 
Chemometric analysis was conducted in order to further analyse and confirm the distinct 
chemical difference between SA propolis and the Brazilian controls. Chemometric modelling 
led to the construction of a PCA plot that displayed 74% of SA samples as having similar 
chemical profiles and hence were seen as a tight blue cluster, whilst the Brazilian controls 
were observed as completely separated as a red cluster in Figure 2.8a. The construction of an 
OPLS-DA model led to a similar pattern as seen in the PCA graph in Figure 2.6a. The 
advantage of an OPLS-DA plot is that it allows for the variation which is identified in a PCA 
to be analysed separately as these correlate to the classes (predictive) and orthogonal variation 
which could be due to other environmental factors. The LC-MS chromatogram (Figure 2.10) 
provided for another chemical distinction to be made between SA propolis and the Brazilian 
control samples, thereby confirming patterns seen in both HPTLC and chemometric analysis. 
From Figure 2.10, SA propolis (Figure 2.10b and c) is once again seen as chemically distinct 
from Brazilian propolis (Figure 2.10a) which contained an abundant amount of artepillin C 
(higher peak seen at retention time 12.64 with an abundance of > 30 000), whilst SA propolis 
was found to contain greater amounts of two compounds in addition to other compounds 
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reported in Table 2.3, namely pinocembrin and galangin (higher peaks seen at retention times 
of 6.19 and 6.38, respectively with an abundance of >50 000). 
 
In Chapter 1, Figure 1.4 provided a brief summary of the data tabulated in Appendix H, by 
highlighting the specific compounds that have been frequently reported in literature reviewed 
in this study. In alignment with these previous studies and Figure 1.4, this study established 
findings of the presence of pinobanksin, quercetin, chrysin, galangin, caffeic acid, p-coumaric 
acid and pinocembrin. Furthermore, this study found that these compounds with the exception 
of p-coumaric acid, caffeic acid and quercetin have not been reported in Brazilian propolis to 
date. In this study the major compound found in the Brazilian comparator samples was 
artepillin C, also found by other studies (de Paula et al., 2009; de Aguiar et al., 2013). 
 
2.5. Conclusion  
This study is the first comprehensive report on the chemical profiling of SA propolis from 
various regions using HPTLC, UPLC-PDA-qTOF-MS/MS and chemometric analysis. This 
approach confirmed that the majority of SA propolis samples are characteristically rich in 
phenolic acids and flavonoids, and these chemical profiles are highly consistent with propolis 
produced in the temperate regions of the world. UPLC-PDA-qTOF-MS/MS analysis studies 
of the 39 SA propolis samples led to the identification of six novel compounds never 
previously identified in SA propolis. The use of chemometric algorithms has revealed a clear 
distinction between SA propolis and Brazilian propolis. Variations in the chemical profiles of 
SA propolis were also observed resulting in two clear clusters each representing a different 
chemotype. An uncommon type of propolis observed in Gauteng and the Western Cape 
provinces, which exhibited distinct chemical profiles from propolis produced in the temperate 
and tropical regions, could be a characteristic and unique chemotype from SA. Findings of 
this study will contribute to the future chemical characterisation of SA propolis and will assist 
in the development of quality control standards for raw and finished products containing 
propolis. 
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Chapter 3: Antimicrobial efficacy and chemometric 
modelling of SA propolis. 
 
3.1. Introduction 
Globally, research has been dedicated to studying the antimicrobial properties of propolis 
from various geographical and climatic regions (Appendix G). However, as mentioned in 
Chapter 1, Section 1.4; from a SA perspective, the antimicrobial investigation of propolis has 
been neglected. Considering that SA plants has previously been reported as demonstrating 
promising anti-infective properties (van Vuuren, 2008), the probability that propolis derived 
from SA flora could potentially be an effective antimicrobial is high. Therefore, an in-depth 
antimicrobial investigation of propolis from all geographical areas within SA warranted 
attention. 
The objective of this chapter was to investigate the antimicrobial properties of 39 SA propolis 
samples obtained from different provinces of SA using the minimum inhibitory concentration 
assay and the minimum bactericidal concentration assay and compare activity to Brazilian 
control samples. Hereafter, the interactive efficacy of the ten most active SA propolis samples 
with conventional antimicrobials and an antimicrobially active SA honey sample was 
determined and the fractional inhibitory concentration (ΣFIC) calculated. The correlation 
between liquid chromatography-mass spectrometry (LC-MS) chemical data and the 
antimicrobial activity of propolis extracts was investigated using chemometric modelling. 
 
3.2. Materials and methods 
3.2.1. Preparation of extracts 
A weighed quantity of macerated propolis was submerged in absolute ethanol. For every 3 g 
of crude propolis, 10 ml of absolute ethanol was used for extraction(Figure 3.1) (Sawaya et 
al., 2004).Extraction took place in an orbital shaker incubator (Labcon) at 37°C for 7 days. 
Thereafter, ethanol was siphoned off and the extract was allowed to dry at ambient 
temperature, dry ethanolic extracts of propolis (EEP) were stored at -4°C (Bosio et al., 2000; 
Sawaya et al., 2004; Scazzocchio et al., 2006;Sawaya et al., 2010). 
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Figure 3.1: Preparation of extracts for antimicrobial studies. 
 
 
3.2.2. Screening of propolis for antimicrobial activity 
3.2.3.1. Preparation of extracts for antimicrobial testing 
Samples used for the minimum inhibitory concentration (MIC) assays were prepared by 
dissolving a known amount of dry crude extract in acetone to a final standard concentration of 
25 mg/ml. Acetone was used as the solvent as it is reported to have negligible antimicrobial 
effects (van Vuuren et al., 2010). 
 
3.2.3.2. Preparation of cultures for antimicrobial assays 
Cultures were prepared as stated in the National Committee for Clinical Laboratory Standards 
(NCCLS) guidelines (2009). Six American Type Culture Collection (ATCC) strains were 
selected for this study. These included two Gram-positive micro-organisms; Staphylococcus 
aureus ATCC 25923 and Enterococcus faecalis ATCC 29212, two Gram-negative micro-
organisms; Pseudomonas aeruginosa ATCC 27858, and Escherichia coli ATCC 25922; and 
also included were two yeast strains; Candida albicans ATCC 10231 and Cryptococcus 
neoformans ATCC 14116. In order to correlate this study to previous studies conducted 
worldwide, pathogens were selected based on the most common pathogens tested against by 
these previous studies (Appendix G). A waiver for the use of these micro-organisms was 
Weighing of 
macerated propolis 
Maceration of 
propolis 
Addition of 
calculated volume of 
absolute ethanol  
Extracts for antimicrobial studies 
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granted by the University of the Witwatersrand Human Research Ethics Committee 
(Reference W-CJ-131026-1; Appendix I). 
 
Bacterial cultures were grown in Tryptone Soya broth (TSB) (Oxoid) at 37°C for 24 hours for 
bacterial strains and 37°C for 48 hours for yeast strains. All micro-organisms were kept viable 
by sub-culturing every two weeks. Cultures were streaked out onto Tryptone Soya agar 
(TSA) plates and incubated under optimal conditions in order to confirm purity of cultures. 
 
3.2.4. Antimicrobial assay 
3.2.4.1. Minimum inhibitory concentration assay (MIC) 
Serial micro-dilution assays were conducted in order to quantify the MIC values for the 
ethanolic extracts of propolis (EEP), using p-Iodonitrotetrazolium violet solution as an 
indicator of bacterial/yeast growth (van Vuuren et al., 2010).With the aid of aseptic 
manipulations, 100 μl of sterile deionised water was introduced into each well of a 96 well 
micro-titre plate. In order to test the antimicrobial properties of SA propolis samples, 100 μl 
of propolis extracts at a starting concentration of 25 mg/ml in acetone were individually 
transferred into the top row of the micro-titre plate and serial dilutions were performed, all 
samples were tested in duplicate to ensure accuracy of results. Each assay was conducted in 
duplicate to ensure accurate, reproducible results. 
 
Before addition to the micro-titre plates, all cultures used were sub-cultured into suitable 
broth. Culture was diluted until just turbid (0.5 McFarland standard). This was then adjusted 
to a 1:100 ratio to ensure an approximate concentration of 1 x 10
6
(CFU/ml). Hereafter 100 µl 
of sub-culture was added to all 96 wells. Each plate was subsequently sealed with a sterile 
adhesive sealing film (AEC Amersham). This was done to prevent evaporation of the test 
sample. Micro-titre plates were then incubated at 37°C for 24 hours and at 37°C for 48 hours 
for bacteria and yeasts respectively. After incubation, 40 µl of a 0.04% w v⁄  p-
Iodonitrotetrazolium (INT) chloride (0.04% w/v) (Sigma-Aldrich) indicator solution was 
added to each well of the micro-titre plates. When the indicator INT was added, colour 
change (from colourless to pink) was monitored within the culture control row. Once an 
observable colour change was noticed within the culture control column, the plate was 
analysed and the MIC values recorded appropriately as the lowest concentration of propolis 
that inhibited the growth of the test micro-organism (i.e. no visible growth in that well) (van 
Vuuren et al., 2010). This observable colour change is dependent on the relevant growth 
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pattern of the pathogen being tested; it could take anything from two hours (e.g. E. coli) to 24 
hours after re-incubation (e.g. C. albicans) (Figure 3.2). 
 
 
Figure 3.2: Representation of the MIC micro-dilution assay 
 
 
3.2.4.2. Negative, positive and culture controls  
Negative controls of acetone were prepared at 25 mg/ml and were included in order to 
ascertain if the solvent itself exhibited any antimicrobial effects towards the pathogens tested. 
Positive controls (conventional antimicrobials) of ciprofloxacin (Sigma-Aldrich) and 
amphotericin B (Sigma-Aldrich) were used as reference antimicrobial agents to confirm 
microbial susceptibility. These conventional antimicrobials were selected due to their broad-
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 52 
  
 
spectrum activity against a wide range of pathogens. Positive controls were prepared using 
sterile deionised water to yield stock concentrations of 0.01 mg/ml (ciprofloxacin) and 0.1 
mg/ml (amphotericin B). A culture control was included to verify that the broth was capable 
of supporting microbial growth. This culture control was also utilized as the standard to read 
results. 
 
3.2.5. Minimum bactericidal concentration assay (MBC) 
The MBC is the lowest concentration of propolis that kills off a micro-organism after sub-
culturing onto an agar plate (Andrews, 2001). Once MIC assays were recorded, an MBC 
assay was undertaken by streaking (culture/sample mix) out of wells where inhibition was 
apparent, onto a sub-divided TSA plate (Figure 3.3). The plates were incubated at 37°C for 24 
hours and 37°C 48 hours for bacteria and yeasts, respectively. Results were recorded as the 
lowest concentrations of propolis where no growth of the micro-organism was observed. 
 
 
Figure 3.3: Visual representation of minimum bactericidal concentration assay where 3A-E 
represents decreasing concentrations of propolis; 3A= 6250 µg/ml, 3B= 3125 µg/ml, 3C= 
1563 µg/ml, 3D= MBC= 781 µg/ml; 3E=Growth at 391µg/ml. 
 
 
3.2.6. Interactive efficacy studies with conventional antimicrobials 
Ten of the most antimicrobially active propolis samples were investigated for their interactive 
efficacies, samples were selected based on their promising MIC values correlating to all three 
Growth  
Minimum 
bactericidal 
concentration 
(MBC) 
 53 
  
 
chosen pathogens (i.e. MIC’s between 6 - 24 µg/ml against S. aureus, MIC’s ≤  195 µg/ml 
against P. aeruginosa and MIC’s 12 - 49 µg/ml against C. neoformans). These samples were 
combined with two broad-spectrum commercial antimicrobials specific to the pathogen being 
tested. Combinations were tested against one Gram-positive bacteria; S. aureus (ATCC 
25923), one Gram-negative bacteria; P. aeruginosa (ATCC 27853), and one yeast; C. 
neoformans (ATCC 14116). Ciprofloxacin and penicillin G were tested against S. aureus; 
ciprofloxacin and gentamicin were tested against P. aeruginosa and amphotericin B and 
nystatin were tested against C. neoformans. One Brazilian sample that displayed the lowest 
MIC value was selected for comparative purposes. The antibiotics were introduced at starting 
concentrations of 0.01 mg/ml for antibacterials and 0.10 mg/ml for antifungals (van Vuuren 
and Viljoen, 2006; van Vuuren et al., 2010). This MIC assay was carried out as described 
previously (Chapter 3, Section 3.2.4.1) using a 1:1 ratio (50 µl of propolis and 50 µl of 
antimicrobial) of propolis to a conventional antimicrobial (i.e. antibacterial/antifungal).  
 
The sum of the fractional inhibitory concentration (ΣFIC) was calculated accordingly and 
used to determine the interactive correlation between propolis and the conventional 
antimicrobial. The ΣFIC was calculated using the following equation, where (a) represents the 
MIC value obtained for the propolis sample and (b) represents the MIC value obtained for the 
conventional antimicrobial sample (van Vuuren and Viljoen, 2011): 
 
 
 
The ΣFIC is then calculated using the following equation; ΣFIC = FIC (i) + FIC (ii). The 
interactions between the combinations of propolis samples and the conventional 
antimicrobials were further classified using the sum of the fractional inhibitory concentration 
(ΣFIC). The interactions were classified as synergistic for ΣFIC values ≤ 0.5, additive for 
ΣFIC values >0.5-1.0, indifferent for ΣFIC values >1.0 ≤ 4.0, or antagonistic for ΣFIC values 
>4.0 (van Vuuren and Viljoen, 2011).  
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3.2.7. Interactive efficacy studies with a natural product derived from the hive 
The ten samples tested in combination with conventional antimicrobials were also 
investigated for their interactive efficacies in combination with a SA honey sample showing 
the greatest broad-spectrum activity, as identified in a previous study conducted by Khan et 
al. (2014)where a sample was obtained from Mossel Bay (Western Cape province) had a 
mean MIC % value of 10.42 SD ± 8.27. Combinations were tested against one Gram-positive 
bacterium; S. aureus (ATCC 25923), one Gram-negative bacteria; P. aeruginosa (ATCC 
27853), and one yeast; C. neoformans (ATCC 14116).This assay was conducted on the ten 
SA propolis samples as tested in the antibiotic: propolis combination component. The honey 
sample was diluted to a starting concentration of 50% v v⁄  in sterile distilled water. This assay 
was carried out as described previously (Chapter 3, Section 3.2.4.1) using a 1:1 ratio (50 µl of 
propolis and 50 µl of honey) of propolis to honey. The ΣFIC was calculated in the same way 
as in the antibiotic interactive efficacy study with the conventional antimicrobial, and used to 
determine the interactive correlation between propolis and the honey sample.  
 
3.2.8. Chemometric data analysis to correlate liquid chromatography-mass 
spectrometry (LC-MS) profiles to antimicrobial activity 
In order to correlate the antimicrobial activity to specific chemical constituents in the propolis 
extracts, a metabolomics approach was applied. Using Simca-P+ 13.0 (Umetrics, Umeå, 
Sweden) chemometrics software, multivariate data analysis tools were applied to a dataset 
consisting of both positive and negative liquid chromatography mass spectrometry(LC-MS) 
profiles of 42 propolis extracts (same dataset used for chemometric analysis in Chapter 2, 
Section 2.3) and their corresponding MIC values. The propolis extracts were assigned to 
classes based on the level of antimicrobial activity observed. For the purpose of biomarker 
identification, extracts with MICs ≤500 µg/ml were classified as having good activity and 
were assigned to class 1. Conversely, extracts with MICs ≥ 500 µg/ml were considered to be 
poorly active and assigned to class 2. A dummy Y-variable was assigned to this classification 
to allow for an orthogonal projection to latent structures (OPLS) and a model was 
constructed.  
Initially, PCA was performed on the X-data (LC-MS) to observe chemical variation within 
the propolis extracts. The X-data was pareto scaled to reduce the relative importance of larger 
values by decreasing large fold changes more than the smaller changes while maintaining the 
data structure partially intact (Eriksson et al., 1999). An OPLS model was constructed 
following PCA. This is a supervised classification algorithm that investigates chemical 
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variations (predictive) within the X-matrix (LC-MS data) that are correlated to the predefined 
classes (dummy Y-variable). Additionally, the algorithm further identifies variation that is 
uncorrelated (orthogonal) to the Y-variable. Score scatter plots were used to evaluate the 
(dis)similarities among the propolis extracts by observing clustering patterns. An S-plot was 
used to identify putative biomarkers (retention time-mass pairs) that are associated with the 
active and less-active samples. The identification of the corresponding compounds were 
performed using mass spectrometry (MS) fragment comparisons, library database searches 
and literature reviews. 
 
3.3. Results 
3.3.1. Antimicrobial assay 
The average MICs and MBCs of each of the 39EEP samples collected from various 
geographical regions of SA as well as the overall average activity across all pathogens tested 
are reported in Table 3.2 and their percentage yields are reported in Chapter 2, Table 2.1. 
Propolis extracts where MIC values are <125 µg/ml are considered as having noteworthy 
activity, propolis extracts where MIC values are 125 - 500 µg/ml are considered as having 
moderate activity and propolis extracts where MIC values are >500 µg/ml are considered as 
having weak activity (Alencar et al., 2007; Velazquez et al., 2007; Seidal et al., 2008). The 
inhibitory activity of EEP against all pathogens tested ranged from 6 to 1563 µg/ml. 
According to the criteria defined herewith, 28 (i.e. 71%) propolis extracts displayed 
noteworthy activity (MIC ≤ 125 µg/ml) against S. aureus. Three propolis extracts, GP9, NW2 
and WC8, displayed noteworthy activity (MIC ≤ 125 µg/ml) against E. faecalis. Two propolis 
extracts, WC9 and WC10, displayed noteworthy activity (MIC ≤ 125 µg/ml) against C. 
albicans. Thirty-one (i. e. 79%) propolis extracts displayed noteworthy activity when tested 
against C. neoformans. Three propolis samples originating  from Honeydew (GP9), Edenvale 
(GP11), and the southern suburbs of Cape Town (WC8), Gauteng, and Western Cape, 
respectively were found to display exceptional noteworthy activity with MICs as low as 6 
µg/ml against S. aureus.  
 
More than half of the SA propolis samples, when tested against S. aureus, displayed MIC 
values lower than the Brazilian propolis extracts which were added as comparative controls. 
Of the 39 SA samples tested, 30% showed better inhibition than the Brazilian comparator 
when tested against the Gram-negative P. aeruginosa strain. Furthermore, when tested 
against the yeast species C. neoformans, 77% displayed greater inhibition with MIC values 
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(GP9- 12 µg/ml) lower than that of the Brazilian samples. Against C. albicans 64% of the 39 
SA EEP samples tested showed better inhibition than two of the Brazilian control EEPs, BR1 
and BR3. Of the 39 SA EEP samples, 56% showed inhibitory activity against E.coli 
equivalent to the inhibitory activity of all three Brazilian control EEPs and one sample WC9 
from the Southern suburbs of Cape Town in the Western Cape displayed inhibitory activity of 
391 µg/ml. 
The average antimicrobial activity ranged from 155-1496 µg/ml (Table 3.2). In order to 
compare against all three Brazilian samples, the average broad-spectrum activity of all three 
samples was determined. Of the 39SA propolis samples tested it was found that 56% 
displayed better average inhibitory antimicrobial activity (i.e. against all six pathogens tested) 
than the three Brazilian control samples tested.  
 
The break point expectation ranges for the conventional antimicrobials used as positive 
controls in this study; ciprofloxacin and amphotericin B are displayed in Table 3.1. All 
conventional antimicrobials used as positive controls against each pathogen in this study fell 
within the break point expectation ranges. This correlation was undertaken in order to ensure 
that the assay was responding to antimicrobials in a predictable manner and thus confirm 
methodology accuracy (CLSI, 2012). 
 
 
Table 3.1: Breakpoint expectation ranges of conventional antimicrobials (µg/ml). 
Micro-organism Ciprofloxacin Micro-organism Ciprofloxacin Micro-organism Amphotericin 
S. aureus  0.12-0.5 E. coli 0.004-0.016 C. albicans - 
E. faecalis 0.25-2 P. aeruginosa 0.25-1 C. neoformans - 
– no values could be found in available literature (CLSI guidelines, 2012; van Vuuren, 2007) 
 
 
The MBC assays undertaken demonstrated that the propolis demonstrated noteworthy (≤ 125 
µg/ml) cidal activity against the Gram-positive S. aureus and yeast C. neoformans (Table 
3.2). Propolis samples obtained from Honeydew (Gauteng), Edenvale (Gauteng), and the 
southern suburbs of Cape Town (Western Cape), displayed MBCs as low as 6 µg/ml against 
S. aureus. 
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Table 3.2: Antimicrobial activity (µg/ml) of SA propolis against six pathogens. 
Code Source of sample 
S. aureus E. faecalis E. coli P. aeruginosa C. albicans C. neoformans Average 
activity * (ATCC 25923) (ATCC 29212 ) (ATCC 25922) (ATCC 27853) (ATCC 10231) (ATCC 14116) 
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC  
Eastern Cape province 
EC1 Baviaanskloof - PE 1563 1563 1563 1563 781 1563 391 >6250 781 781 391 391 912 
Free State province 
FS1 Bloemfontein 49 49 391 521 1563 >6250 195 6250 391 521 98 98 448 
Gauteng province 
GP17 Beaulieu - Midrand 24 24 195 195 1563 >6250 391 >6250 195 293 49 49 403 
GP19 
Devon - Sedibeng 
area  
49 49 391 391 781 >6250 391 3125 195 293 98 98 
318 
GP10 Edenvale 1 24 24 391 586 781 >6250 195 >6250 391 586 98 98 313 
GP11 Edenvale 2 6 9 195 488 781 >6250 195 6250 391 391 49 49 270 
GP9 Honeydew 6 6 49 49 781 2604 391 1563 195 456 12 49 239 
GP5 Johannesburg 1 49 49 195 586 781 >6250 391 3125 391 391 49 65 309 
GP6 Johannesburg 2 195 456 1563 6250 781 >6250 391 >6250 781 781 24 49 623 
GP7 Johannesburg 3 24 37 391 2344 1563 >6250 195 >6250 781 781 49 65 501 
GP8 Lakeside/Westlake 98 98 781 2604 1563 >6250 195 >6250 391 521 49 49 513 
GP14 
Lydiana Gardens 1- 
Pretoria 
98 98 1563 1563 781 1563 391 >6250 781 1953 195 195 635 
GP15 
Lydiana Gardens 2- 
Pretoria 
24 37 781 1172 1563 >6250 391 6250 781 1953 49 49 598 
GP1 Northern Pretoria 391 391 781 1172 1563 >6250 391 >6250 781 781 98 260 668 
GP18 President Park – 49 49 391 391 781 3125 391 1563 195 391 24 24 305 
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Code Source of sample 
S. aureus E. faecalis E. coli P. aeruginosa C. albicans C. neoformans Average 
activity * (ATCC 25923) (ATCC 29212 ) (ATCC 25922) (ATCC 27853) (ATCC 10231) (ATCC 14116) 
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC  
Midrand 
GP12 Pretoria 1 24 37 781 781 781 >6250 391 >6250 781 781 195 195 492 
GP13 Pretoria 2 24 24 781 781 781 >6250 391 3125 391 391 98 98 411 
GP3 Springs 24 41 195 195 1563 >6250 391 1563 195 260 49 65 403 
GP2 
Walkerville 
(Vereeniging) 
98 98 195 195 781 >6250 391 1563 195 391 98 98 293 
GP16 
Wilgerivier – 
Bronkhorstspruit 
49 98 391 391 781 >6250 391 >6250 391 586 98 98 350 
KwaZulu-Natal province 
KZN1 KwaZulu-Natal 1 195 195 781 781 781 1563 391 3125 391 586 195 195 456 
Northern Cape province 
NC3 Douglas 49 65 391 2344 1563 >6250 195 6250 391 521 98 98 448 
NC2 Northern Cape 1 195 586 781 3646 781 >6250 391 >6250 391 651 98 130 440 
NC4 Northern Cape 2 24 24 195 195 781 1563 195 3125 195 293 24 24 236 
NC1 Orange River 1563 1563 1563 2344 1563 >6250 391 >6250 391 521 98 130 928 
North-West province 
NW2 Christiana 1 49 74 98 147 781 >6250 391 >6250 195 260 98 98 269 
NW3 Christiana 2 49 49 195 195 781 >6250 195 >6250 195 260 98 98 252 
NW4 Mooinooi 1563 3125 1563 6250 1563 >6250 781 3125 3125 3125 391 391 1496 
NW1 North West 391 391 1563 1563 1563 >6250 391 >6250 781 781 195 195 814 
Western Cape province 
WC6 Beaufort West  1563 >6250 1563 1563 781 >6250 781 >6250 1563 1172 195 391 1074 
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Code Source of sample 
S. aureus E. faecalis E. coli P. aeruginosa C. albicans C. neoformans Average 
activity * (ATCC 25923) (ATCC 29212 ) (ATCC 25922) (ATCC 27853) (ATCC 10231) (ATCC 14116) 
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC  
WC4 Botrivier 195 195 781 2084 1563 >6250 391 >6250 781 1042 98 195 635 
WC5 Graafwater 391 651 1563 3907 1563 >6250 781 >6250 781 781 195 260 879 
WC1 
Outeniqua 
Mountains, 
Oudtshoorn 
12 12 195 293 1563 6250 391 >6250 781 781 98 130 507 
WC3 Somerset West 391 521 1563 6250 1563 >6250 391 >6250 391 781 195 195 749 
WC8 
Southern Suburbs - 
Cape Town 1 
6 6 98 98 781 1563 195 2604 195 488 24 24 217 
WC9 
Southern Suburbs - 
Cape Town 2 
24 24 195 195 391 1563 195 >6250 98 147 24 24 
155 
WC10 
Southern Suburbs - 
Cape Town 3 
24 49 195 195 1563 >6250 391 >6250 98 147 49 49 387 
WC2 Western Cape 1 195 228 781 3125 781 >6250 195 >6250 781 781 195 130 488 
WC7 Western Cape 2 24 24 195 195 781 3125 195 3125 195 195 49 49 240 
South America 
BR1 Brazil 1 98 195 781 1953 781 >6250 391 3125 781 781 195 195 505 
BR2 Brazil 2 98 147 781 781 781 >6250 391 >6250 195 651 195 195 407 
BR3 Brazil 3 195 260 781 781 781 >6250 391 >6250 781 781 24 41 492 
 Positive control ** 0.313 0.625 0.02 0.313 6.25 0.78  
 Negative control >6250 >6250 >6250 >6250 >6250 >6250  
 Culture control >6250 >6250 >6250 >6250 >6250 >6250  
* MIC calculated across all six pathogens and averaged; **Ciprofloxacin used for bacterial strains and Amphotericin B for yeast strains
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Of the 39 SA EEP samples tested, 67% displayed a cidal activity at the same inhibitory 
concentration for S. aureus. This demonstrates that the majority of the EEP samples not only 
inhibited the pathogen but also demonstrated cidal effects equivalent to the inhibitory 
concentrations. Similar effects were noted for C. neoformans. For E. faecalis and C. albicans 
41% of all EEP samples displayed cidal effects equivalent to the inhibitory efficacy. 
 
3.3.1 Interactive efficacy studies 
Interactive efficacy studies were conducted on ten of the most active SA propolis samples and 
one Brazilian comparator, against conventional antimicrobials. Of the 60 combinations (EEP 
+ ciprofloxacin/gentamicin/penicillin G/amphotericin B/nystatin) tested, nine combinations 
displayed synergism and 16 combinations displayed additive activity (Table 3.3). A sample 
obtained from Springs in Gauteng, displayed enhanced synergistic interactive efficacy when 
combined with gentamicin (ΣFIC of 0.19) against P. aeruginosa (Table 3.3). Synergism was 
also noted with samples from Northern Cape and Western Cape (ΣFIC of 0.31) and 
Honeydew (ΣFIC of 0.37) in combination with gentamicin against P. aeruginosa. When 
propolis was combined with ciprofloxacin, more than half of the combinations displayed 
additive activity against P. aeruginosa, however, three samples, from Outeniqua mountains 
(WC1), Oudtshoorn, Springs and Honeydew displayed synergism (ΣFIC 0.31-0.37). Two 
samples, from Honeydew and Southern suburbs of Cape Town displayed synergism (ΣFIC of 
0.50) when combined with ciprofloxacin against S. aureus. Combinations of propolis with 
antifungals yielded mainly non-interactive efficacies. The Brazilian sample tested during 
interactive efficacy studies showed only additive and non-interactive interactions, and was 
found to be the only sample to display antagonism when combined with amphotericin B and 
nystatin, against C. neoformans.  
 
 Interactive efficacy studies were also conducted on ten of the most active SA propolis 
samples and one Brazilian comparator, against an antimicrobially active SA honey sample 
(Khan et al., 2014). Of the 30 combinations (EEP + honey) tested, two combinations 
displayed synergistic activity (ΣFIC of 0.25 and 0.5) and 16 combinations displayed additive 
activity (Table 3.4). A sample obtained from the southern suburbs of Cape Town, Western 
Cape, displayed enhanced synergistic activity with a ΣFIC as low as 0.25 against C. 
neoformans (Table 3.4).  
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Table 3.3: Interactive efficacy of SA propolis with conventional antimicrobials. 
Location 
S. aureus (ATCC 25923) P. aeruginosa (ATCC 27853) C. neoformans (ATCC 14116) 
Ciprofloxacin Penicillin G Ciprofloxacin Gentamicin Amphotericin B Nystatin 
ΣFIC Interpretation ΣFIC Interpretation ΣFIC Interpretation ΣFIC Interpretation ΣFIC Interpretation ΣFIC Interpretation 
Outeniqua Mountains, 
Oudtshoorn 
1.02 
Non-
interactive 
2.54 
Non-
interactive 
0.37 Synergistic 0.75 Additive 1.49 
Non-
interactive 
1.24 
Non-
interactive 
Springs 1.05 
Non-
interactive 
3.02 
Non-
interactive 
0.37 Synergistic 0.19 Synergistic 1.25 
Non-
interactive 
1.13 
Non-
interactive 
Johannesburg 0.52 Additive 1.52 
Non-
interactive 
1.25 
Non-
interactive 
1.25 
Non-
interactive 
2.49 
Non-
interactive 
1.13 
Non-
interactive 
Brazil 0.62 Additive 2.45 
Non-
interactive 
0.75 Additive 1.50 
Non-
interactive 
4.56
 
Antagonistic 8.65
 
Antagonistic 
Honeydew 0.50 Synergistic 0.56 Additive 0.31 Synergistic 0.37 Synergistic 1.06 
Non-
interactive 
0.52 
Additive 
Edenvale 1.01 
Non-
interactive 
2.25 
Non-
interactive 
0.56 Additive 0.62 Additive 1.25 
Non-
interactive 
1.13 
Non-
interactive 
Northern Cape 1.05 
Non-
interactive 
1.52 
Non-
interactive 
0.56 Additive 0.31 Synergistic 2.29 
Non-
interactive 
2.17 
Non-
interactive 
Western Cape 0.52 Additive 1.52 
Non-
interactive 
0.56 Additive 0.31 Synergistic 1.25 
Non-
interactive 
1.13 
Non-
interactive 
Southern Suburbs- 
Cape Town 
0.50 Synergistic
 2.25 
Non-
interactive 
0.62 Additive 0.62 Additive 0.56 Additive 1.08 
Non-
interactive 
Southern Suburbs- 
Cape Town 
2.10 
Non-
interactive 
1.52 
Non-
interactive 
0.62 Additive 0.62 Additive 2.29 
Non-
interactive 
2.17 
Non-
interactive 
synergistic interactions highlighted in bold; antagonistic interactions highlighted in italics 
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The Brazilian sample tested displayed additive and non-interactive properties, and was found to be 
the sample to display the greatest antagonism when combined and tested against C. neoformans 
with a ΣFIC as high as 8.21. One SA sample from the Outeniqua mountains (WC1), Oudtshoorn in 
the Western Cape was found to display antagonism against S. aureus with a ΣFIC of 4.09. 
 
 
Table 3.4: Interactive efficacy of SA propolis with honey. 
Location 
Honey 
S. aureus P. aeruginosa C. neoformans 
(ATCC 25923) (ATCC 27853) (ATCC 14116) 
ΣFIC Interpretation ΣFIC Interpretation ΣFIC Interpretation 
Outeniqua 
Mountains, 
Oudtshoorn 
4.09 Antagonistic 1.06 
Non-
interactive 
2.06 
Non-
interactive 
Springs 2.05 
Non-
interactive 
0.53 Additive 1.02 Additive 
Johannesburg 1.02 Additive 2.07 
Non-
interactive 
1.02 Additive 
Brazil 1.03 Additive 1.06 
Non-
interactive 
8.21 Antagonistic 
Honeydew 1.00 Additive 0.53 Additive 0.50 Synergistic 
Edenvale 2.00 
Non-
interactive 
1.03 Additive 1.02 Additive 
Northern Cape 2.05 
Non-
interactive 
0.52 Additive 2.06 
Non-
interactive 
Western Cape 1.02 Additive 0.52 Additive 0.51 Additive 
Southern Suburbs - 
Cape Town 
2.00 
Non-
interactive 
1.03 Additive 0.25 Synergistic 
Southern Suburbs - 
Cape Town 
1.02 Additive 0.52 Additive 2.06 
Non-
interactive 
synergistic interactions highlighted in bold; antagonistic interactions displayed in italics 
 
 
3.3.3. Chemometric data analysis correlating LC-MS profiles with antimicrobial activity 
The correlation between chemical data and antimicrobial activity was investigated using 
multivariate data analysis tools. Two OPLS models were created for the two Gram-positive bacteria 
(E. faecalis and S. aureus) and C. albicans where higher antimicrobial activities were observed. 
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Figure 3.4 shows the OPLS scores scatter plot of propolis extracts discrimanting between the active 
class (red) and poorly active class (blue) along the predictive component (tp1) with a 10% chemical 
variation (R
2
Xp = 0.10) being attributed to this classification. Pareto scaling provided maximum, 
clean separation of the data compared to other scaling methods. The separation demonstrates that 
almost 50% of extracts are highly active while the other 50% are poorly active against E. faecalis. 
Although a general conclusion could not be drawn on the influence of geographical locality to 
antimicrobial activity, a few scenarios dominated from the plot where all the propolis from Brazil 
and Lydiana (Pretoria) demonstrated low activity while propolis from Cape Town, Edenvale and 
Western Cape showed consistently high activity against E. faecalis.  
 
 
 
Figure 3.4: OPLS scores plot showing separation of active propolis (●) and poorly active propolis 
(▲) extracts against E. faecalis. 
 
 
For illustration purposes, a detailed explanation of the model developed for E. faecalis is provided 
whilst a summary of the model statistics and the biomarkers identified for all three micro-organims 
is provided in Table 3.5. Using the filtered retention times (min) in combination with the mass-scan 
number combinations, it was possible to identify the active constituents in propolis for the three 
models (Table 3.5). Table 3.5 lists the active constituents in propolis as chrysin, pinocembrin, 
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galangin and pinobanksin-3-O-acetate.To investigate the bioactive markers within the propolis 
extracts, an S-plot of covariance and correlation was constructed for the X-variables (Figure 3.5). 
The points in the S-plot represent the LC-MS retention times (min) while the corresponding mass-
scan pairs were identified as secondary observations in the data set. The extreme ends of the S-plot 
show variables of high magnitude and high reliability in the differentiation of the two propolis 
classes. The highlighted variables in the left bottom quadrant (red) are the biomarkers that are 
correlated to high antimicrobial activity of the propolis extracts while the top right (blue) show low 
activity.  
 
Figure 3.6 is the UPLC-ESI
+
-MS chromatograph of the ethanol propolis extract showing the 
identified biomarkers and the corresponding structures. Three of the active compounds have been 
identified as major compounds in propolis extracts so it can be concluded that extracts containing 
higher levels chrysin, pinocembrin, and galangin are more likely to possess higher antimicrobial 
activity when compared to the others. 
 
 
Table 3.5: Model statistics and identified biomarkers contributing to good activity of propolis 
extracts against selected micro-organisms.  
Organism Model statistics 
Retention time 
(min) 
(Biomarkers) 
Mass Identity 
E. faecalis 
A = 1+4; R
2
Xp = 0.10;  
R
2
Xcum = 0.58; Q
2
cum = 0.48 
5.8661 
6.2039 
6.3759 
255.066 
257.082 
271.061 
Chrysin 
Pinocembrin 
Galangin 
S. aureus 
A = 1+2; R
2
Xp = 0.07;  
R
2
Xcum = 0.58; Q
2
cum = 0.29 
6.2039 
6.4064 
6.6038 
257.082 
301.072 
227.072 
Pinocembrin 
Galangin 
Pinobanksin-3-O-acetate 
C. albicans 
A = 1+1; R
2
Xp = 0.20;  
R
2
Xcum = 0.37; Q
2
cum = 0.42 
5.8661 
6.2065 
6.3759 
255.066 
257.082 
271.061 
Chrysin 
Pinocembrin 
Galangin 
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Figure 3.5: An S-plot showing putative biomarkers that have been identified as contributing 
noteworthyly to good activity (▲left bottom quadrant) and poor activity (▲top right quadrant) 
against E. faecalis. 
 
 
Figure 3.6: UPLC-ESI
+
-MS chromatogram of propolis ethanol extract showing the biomarkers 
contributing noteworthyly to the antimicrobial activity as identified in the S-plot. 
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3.4. Discussion 
As seen in Chapter 2, Table 2.1, a majority of samples had higher yields. These samples were noted 
to display better antimicrobial activity with the exception of an outlier (WC2), which had a low 
yield of 7.27% but displayed a noteworthy antimicrobial activity of 6 and 24 µg/ml against S. 
aureus and C. neoformans, respectively. Highlighted by this study in Chapter 1, Figure 1.3, is the 
fact that propolis from Africa and South Africa in particular is severely understudied, this study 
reported EEP samples from SA as displaying activity better than the vastly studied “gold standard” 
Brazilian propolis (South America), and European propolis samples (Turkish, Italian, Iranian, etc). 
 
Propolis from regions of Argentina have previously been reported to exhibit better Gram-positive 
than Gram-negative activity with MICs as low as 15.30 µg/ml against S. aureus (Nieva Moreno et 
al., 1999). The antimicrobial activity of propolis from various regions of Anatolia, Turkey, reported 
low MICs against Gram-positive S. aureus (8 - 16 µg/ml), Gram-negative P. aeruginosa (32 - 256 
µg/ml) E. coli (16 - 128 µg/ml), and the yeast Candida albicans (4 - 32 µg/ml) (Uzel et al., 2005). 
Furthermore, another study conducted on propolis from Turkey also reported a low MIC against 
Gram-positive S. aureus (9 µg/ml) (Keskin et al., 2001).Propolis from Oman was found to display 
MICs ranging from 42 - 169 µg/ml against S. aureus and 169 - 356 µg/ml for E. coli (Popova et al., 
2013). In another study conducted on Brazilian red propolis from Maceió and the state of Algoas, 
the growth of S. aureus was reported to be inhibited by very low concentrations (exact 
concentration is not reported), MICs of 256 µg/ml were reported against P. aeruginosa and C. 
albicans and 512 µg/ml against E. faecalis and E. coli (Righi et al., 2011). 
 
In comparison to these previous studies on the inhibitory efficacy of propolis (Nieva Moreno et al., 
1999; Uzel et al., 2005; Righi et al., 2011; Popova et al., 2013), this study demonstrated that three 
SA propolis samples, GP9, GP11 and WC8 (Table 3.2) displayed greater inhibitory efficacy than 
Brazilian propolis. Furthermore, activities from the SA samples were higher than propolis samples 
from other regions of the world (Suleman et al., 2015). It was noted that the majority of these whole 
propolis extracts, when tested against Gram-positive S. aureus, and the yeast species C. 
neoformans, demonstrated activities comparable to antimicrobial activities displayed by isolated 
bioactive compounds(van Vuuren, 2008), thus suggesting a natural product with superior activity. 
Predominant cidal activity against Gram-positive bacteria and yeasts was also observed. Keskin et 
al. (2001), tested EEP samples from Turkey and reported an MBC against S. aureus of 16 µg/ml. In 
comparison, this current study reported that three EEP samples from SA, namely; WC8, GP9 and 
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GP11displayed better cidal activity than that reported in literature with MBCs of 6 µg/ml (WC8 and 
GP9) and 9 µg/ml (GP11) against S. aureus. 
 
It was noted that all propolis extracts tested were distinctive in colour, the colour of samples ranged 
from colourless/whitish-grey → light yellow-brown/golden → dark reddish-brown/maroon (Figure 
3.7). A majority of samples (74% against S. aureus; 28-33% against P. aeruginosa, C. albicans and 
E. faecalis respectively; 93% against C. neoformans) ranging in colour from light yellow-
brown/golden → dark reddish-brown/maroon were the samples that displayed exceptional 
inhibition with MICs ≤  195 µg/ml. Dark reddish-brown/maroon extracts (e.g. GP9 and WC8) were 
found to display greater inhibition against Gram-positive S. aureus and the yeast C. neoformans 
than colourless/whitish grey extracts (e.g. WC6 and NW4) (Table 3.2).Although seasonality and 
age of propolis has been mentioned and studied previously (Bonvehí et al., 2000; Teixeira et al., 
2010; de Souza et al., 2014; Schmidt et al., 2014), extract colour has not been explored or reported 
as a possible factor correlating to biological activity. 
 
 
 
Figure 3.7: Visual representation of colour variances between EEP samples. (colourless/whitish 
grey (e.g. sample 30) → light yellow-brown/golden (e.g. samples 19, 22 and 23) → dark reddish-
brown/maroon (e.g. samples 14, 20 and 24)) 
 
 
The use of propolis independently, as well as in combinations with other natural products and 
conventional antimicrobials has shown a dramatic increase in popularity (Miguel and Antunes, 
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2011). Resistance to current conventional antimicrobials is of a growing concern in the industry of 
medical health. Hence, scientists are relentlessly looking for an unconventional means of inhibiting 
microbial growth as well as enhancing the potencies of currently available conventional 
antimicrobials. Propolis has also previously been reported to displaying synergism with 
conventional antimicrobials such as clarithromycin, ampicillin, ceftriaxone, doxycycline, amikacin,  
nystatin, ciprofloxacin and more (Chapter 1) (Stepanović et al., 2003; Fernandes et al., 2005; Orsi 
et al., 2006; Onlen et al., 2007; Rahman et al., 2010; Helaly et al., 2011; Naher et al., 2011; Orsi et 
al., 2012). This study found that nine combinations displayed synergism with conventional 
antimicrobials, including ciprofloxacin and nystatin. Mantovani et al. (2008) postulated that 
synergistic interactions may be linked to the flavonoid content of the sample. 
 
Hübsch et al. (2014) reported that most combination studies found in the literature emphasized 
mainly synergistic interactions; however, the reporting of antagonism has been greatly neglected. In 
the current study an antagonistic interaction was identified when Brazilian propolis was combined 
with antifungals, amphotericin B and nystatin against C. neoformans. Also, when Brazilian propolis 
was combined with another natural product of the hive, honey, against S. aureus and C. 
neoformans, an antagonistic interaction was seen. In light of this finding, combinations of propolis 
(against yeasts) with antifungals and other natural products should always be administered with 
caution and in a controlled environment, such as a hospital or clinic environment where any allergic 
reaction or anaphylaxis can be easily treated.  
 
A study conducted in Nigeria by Adewumi and Ogunjinmi (2011), also combined propolis with 
honey as was done in the current study. The honey and propolis were combined in a lotion and 
applied to the septic wounds of patients, three times a day. The study reported a 100% healing rate 
by the end of the 15
th
 day, however, the study used no control sample (e.g. known lotion used for 
wound healing). As suggested by the aforementioned study, this current study also found that some 
EEP samples displayed synergistic activity when combined with an antimicrobially active SA 
honey sample. Propolis has also been combined with other natural products such as; Aloe vera, 
myrrh, garlic, essential oils and minerals like calcium hydroxide and zinc (in the treatment of otitis 
media in children) (Lofty et al., 2006; de Rezende et al., 2008; Bertolini et al., 2010; Marchisio et 
al., 2010; Probst et al., 2011; Maekawa et al., 2013, Moreno-Cruz et al., 2014). 
 
As elaborated previously in Chapter 1, the chemical composition of propolis is largely variable. In 
Europe and in the more temperate zones, propolis is found to contain more flavonoids and phenolic 
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acid esters as opposed to propolis found in Cuba and Venezuela. The main constituents found in 
Cuban red propolis are benzophenones. Furthermore, red Mexican propolis is found to contain a 
vast amount of flavones, isoflavans and pterocarpans (Hernández et al., 2005; Lotti et al., 2010; 
Righi et al., 2011). Our earlier study (Kasote et al., 2014a) was the first comprehensive report to be 
published on the chemical profiling of propolis samples from various regions in SA, which included 
an extensive sample bank consisting of propolis samples from the various provinces of SA. Results 
of this study supported the findings of earlier studies confirming that SA propolis is rich in 
flavonoids with the main constituents being, pinocembrin, galangin, chrysin, myricetin and 
pinobanksin and is chemically distinct from Brazilian propolis which was found to contain high 
concentrations of only one compound, a derivative of p-coumaric acid, artepillin C.  
 
The presence of flavonoids and derivatives of caffeic acid are known to be associated with the 
bactericidal activities of propolis (Bosio et al., 2000). The antimicrobial properties of propolis are 
also known to be attributed to high flavonoid content, especially galangin, chrysin and pinocembrin 
(Hegazi and Abd El Hady, 2001; Bosio et al., 2000; Cushnie and Lamb, 2005). Due to the high 
flavonoid content, propolis is noted to have good activity against dermatophytes as well as some 
Candida spp. (Cafarchia et al., 1999; Cushnie and Lamb, 2005). Chrysin, a flavonoid also found in 
propolis has been proven to inhibit the viral replication of the herpes simplex virus (HSV) and 
rotavirus and has been reported to have good antibacterial activity (Melliou and Chinou, 2004; 
Cushnie and Lamb, 2005). Galangin has also been found to display good antimicrobial activity 
against Aspergillus and Penicillium spp. as well as antiviral activity against HSV (Cushnie and 
Lamb, 2005). In a recent study, pinocembrin was found to be the compound responsible for 
observed antifungal activity of propolis, whilst pinobanksin was reported to be responsible for 
observed antibacterial activity (Kasote et al., 2014b).  
 
In our previous study, the chemical profiling techniques demonstrated that SA samples were 
chemically distinct from the Brazilian comparator samples (Kasote et al., 2014a). LC-MS analysis 
found that pinocembrin, chrysin, galangin and pinobanksin are the major constituents of SA 
propolis, whilst the major constituent of the Brazilian propolis samples tested was artepillin C. 
Pinocembrin and chrysin are flavanones, while galangin is a flavonol and pinobanksin-3-O-acetate 
a dihydroflavonol (flavonol). Flavonones and flavonols are types of flavonoids found in propolis 
and other natural products such as honey and medicinal plants (Melliou and Chinou, 2004). Melliou 
and Chinou (2004) reported on the antimicrobial activity of flavonoids found in propolis, the study 
reported that pinocembrin and chrysin displayed respective MIC values of 0.25 mg ml (250 µg/ml) 
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and 3.40 mg/ml (3400 µg/ml)  against S. aureus, and 0.10 mg/ml (100 µg/ml) and 0.05 mg/ml(50 
µg/ml) against C. albicans. The activity of 23 EEP samples tested in the current study against S. 
aureus (6 - 49 µg/ml) and 15 EEP samples tested against C. neoformans (12 - 49 µg/ml) displayed 
antimicrobial activities lower than the activities displayed by the single bioactive compound 
pinocembrin found by Melliou and Chinou (2004).  
 
Furthermore, Pepeljnjak and Kosalec (2004) reported on the antimicrobial activity of galangin 
against MRSA, Enterococcus spp. and P. aeruginosa. The study reported that galangin inhibited the 
growth of MRSA, Enterococcus spp. and P. aeruginosa with MICs of 0.16 mg/ml (160 µg/ml), 
0.24 mg/ml (240 µg/ml) and 0.17 mg/ml (170 µg/ml), respectively. Of the 39 SA EEP samples 
tested in the current study, 14 samples tested against E. faecalis an Enterococcus spp. displayed 
lower antimicrobial activities (98 - 195 µg/ml) than the activity displayed by the single bioactive 
compound galangin found by Pepeljnjak and Kosalec (2004).  
 
3.5. Conclusion 
In conclusion, this study demonstrated that a wide range of SA propolis displayed noteworthy (< 
125 µg/ml) as well as bactericidal activity. In alignment with literature, Gram-positive bacteria 
displayed greater sensitivity towards SA propolis than Gram-negative bacteria. Staphylococcus 
aureus was found to be inhibited and killed by low concentrations of propolis (6 µg /ml), thus 
making SA propolis a possible and valuable future alternative in anti-infective therapy. 
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Chapter 4: Conclusions and future recommendations 
 
4.1. Overview 
Despite the vast number of studies conducted worldwide (Figure 1.3), especially on South 
American (Brazil and Argentina) and European (Turkey and Italy) propolis, studies on African 
propolis and more specifically SA propolis have been severely neglected. Brazilian propolis was 
notably utilized as the “gold standard” for comparison in a vast majority of these studies (Appendix 
G). The antimicrobial efficacies and chemical composition of 39 SA propolis samples and three 
reference Brazilian samples was investigated by undertaking a number of objectives as outlined in 
Chapter 1.  These objectives included; the preparation of extracts of propolis using absolute ethanol 
as an extraction solvent, investigating the antimicrobial activity of EEP using the MIC and MBC 
methods described in Chapter 3. Investigating the interactive efficacy of EEPs with conventional 
antimicrobials and conducting chemical profiling of propolis samples using HPTLCUPLC-PDA-
qTOF-MS/MS. Furthermore, chemical characteristics were correlated with geographical variances 
using chemometric analysis. 
 
4.2. Chemistry 
As elaborated in Chapter 2, the chemical composition of propolis is extremely variable and 
dependant on a number of factors (Markham et al., 1996; Righi et al., 2011). The chemical analysis 
of propolis in this study was principally conducted in order to explore the chemical composition of 
SA propolis samples collected from various regions in the country. Optimal chemical methods such 
as HPTLC, UPLC-ESI-MS and chemometric modelling were used in order to map the possible 
geographical patterns and to compare SA propolis to Brazilian propolis. This study detailed a 
comprehensive report, published on the chemical profiling of propolis samples from various regions 
in SA (Appendix A). The antimicrobial properties of propolis have been reported as being attributed 
to its high flavonoid content, with galangin, chrysin and pinocembrin being the most potent 
bioactive flavonoids.  
 
The SA propolis samples were found (using LC-MS) to be rich in flavonoids with the main 
constituents being, pinocembrin, galangin, chrysin, myricetin and pinobanksin and is chemically 
distinct from Brazilian propolis which contained only artepillin C, a derivative of p-coumaric acid 
(Kasote et al., 2014a). Although this study conducted a comprehensive analysis of propolis 
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compositions, propolis volatiles were not investigated and the chemical composition was not linked 
to the plant origin of active samples as undertaken in other studies (Bankova et al., 2000; 
Kumazawa et al., 2003; Salatino et al., 2005; Toreti et al., 2013). Further chemical analysis could 
possibly include propolis volatiles.  
 
4.3. Antimicrobial properties 
A total of 39 SA propolis samples and three Brazilian control samples were collected, extracts were 
prepared accordingly and screened for antimicrobial activity (both inhibitory (MIC) and bactericidal 
(MBC) activity) against two Gram-positive bacteria, two Gram-negative bacteria and two yeasts. It 
was observed that, SA propolis displayed greater antimicrobial activity, both inhibitory and cidal, 
than the Brazilian samples used as comparators (Chapter 3, Table 3.2). Three SA propolis samples 
(i.e. GP9 (Honeydew), GP11 (Edenvale) and WC8 (southern suburbs- Cape town 1)) demonstrated 
noteworthy (MIC ≤ 125 µg/ml) activities with MICs as low as 6 µg /ml (Table 3.2, Chapter 3). 
More than 50% of SA propolis samples displayed average MIC values which were lower than the 
control Brazilian propolis extracts. In addition 53% of SA propolis samples were found to display 
better average antimicrobial activity (i.e. against all six pathogens tested) than the three Brazilian 
comparators. This study also detailed a comprehensive report, published on the antimicrobial of 
propolis samples from various regions in SA (Appendix B).As discussed in Chapter 3, studies on 
propolis from regions of Argentina, Turkey and Oman have previously reported MICs as low as 
15.30 µg/ml, 8-16 µg/ml and 42-169 µg/ml respectively against S. aureus (Nieva Moreno et al., 
1999; Uzel et al., 2005; Popova et al., 2013). In comparison to these previous studies, the current 
study on SA propolis demonstrated superior inhibitory activity against S. aureus than the samples 
from these regions, with MICs as low as 6 µg/ml. In alignment with available antimicrobial 
literature (Appendix G) this study reports that Gram-positive bacteria (S. aureus) and yeast spp. (C. 
neoformans) were the most sensitive pathogens.  
 
The cidal activity of propolis was predominantly observed against Gram-positive bacteria, S. aureus 
and yeast, C. neoformans. Of the 39 SA EEP samples tested, 67% of samples demonstrated 
predominant cidal activity equivalent to the inhibitory concentration for S. aureus and C. 
neoformans. For E. faecalis and C. albicans 41% of SA EEP samples displayed cidal effects 
equivalent to the inhibitory efficacy observed. 
 
A review by van Vuuren et al. (2008) on the antimicrobial activity of SA plants reported that whole 
extracts having activities where MIC values are ≤ 8 mg/ml are considered as having some 
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antimicrobial activity whilst natural products with MIC values ≤ 1 mg/ml are considered 
noteworthy. This study reports SA propolis extracts as having remarkable noteworthy activity with 
MICs ≤ 6µg/ml. Overall, SA propolis displayed superior inhibitory, cidal as well as average 
antimicrobial activity in comparison to the Brazilian gold standard tested as controls. 
 
A study conducted by Melliou and Chinou (2004) reported that pinocembrin and chrysin displayed 
respective MIC values of 0.25 mg/ml (250 µg/ml) and 3.4 mg/ml (3400 µg/ml) against S. aureus. 
The activity of 23 EEP samples tested in this study displayed MICs of 6 - 49 µg/ml against S. 
aureus. It was found that the antimicrobial activities of these whole extracts were lower than those 
activities displayed by the single bioactive compounds pinocembrin and chrysin as reported by 
Melliou and Chinou (2004). This demonstrates that the compounds within the propolis samples may 
be acting synergistically to enhance activity (Melliou and Chinou, 2004; Mantovani et al., 2008; 
Oldoni et al., 2011). Future studies should identify if this is apparent.  
  
One needs to take into account that even though some noteworthy activities (both inhibitory as well 
as cidal) were obtained, the limitation exists that these results like many others show in vitro 
activity only and further in vivo studies are recommended on SA propolis. Future studies should 
also include other relevant disease specific pathogens (pathogens in nosocomial infections for 
example), as these may yield interesting results. Antimicrobial resistance is currently of growing 
concern globally and therefore further studies detailing the effects of SA propolis on resistant and 
clinical strains should also be considered. 
 
4.4. Interactive antimicrobial properties 
Combination studies were conducted in order to investigate the possible antimicrobial interactions 
between propolis, in a 1:1 combination ratio with conventional antimicrobials (ciprofloxacin, 
gentamicin, penicillin G, nystatin and amphotericin B) and an antimicrobially active SA honey, 
respectively. Of the 60 combinations tested with conventional antimicrobials, nine combinations 
displayed synergism. An ΣFIC of 0.19 was noted against P. aeruginosa, and 16 combinations 
displayed additive activity (Chapter 3, Table 3.3). This study noted that SA propolis enhanced the 
Gram-negative activity of gentamicin, whilst adding to the effects of penicillin G (Chapter 3, Table 
3.3). The comparative Brazilian sample was found to be the only sample to display antagonism 
when combined with antifungals, amphotericin B (ΣFIC of 4.56) and nystatin (ΣFIC of 8.65), 
against C. neoformans. The combination of propolis - with the antimicrobially active honey sample, 
resulted in 30 combinations. Two combinations displayed synergistic activity against C. 
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neoformans and 18 combinations displayed additive activity (Chapter 3, Table 3.4). The Brazilian 
sample tested in combination with this honey sample displayed additive and non-interactive 
interactions, and was once more found to be the sample displaying the greatest antagonism when 
combined against the yeast species C. neoformans with a ΣFIC of 8.21. It is important to note that 
SA propolis did not display any antagonism when combined with the conventional antimicrobials 
tested in this study. Other propolis samples have previously been reported to display synergism with 
various conventional antimicrobials including ciprofloxacin and gentamicin (Fernandes et al., 2005; 
Orsi et al., 2006; Rahman et al., 2010; Helaly et al., 2011; Naher et al., 2011; Orsi et al., 2012), this 
is in keeping with what has been uncovered in this study.  
 
Although conventional antimicrobials were tested in 1:1 ratios with SA propolis, one needs to 
consider what the possible results would be if varied ratio studies were conducted. Furthermore, the 
interactive efficacy of combinations of the major compounds (i.e. pinocembrin, chrysin, 
pinobanksin, galangin, etc) identified in SA propolis should be studied in order to determine which 
compounds or combinations of compounds are responsible for the observed efficacy of SA propolis. 
Even though SA propolis was tested here in combination with honey, other natural products and 
minerals (e.g. essential oils and other plant extracts) could also be considered for further 
investigation. 
 
4.5. Other aspects 
Distinct colour variations in SA propolis extracts were noted by this study. Extracts varied from 
colourless/whitish grey → light yellow-brown/golden → dark reddish-brown/maroon. Further 
analysis of the antimicrobial results lead to the hypothesis that dark reddish-brown/maroon extracts 
(e.g. GP9 and WC8) displayed greater inhibition against Gram-positive S. aureus and the yeast C. 
neoformans than colourless/whitish grey extracts (e.g. WC6 and NW4) (Chapter 3, Table 3.2). This 
study additionally established that a majority of samples (74% against S. aureus and 93% against C. 
neoformans) ranging in colour from light yellow-brown/golden → dark reddish-brown/maroon 
displayed the highest inhibition with MICs ≤ 195 µg/ml. No other studies have reported such 
differences in antimicrobial activity in relation to the colour of their extracts. Thus, another future 
recommendation made by this study is the chemical analysis of samples in order to ascertain if 
darker samples contain more of a certain active flavonoid (e.g. pinocembrin) thus lending to its 
greater antimicrobial activity, than those samples with lighter colour and lesser antimicrobial 
efficacy. 
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The toxicity of SA propolis has never been studied. However, Burdock (1998) tested the toxic 
effects of propolis on rats and cats and reported that by employing a safety factor of 1000 to account 
for the lack of chronic toxicity studies a safe dose could be calculated for humans. A safe dose for 
humans would therefore be 1.4 mg/kg of body weight/day, which is equivalent to approximately 70 
mg/day. Owing to the lack of toxicity information available on SA propolis it is recommended that 
future toxicity studies be investigated. 
 
Not many studies have been conducted on determining the quality of propolis and Bankova et al. 
(2005a) discusses the problems with standardisation of propolis due to chemical diversity at length. 
However, Bonvehí (2000) and  Kosalec (2003) postulate that the quality of propolis can be 
determined by a measurement of its flavonoid content thereby leading to the provision of grading of 
propolis samples into groups according to “quality”. Cui-ping et al. (2014) recently stated that the 
quality grading of poplar type propolis be made by measuring the content of specific compounds 
namely; pinobanksin, pinocembrin, 3-O-acetylpinobanksin, chrysin, and galangin. The quality of 
SA propolis has not been studied here and therefore, it is the recommendation of this study that 
future quality control studies be conducted on SA propolis. In addition, the effects of age of sample 
and seasonality on SA propolis have not been studied. Future studies on the effects of age (old vs. 
fresh) of samples and seasonality (collection during summer vs. winter, etc) on the antimicrobial 
activity of SA propolis may be worthy of investigation. 
 
Although many studies on SA propolis are still required, this study is the first of its kind detailing 
the antimicrobial activity, interactive efficacy and chemical profiling of SA propolis using a large 
sample size (n=39). This study concludes that SA propolis displays superior antimicrobial activity, 
both inhibitory and cidal activity (6 µg/ml for selected samples), in comparison to the control “gold 
standard” Brazilian propolis samples (98 µg/ml) included as comparators in this study. 
Furthermore, many synergistic as well as additive interactions were observed when SA propolis 
samples were combined with conventional antimicrobials. This could possibly be due to synergistic 
interactions between compounds present in SA propolis and could lead to an improvement in 
current empirical treatments. Furthermore, six compounds namely; quercetin, galangin-5-methyl 
ether, pinobanksin-3-O-propionate, pinobanksin-3-O-butyrate or isobutyrate, pinobankin-3-O-
pentanoate or 2-methylbutyrate and pinobanksin-3-O-hexanoate were identified for the first time in 
SA propolis by this study. This study concluded that SA propolis demonstrated not only superior 
activity in comparison to the gold standard but also possessed superior antimicrobial activity in 
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comparison to other vastly studied propolis from Argentina, Turkey, Italy and Oman (i.e. South 
America, Europe and Asia) against the tested pathogens.  
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Appendix C:Oral presentation abstract, Postgraduate 
Symposium, University of Johannesburg (UJ), 2013 
 
INVESTIGATING THE ANTIMICROBIAL AND CHEMICAL PROPERTIES OF SOUTH 
AFRICAN PROPOLIS. 
Tasneem Suleman
a*
, A. M Viljoen
b
, D. Kasote
b
 and M. S. Sandasi
b
, S. F. van Vuuren
a*
. 
a*
Department of Pharmacy and Pharmacology, Faculty of Health Science, University of the 
Witwatersrand, Parktown, Johannesburg 2193, South Africa 
b
Department of Pharmaceutical Sciences, Tshwane University of Technology, Private Bag 
X680, Pretoria 0001, South Africa 
Email: tasneem.suleman@students.wits.ac.za; sandy.vanvuuren@wits.ac.za. 
Propolis is a sticky resin collected from various flora by bees (Apis Mellifera) and is 
masticated and mixed with salivary enzymes. It is used by the bees to seal off holes in the 
hive from intruders, prevent putrefaction, as well as prevent infections of the colony. Studies 
on a global scale have reported on the broad-spectrum antimicrobial activity of propolis. The 
chemical diversity of propolis is also clearly apparent and extensively studied. However, 
chemical and antimicrobial properties of propolis samples from South Africa, have not yet 
been extensively researched. This study investigated the antimicrobial activities of 42 
propolis samples from regions of South Africa, using the minimum inhibitory concentration 
and minimum bactericidal concentration assays. Also investigated were the chemical 
fingerprinting profiles using high performance thin layer chromatography (HPTLC), ultra 
performance chromatographic-photodiode array detector-quadrupole-time of flight- mass 
spectrometry (UPLC-PDA-qTOF-MS). Propolis samples were found to be highly 
antimicrobially active with efficacies as low as 3 µg/ml. This study also concluded that South 
African propolis is clearly chemically different from the Brazilian standard. Furthermore, 
South African propolis demonstrates noteworthy antimicrobial activity in comparison with 
other natural products. 
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South African Propolis: Antimicrobial Activity, Chemical Properties and Interactive 
Efficacy.                                                                                                                                            
Tasneem Suleman
a*
, S. F. van Vuuren
a*
, A. M Viljoen
b
, D. Kasote
b
,  M. S. Sandasi
b
. 
a*
School of Therapeutic Sciences. Department of Pharmacy and Pharmacology, University of 
the Witwatersrand, Medical School. 
b
Department of Pharmaceutical Sciences, Tshwane University of Technology, Private Bag 
X680, Pretoria 0001, South Africa 
 
Propolis is a sticky resin collected from various flora by bees (Apis Mellifera). It is used by 
bees to seal off holes in the hive, prevent putrefaction and prevent infections of the colony. 
Studies on a global scale have reported on the broad-spectrum antimicrobial activity of 
propolis. The chemical diversity of propolis is also clearly apparent and has been extensively 
studied. However, chemical and antimicrobial properties of South African (SA) propolis, has 
only been briefly researched. Therefore, this study investigated the antimicrobial activities of 
46 propolis samples from the various provinces of SA, using the minimum inhibitory 
concentration and minimum bactericidal concentration assays. Chemical fingerprinting 
profiles of 42 samples using high performance thin layer chromatography (HPTLC) and ultra 
performance chromatographic-photodiode array detector-quadrupole-time of flight- mass 
spectrometry (UPLC-PDA-qTOF-MS) were studied. Propolis samples were found to display 
noteworthy antimicrobial activity with concentrations as low as 6µg/ml. Interactive efficacy 
studies with ciprofloxacin revealed an FIC value of 0.4 (synergistic activity) against P. 
aeruginosa. SA propolis is clearly chemically different when compared to the Brazilian 
samples.                                                                                                                                 
Key words: Propolis, Antimicrobial, Chemistry, Interactive efficacy. 
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Appendix F: HPTLC, UPLC-TOF-MS profiling and 
chemometric analysis of South African propolis 
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Appendix G: Overview of antimicrobial studies 
conducted on propolis, globally. 
 
Origin Results of study References 
France 
At a dilution of 1:20 in nutrient agar, propolis 
completely inhibited the growth of Staphylococcus 
aureus (including strains of MRSA), S.  epidermidis, 
Enterococcus spp., Branhamella catarrhalis, 
Corynebacterium and Bacillus cereus. A strain of 
Mycobacterium tuberculosis was completely inhibited 
at a propolis concentration of 1:320 and partially 
inhibited at propolis concentrations of 1:640. 
Grange  and 
Davey , 1990 
United 
Kingdom - 
bee health 
Ltd. 
Reported on the concentration-dependant inhibitory 
action of propolis against E.coli and Bacillus subtilis. 
The concentration of propolis that inhibited B. subtilis 
by 50% was 200 µg/ml and the concentration that 
inhibited the growth of E.coli by 50% was 450 µg/ml.  
Mirzoeva et al., 
1997 
Brazil 
Water and ethanolic extracts of propolis were tested 
against S. aureus. Water extracts exhibited no 
inhibition, however, 70% EEP displayed the best 
inhibition of S. aureus with a ZOI of 1.5 mm. 
Park and Ikegaki, 
1998 
Brazil Against S. mutans zones of inhibition ranged 0 to 3 mm. Park et al., 1998 
Brazil 
Antibacterial and antifungal activity of EEP tested 
against S. aureus and C. albicans. Study reported ZOIs 
of 10.5±0.5 mm and 15±1 mm, respectively. 
Bankova et al., 
1999 
Bulgaria 
(Bg) 
Ethanolic extracts of propolis (EEP) were tested against 
S. aureus, E. coli and C. albicans. EEPs were found to 
display inhibitory zones as follows: Bg = 13.7 ± 0.3 
mm, Alb = 13.8 ± 0.6 mm, Mong = 16.2 ± 0.3 mm, 
Egypt = 15.3 ± 1.5 mm, Br 1-4 = 11.0 - 12.0 mm ± 0.8 -
Kujumgiev et al., 
1999 
Albania 
(Alb) 
Mongolia 
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Origin Results of study References 
(Mong) 1.0mm , K1-2 = 17.3 - 29.0 mm ± 0.7 - 1.2 mm against 
S. aureus and Bg = 17.7 ± 1.2 mm, Alb = 17.0 ± 1.0 
mm, Mong = 18.00 ± 1.0 mm, Egypt 17.3 ± 0.4 mm, 
Br1-4 = 14.3 - 18.2 ± 0.3 – 1.2 mm, K1-2 = 17.0 – 18.0 
± 0.7 - 1.0 mm.  
Egypt 
Brazil (Br1-
4) 
Canary 
Islands (K1-
2) 
Turkey 
The effect of water extracts of propolis (WEP) was 
tested against moulds; Aspergillus parasiticus, A. niger, 
Alternaria alternata, Botrytis cinerea, Penicillium 
digitatum and Fusarium oxysporum. After a seven day 
incubation period the study found that higher 
concentrations of propolis (i.e. 4%) were more effective 
at inhibiting the growth of all moulds with P. digitatum 
being the most sensitive with a percentage inhibition of 
76.7%. 
Özcan, 1999 
Argentina 
Tested EEP against S. aureus, E. faecalis, S. pyogenes, 
S. agalactiae, K. pneumoniae, S. marcescens, 
Acinetobacter spp, Stenotrophamonas maltophilia, E. 
coli and Pseudomonas aeruginosa. All samples tested 
were found to display antimicrobial activity only 
against Gram-positive bacteria. Propolis obtained from 
El Molino displayed MICs as low as 15.30 µg/ml 
against S. aureus and propolis samples from La Banda 
Oeste displayed MIC values > 50 µg/ml against S. 
agalactiae. 
Nieva Moreno et 
al., 1999 
Brazil 
EEP tested against Actinobacillus 
actinomycetemcomitans, Fusobacterium spp. and 
Bacteroides fragilis. Against A. actinomycetemcomitans 
MICs ranged 0.05 to 0.5%. Fusobacterium found to be 
more susceptible MICs 0.05 to 0.25%. 
Santos et al., 
1999 
Uruguay EEP tested against E. coli, B. subtilis and S. aureus. Bonvehí and 
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Origin Results of study References 
and China Reported MICs of 800-1000 µg/ml against E. coli and 
80-130 µg/ml against S. aureus and B. subtilis, 
respectively. 
Coll, 2000 
Italy 
Study concluded that 50% of S. pyogenes strains were 
killed by solutions containing 58.5 µg/ml of propolis. 
All strains however, were killed by solutions containing 
234 µg/ml concentrations of propolis. 
Bosio et al., 2000 
Brazil 
Study reported MIC values between 25-400 µg/ml 
against S. mutans, S. sobrinus and S. cricetus. 
Koo et al., 2000 
Brazil 
Tested the seasonal effects of propolis on S. aureus, P. 
aeruginosa, E. coli and Salmonella typhimuruim. No 
significant difference in antimicrobial activity found.  
Sforcin et al., 
2000 
Brazil 
Antimicrobial activity of EEP tested against E. coli, S. 
aureus and C. albicans. Study reported weak inhibitory 
activity against E. coli and C. albicans with ZOIs 0-
13mm and 11-13.3 mm, respectively. Study further 
reported S. aureus as being the most sensitive test 
micro-organism with ZOI 10-18.3 mm.  
Velikova et al., 
2000 
Egypt 
Against S. aureus, MICs ranged from 1000 - 8400 
µg/ml, against E.coli MICs ranged from 1400 - 6400 
µg/ml and against C. albicans MICs ranged from 1400 - 
6400 µg/ml. 
Hegazi et al., 
2001 
Turkey 
EEP samples were tested against pathogens such as S. 
aureus, E. coli and P. aeruginosa. The EEP sample 
obtained from Istanbul showed greater activity against 
S. aureus with an MIC of 9 µg/ml and MBC of 16 
µg/ml, whereas the EEP sample obtained from Balikesir 
displayed MIC and MBC activity against S. aureus of 
175 and 310 µg, respectively. Both samples displayed 
poorer activity against the Gram-negative bacterial 
strains E.coli and P. aeruginosa 
Keskin et al., 
2001 
El Salvador EEP antimicrobial activity tested against S. aureus, Popova et al., 
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E.coli and C. albicans. No activity reported against 
Gram-negative E. coli, ZOIs of 11 and 12 mm reported 
for C. albicans and S. aureus, respectively. 
2001 
Egypt 
EEP tested against C. albicans, E. coli and S. aureus. 
Reported MICs of 1320 µg/ml, 1200 µg/ml and 2400 
µg/ml against C. albicans, E. coli and S. aureus, 
respectively. 
Abd El Hady and 
Hegazi, 2002 
Korea 
Antifungal activity of propolis was tested against C. 
neoformans and C. albicans. C. neoformans was 
reported as being the most sensitive with MICs 2-4 
mg/ml whilst C. albicans was reported as being less 
sensitive with MICs of 16 mg/ml. 
Chee, 2002 
Brazil 
The inhibitory activity of propolis extracts was tested 
against bacteria that cause periodontitis. Reported that 
all bacterial strains tested against showed susceptibility 
to propolis with MICs between 64  and 1024 mg/ml. 
Santos et al., 
2002 
Bulgaria 
Inhibitory effects of EEP were tested against H. pylori 
and Camphylobacter spp. Study reported mean ZOIs of 
21.4 mm against H. pylori and 13.6 mm against 
Camphylobacter spp. 
Boyanova et al., 
2003 
Italy 
Tested against 44 strains of S. aureus. All strains 
showed susceptibility, 42 of the 44 strains displayed 
MICs 0.09 - 0.21 mg/ml. 
Dolci and Ozino, 
2003 
Turkey 
Different ethanolic extracts of propolis displayed 
antibacterial activity against; S. aureus (9 - 11mm), S. 
epidermidis (10 - 12mm), and B. subtilis (9 - 11mm). 
The ethanolic extracts of Kazan propolis displayed 
antibacterial activity against C. diphtheriae (10 - 
12mm), B. catarrhalis (8mm), and C. albicans (8 - 
10mm). However, when tested against S. pyogenes, P. 
aeruginosa, E. coli, K. pneumoniae, and E. faecalis no 
antimicrobial activity was found. 
Kartal et al., 
2003 
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Croatia 
EEP tested against B. subtilis, reported ZOI of 13-18 
mm.  
Kosalec et al., 
2003 
Brazil 
Against S. aureus, the inhibitory activity of propolis 
produced by Apis Mellifera ranged between 0.36 - 3.65 
mg/ml and propolis produced by Tetragonisca 
angustula ranged between 0.44 - 2.01 mg/ml. 
Miorin et al., 
2003 
Serbia 
Propolis samples tested against different bacterial 
strains (Gram-positive, Gram-negative and yeasts). 
MICs for Gram-positive bacteria ranged between 
0.078% and 1.25%, Gram-negative bacteria between the 
ranges of 1.25% - 5% and lastly yeasts ranged from 
0.16 - 1.25%. Study concluded that E. faecalis was the 
most resistant Gram-positive bacteria, Salmonella the 
most resistant Gram-negative bacteria and C. albicans 
as the most resistant yeast. 
Stepanović et al., 
2003. 
Colombia, 
Ethiopia, 
Germany, 
Italy, 
Kazakhstan, 
Poland, 
Russia and 
South 
Africa 
Reported that filamentous fungi are less sensitive to the 
actions of propolis. MIC values of various propolis 
samples tested lay between 0.005 and 0.5% w/v, with 
the exception of E.coli 
Garedew et al., 
2004 
Northwest 
Greece 
MICs for Gram-positive bacteria 0.50 - 0.80 mg/ml, for 
Gram-negative MICs 0.65 - 0.90 mg/ml and 0.50 - 0.80 
mg/ml against yeast spp.  
Melliou and 
Chinou, 2004 
Croatia 
Antimicrobial activity of EEP tested against MRSA, 
MSSA, P. aeruginosa and Enterococcus spp. Reported 
ZOIs of 9.3-22.1 mm; MICs of 0.65-14.16 mg/ml and 
MBCs 1.38-23.44 mg/ml against all micro-organisms 
tested. 
Pepeljnjak and 
Kosalec, 2004 
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Turkey 
Found that the antimicrobial activity of propolis varied 
depending on not only the propolis sample but also the 
dosage of propolis used and extraction solvents used. 
DMSO extracts were more active than acetone extracts. 
Against Brucella meliteni, the acetone extracts showed 
a greater activity. The study concluded that the most 
sensitive organism to propolis was Shigella sonnei from 
the Gram-negative group (0.00 -11.2 mm) and S. 
mutans from the Gram-positive group (0.0- 10.2 mm). 
But the least sensitive to the propolis was C. albicans. 
Ugur and Arslan, 
2004 
Brazil 
MIC of 90% EEP was shown to be 0.4% v/v. Fernandes Jr et 
al., 2005 
Brazil 
Propolis tested on caries development. Reported MICs 
of EEP 25 - 400 µg/ml against S. sobrinus and S. 
mutans. 
Hayacibara et al., 
2005 
Turkey 
MIC distributions for samples from Mamak and 
Kemaliye against methicillin-resistant S. aureus and 
vancomycin-resistant Enterococcus faecium were in the 
range of 7.8 - 31.2 µg/ml, 70.3 - 281.2 µg/ml and 35.1 - 
140.4 µg/ml, all samples showed great activity against 
MRSA and VREF. 
Kilic et al., 2005 
Taiwan 
Various factors were considered, such as the effects of 
cell age, incubation temperature, geographical location, 
concentration and pH on the antibacterial activity of the 
propolis samples against S. aureus. The study reported 
that the MIC of EEP samples ranged from < 3.75 - 60 
µg/ml.  
Lu et al., 2005. 
Turkey 
Tested 30% EEP against S. aureus and E. coli. Reported 
S. aureus to be more susceptible to lower concentrations 
(<0.1 - 0.4 ml) of propolis than E. coli (0.2- >14 ml).  
Popova et al., 
2005 
Lithuania 
and Czech 
Antimicrobial activity of EEP was tested against 
multiple organisms including; E. faecalis, Bacillus spp., 
Savickas et al., 
2005 
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Republic S. aureus, P. aeruginosa, E. coli, and C. albicans. All 
samples showed inhibitory activity even after a four 
times dilution with ZOIs >10 mm.  
Turkey 
Study tested propolis produced by three different 
honeybee species namely Apis mellifera carnica, Apis 
mellifera caucasica and Apis mellifera anatolica. 
Propolis was tested against S. aureus, E. coli, P. 
aeruginosa and C. albicans. Growth of Gram-positive 
bacteria was inhibited better than both Gram-negative 
and yeast species with both MIC50and MIC90 ranging 
from 117 - 7500 µg/ml. 
Silici and 
Kutluca, 2005 
Turkey 
Propolis tested against oral pathogens. Reported that 
10% Turkish propolis displayed no significant activity 
against oral pathogens. 
Sonmez et al., 
2005 
Turkey 
MIC values of propolis were 2 µg/ml against S. 
sobrinus and E. faecalis, 4 µg/ml against Micrococcus 
luteus, C. albicans and Candida krusei, 8 µg/ml against 
S. mutans, S. aureus, S. epidermidis and Enterobacter 
aerogenes, 16 g/ml against E.coli and C. tropicalis and 
lastly 32 µg/ml against P. aeruginosa and S. 
typhimuruim. 
Uzel et al., 2005 
Turkey 
Tested antimicrobial activity of propolis against 15 
plant pathogenic bacteria. Reported ZOIs ranging 6 mm 
to 12 mm. 
Basim et al., 
2006 
Bulgaria 
Propolis samples were found to be highly active against 
anaerobic bacteria. Samples inhibited > 89% of all 
strains tested against. Found to be more effective at 
inhibition of Gram-positive bacteria rather than Gram-
negative bacteria and yeasts. 
Boyanova et al., 
2006 
Korea 
All samples were shown to inhibit growth of all strains 
tested against. Inhibitory zones varied between 2.0 - 6.1 
mm. 
Choi et al., 2006 
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Brazil 
Tested EEP against S. aureus. MIC was described as the 
volume of propolis extract per 100 ml of culture 
medium (%v). All extracts found to display 
antimicrobial activity ranging from 0.2 to 3.2 %v 
da Silva et al., 
2006 
Brazil 
Study tested the effects of two commercial propolis 
products one ethanolic extract (EEP) and the other 
without ethanol (EP) against various pathogens 
including S. mutans, S. aureus, E. coli and C. albicans. 
Both products were found to display ZOIs ranging 6-18 
mm for the EEP product and 6-27 mm for the EP 
product. 
de Rezende et al., 
2006 
Brazil 
Against S. aureus EEP displayed zones of inhibition 
ranging from 8 to 13 mm and did not display any 
inhibitory activity against E. coli. 
Gonsales et al., 
2006 
Turkey 
Tested EEP against various pathogens including S. 
aureus, B. subtilis, E. coli, P. aeruginosa and C. 
albicans. Contrary to previous studies reporting strong 
Gram-positive inhibition, this study reported that EEP 
displayed strong antimicrobial activity against Gram-
negative bacteria with a ZOI of 19 mm against E. coli 
and 16 mm against P. aeruginosa. Good antifungal 
activity with a ZOI of 16 mm against C. albicans was 
also noted. 
Mercan et al., 
2006 
Brazil 
Antifungal activity of EEP was tested against various 
Candida spp. C. parapsilosis was reported as being the 
most sensitive of the species tested with MICs 0.63-5.00 
x 10
-2
 mg/ml whilst C. tropicalis the most resistant with 
MICs 2.50-5.00 x 10
-2 
mg/ml. 
Oliveira et al., 
2006 
Italy 
Against 35 strains of  S. aureus the MIC50 and MIC90 
were both 1.25 mg/ml, against S. epidermidis and 
Staphylococcus spp. were 1.25 and 52.5 mg/ml. 
Scazzocchio et 
al., 2006. 
Argentina Tested the antimicrobial effects of propolis against Quiroga et al., 
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fungal strains. EEP displayed MICs of 77 µg/ml against 
Saccharomyces carlsbergensis and 349 µg/ml against 
Trichoderma spp., Fusarium spp. and Penicillium 
notatum. 
2006 
Brazil 
Antimicrobial activity tested against S. aureus and S. 
mutans, MICs ranged 50 -100 µg/ml. 
Alencar et al., 
2007 
Brazil 
Tested the antifungal activity of commercial and 
aqueous extracts of propolis against Candida spp. 
Commercial extracts were reported as displaying better 
activity than aqueous extracts with ZOIs ranging 12-28 
mm against various Candidal spp. tested.  
Dias et al., 2007 
Italy 
Antimicrobial activity (MIC and MBC) of a new 
propolis formulation known as "Actichelated" propolis 
was tested against various microorganisms including S. 
aureus, S. pyogenes, Enterococcus spp., E. coli, Proteus 
mirabilis and P. aeruginosa. Results were compared to 
the hydroalcoholic extract of propolis. Study reported 
that for actichelated propolis against S. pyogenes MICs 
and MBCs ranged 0.016-0.125 mg/ml and 2-4 mg/ml 
versus the hydroalcoholic extract that ranged 0.084-1.34 
mg/ml and 10.7-21.4 mg/ml, respectively. Concluded 
that the new formulation actichelated propolis possessed 
greater antibacterial action than the usual 
hydroalcoholic extract tested in most studies. 
Drago et al., 
2007 
Bulgaria 
Bactericidal, fungicidal (MBCC) activities of EEP were 
tested against C. albicans, E. faecalis and E. coli. 
MBCCs ranged 1502 ± 320.0 μg/ml against E. faecalis; 
24 306 ± 1706.4 μg/ml against E.coli and 1375 ± 255.2 
μg/ml against C. albicans 
Gardjeva et al., 
2007 
Brazil 
Tested the antibacterial and antifungal activity of a new 
adhesive formulation containing propolis against 
Candida spp., S. aureus, S. mutans and E. faecalis. All 
Gomes et al., 
2007 
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pathogens were found to be sensitive to the formulation 
with MICs ranging 1.75-14.0 µg/ml.  
Turkey and 
Brazil 
Reported MIC values ranging from 4 - 512 µg/ml. 
Concluded that EEP samples were more effective 
against Gram-positive bacteria than Gram-negative 
bacteria. 
Koru et al., 2007 
Iran 
Inhibition of growth was observed against all tested 
microorganisms with the highest activity being against 
Gram-positive bacteria such as S. aureus and S. 
epidermidis with MICs as low as 125 µg/ml. 
Mohammadzadeh 
et al., 2007 
Kenya 
Antibacterial activity of different concentrations (i.e. 
100%, 70%, 50% and 30%) of EEP was tested E. coli, 
S. typhimurium, P. aeruginosa, S. aureus and B. 
subtilis. Gram-positive S. aureus and B. subtilis were 
reported as being the most sensitive with ZOIs 10.5 mm 
and 11.5 mm, respectively, whilst Gram-negatives E. 
coli and P. aeruginosa were less sensitive. 
Muli and Maingi, 
2007 
Brazil and 
Bulgaria 
EEP samples were tested against pathogens associated 
with human infection and the contamination of food 
(poultry) namely; S. typhimurium and S. enteritidis. 
Study found that S. enteritidis was more sensitive to the 
antimicrobial activity of both Brazilian and Bulgarian 
EEP samples than S. typhimurium with MICs ranging 
from 217.5 to 221 mg/ml 
Orsi et al., 2007 
Various 
regions of 
Asia, South 
and North 
America 
and Europe 
Antibacterial activity tested, MIC of 250 µg/ml reported 
against S. aureus 
Popova et al., 
2007 
Argentina 
Antimicrobial activity tested against E. coli. Zones of 
inhibition found were considered negligible. 
Tosi et al., 2007 
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Mexico 
Using broth a microdilution assay EEP was tested 
against S. aureus, E. faecalis, Listeria monocytogenes, 
E. coli and P. aeruginosa. Study found that propolis 
from Ures displayed strong antibacterial activity of 100 
µg/ml, whilst propolis from Caborca displayed only 
moderate activity of 200 µg/ml against S. aureus. No 
samples were found to display activity against Gram-
negative micro-organisms. 
Velazquez et al., 
2007 
Brazil 
Antimicrobial activity of propolis tested against 
Paenibacillus larvae that cause American Foulbrood 
(AFB) disease in honeybees. Study found that inhibitory 
zones varied between 20.5±2.1 mm and 15.5±2.2 mm 
thereby proving some antimicrobial activity against P. 
larvae. 
Bastos et al., 
2008 
Various 
countries 
within 
tropical and 
subtropical 
regions 
EEP from Tanzania and South Africa found to display 
moderate activity with MICs 31.25 - 250 mg/l and 62.5 
- 500 mg/l respectively. Propolis from Cameroon and 
northwestern Tanzania displayed higher activity with 
MICs 7.81 - 125 mg/l and 15 - 62 mg/l respectively. 
American samples displayed moderate activity with 
MICs 31.25 - 500 mg/l. Asian and European samples 
were also found to display moderate activity with MICs 
31.25 - 500 mg/l. 
Seidel et al., 
2008 
Turkey 
MICs ranged 0.12 to > 4.00 mg/ml, greater 
antimicrobial activity observed against Gram-positive 
microorganisms. Mycobacterium smegmatis, S. aureus 
and C. albicans reported as being the most sensitive 
microorganisms with MICs 0.12-0.25 mg/ml. 
Vardar-Ünlü et 
al., 2008 
Italy 
Antimicrobial activity of EEP was tested against 
Camphylobacter spp. Strains of C. jejuni were reported 
as being the most sensitive with MICs 0.156-0.3125 
mg/ml. 
Campana et al., 
2009 
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Argentina 
Tested EEP against S. aureus. Found that 77% of 
samples tested displayed zones of inhibition of> 9 mm. 
Chaillou and 
Nazareno, 2009 
Brazil 
EEP tested against various oral pathogens; fungal and 
bacterial, including S. aureus, Candida spp., 
Streptococcus spp., Bacteroides fragilis, Tanerella 
forsynthesis, Fusobacterium spp., and Porphyromonas 
gingivalis. MICs, MBCs and ZOIs against; Candida 
spp. ranged 20-50 µg/ml, 100-400 µg/ml and 12.3-28.3 
mm; against S. aureus ranged 25-50 µg/ml, 200-
400µg/ml and 16.3 mm; against Streptococcus spp. 
ranged 25-50 µg/ml, 200-400 µg/ml and 18.3-28.6 mm; 
against B. fragilis ranged 25-50 µg/ml, 300-500 µg/ml 
and 15.3 mm; against T. forsynthesis ranged 30-60 
µg/ml, 300-500 µg/ml and 14 mm; against P. gingivalis  
ranged 30-50 µg/ml, 200-400 µg/ml and 14 mm; against 
Fusobacterium spp. ranged 30-60 µg/ml, 200-400 
µg/ml and 15.2-17.3 mm. 
de Paula et al., 
2009 
Brazil 
Study found that 1% ethanol extracts inhibited the 
growth of M. luteus, S. aureus, E. coli and P. 
aeruginosa. 
Farnesi et al., 
2009 
Slovakia 
Antifungal activity of EEP was tested against Candida 
spp., it was found that C. krusei displayed the greatest 
sensitivity to 70% EEP with ZOI 6.00±2.83 mm and C. 
glabrata the being least sensitive ZOI 3.50±0.77 mm. 
Kačániová et al., 
2009 
Central and 
Southern 
Greece, 
Aegean Sea 
islands and 
Cyprus 
Antimicrobial activity tested against 18 bacterial strains 
and two fungal strains. Sensitivity of Gram-positive 
strains varied with S. aureus, S. epidermidis, B. cereus 
and Listeria monocytogenes being the most sensitive. 
Kalogeropoulos 
et al., 2009 
Iraq 
Large inhibition zones displayed against S. epidermidis 
22 - 26 mm, 15 - 22 mm against S. aureus and 16 - 22 
Najmadeen and 
Kakamand, 2009 
 128 
 
Origin Results of study References 
mm against C. albicans. Gram-negative bacteria found 
to display much smaller zones (7 - 9 mm). 
Brazil 
Inhibitory effects of red and green EEP tested against 
Trichophyton spp. Study reported MICs for red EEP 64-
1024 µg/ml and green EEP 256-1024 µg/ml, with the 
most sensitive micro-organism to both EEP samples 
being T. rubrum. 
Siqueira et al., 
2009 
Brazil 
Antimicrobial activity tested against 34 Staph. 
coagulase-positive and Malassezia pachydermatis 
causing canine otitis. Both isolates found to be 
susceptible to propolis with MBCs 10.7 - 21 mg/ml and 
2.4 - 5.3 mg/ml. 
Cardoso et al., 
2010 
Jordan 
Propolis from Al-Hasmeah was found to display high 
antimicrobial activity with zones of inhibition 24.67 
mm against S. aureus. Both samples did not display any 
significant activity against E. coli. 
Darwish et al., 
2010 
Chile 
Commercial Chilean EEP samples were tested against 
oral Candida spp. Study reported MICs ranging 197-
441 µg/ml against C. albicans and 51-253 µg/ml against 
C. glabrata. 
Herrera et al., 
2010 
Serbia  
Tested the antibacterial activity of EEP against various 
pathogens under different pH values, acidic, neutral, 
and alkaline. All EEP samples exhibited antibacterial 
activity regardless of the pH of the solution within 
which they were tested. 
Ivančajić et al., 
2010 
Tunisia 
Antimicrobial activity evaluated against E. faecalis and 
Streptococcus spp. EEP found to display MICs 2 - 64 
µg/ml against Streptococcus. spp. and >500 µg/ml 
against E. faecalis. 
Kouidhi et al., 
2010 
Romania 
EEP tested against Gram-positive bacteria, Gram-
negative bacteria and yeast. Study found that Gram-
positive bacteria were most susceptible with S. aureus 
Marghitas et al., 
2010 
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being the most sensitive with a ZOI of 17 mm, Gram-
negative bacteria were less susceptible and yeast species 
C. albicans displayed moderate susceptibility with a 
ZOI of 10mm.  
Nigeria 
The activity of EEP samples were tested against 
pathogens known to cause upper respiratory tract 
infections, bacteria found from throat swabs included S. 
pneumoniae, K. pneumoniae, S. pyogenes and M. 
catarrhalis. S. pneumoniae was found to be the most 
sensitive pathogen with a ZOI of 32 mm, S. pyogenes 
was found to be the least sensitive microorganism with 
a ZOI of 10 mm. 
Ophori and 
Wemabu, 2010 
Nigeria 
An antimicrobial effect of varying concentrations of 
EEP was tested against S. mutans. Study reported a ZOI 
of 24±4 mm at an MIC of 32 µg/ml.   
Ophori et al., 
2010 
Turkey 
The antimicrobial, both MIC and MBC of EEP samples 
were tested against eleven different anaerobic bacteria 
including Lactobacillus acidophilus, Prevotella 
intermedia and Actinomyces odontolyticus. Actinomyces 
odontolyticus was reported as the most susceptible 
microorganism with MICs 0.4-5.8 mg/ml and MBCs of 
0.8-11.6 mg/ml. 
Özen et al., 2010 
Kenya 
Sample from Mwingi showed no inhibition against S. 
aureus, sample from Voi displayed zone of inhibition of 
18 mm against S. aureus. Both samples displayed no 
activity against C. albicans and E.coli. 
Petrova et al., 
2010 
Canada 
Tested against E.coli and S. aureus, reported propolis 
concentrations of 2.74 - 5.48 mg/ml as having the 
largest inhibitory zone of 15.0 ± 0.11mm against S. 
aureus. The study concluded that 2.74 mg/ml of 
propolis is effective against S. aureus. 
Rahman et al., 
2010 
Iran Study reported a ZOI of 21±1 mm against S. aureus. Trusheva et al., 
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2010 
Iran 
Effects of EEP tested against various pathogens causing 
diseases in fish such as; Aeromonas hydrophilia, 
Yersinia ruckeri and Streptococcus iniae. EEP samples 
inhibited the growth of all bacteria with MICs and 
MBCs ranging 195.31 µg/ml against S. iniae to 781.25 
µg/ml against A. hydrophilia and 195.31 to 1562.5 
µg/ml, respectively.  
Tukmechi et al., 
2010 
Turkey 
Inhibitory and cidal activity of EEP was tested against 
E. faecalis and C. albicans. Against E. faecalis, study 
reported better inhibition with an MIC and MBC of 0.3 
and 0.6 mg/ml respectively. Greater inhibition was 
observed against C. albicans with an MIC of 0.075 
mg/ml; the cidal activity of EEP against C. albicans 
however, was poorer with an MBC of 0.150 mg/ml. 
Arslan et al., 
2011 
Brazil 
Tested EEP against S. mitis, S. mutans and S. salvarius 
(cariogenic bacteria). Study reported zones of inhibition 
of 15.8 mm, 7.5 mm and 15.9 mm against S. salvarius, 
S. mitis and S. mutans respectively. 
de Castro Ishida 
et al., 2011 
Brazil 
EEP as well as propolis microparticles (PMs) were 
tested against Candida spp. isolated from vulvovaginal 
candidasis. Study reported that all yeasts were inhibited 
by EEP at a concentration of 1100 µg/ml,  and by PMs 
inhibition was observed at a concentration of 5570 
µg/ml. 
Dota et al., 2011 
Iran 
Antifungal activity of EEP was tested against 
Epidermophyton flucosum, Trichophyton violaseum and 
Trichophyton tonsorans in varying concentrations from 
20-0.312 mg/ml. At concentrations of 0.625 and 0.312 
mg/ml the diameter of colonies of the dermatophyte 
spp. ranged from 2-17 mm and 3-22 mm at these 
respective concentrations. 
Gavanji et al., 
2011 
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Iraq 
EEP tested against various pathogens including E. coli, 
S. aureus, S. typhimurium, K. Pneumonia, C. albicans 
and P. aeruginosa. EEP was tested at various 
concentrations, at the lowest concentration of 10% good 
antimicrobial activity was noted, with S. aureus 
displaying the greatest sensitivity, EEP was found to 
exert no effect on C. albicans 
Hendi et al., 
2011 
Iran 
Tested the effects of EEP against oral pathogens 
including; E. faecalis, S. mutans and S. aureus. Study 
reported that all three pathogens were inhibited at the 
same EEP concentration of 250 µg/ml. 
Kashi et al., 2011 
Korea 
Tested propolis against foodborne pathogens. Found to 
display MICs 0.036 mg/µl against B. cereus on agar 
medium. When tested in nutrient broth, displayed MICs 
1.8 mg/ml. 
Kim and Chung, 
2011 
Brazil 
Propolis extracts displayed inhibitory zones of 10 - 13 
mm against S. mutans and 9 - 13 mm against C. 
albicans. 
Liberio et al., 
2011 
Turkey 
Study tested the effects of a triantibiotic mixture (TAM) 
and calcium hydroxide in comparison to EEP in the 
treatment of E. faecalis infected root canals. EEP was 
reported as being the only test sample producing the 
highest reduction in colony counts of E. faecalis with a 
100% reduction rate after only 2 days of treatment. 
Madhubala et al., 
2011 
Brazil 
Reported antimicrobial activity against S. aureus MICs 
62.5 - 125 µg/ml and against S. mutans MICs 62.5 - 125 
µg/ml 
Oldoni et al., 
2011 
Brazil 
Study tested the antimicrobial activity of EEP samples 
against 210 strains of S. aureus; MRSA and methicillin 
sensitive S .aureus (MSSA). Reported that MICs ranged 
from 710 to 2850 µg/ml when tested against both 
MRSA and MSSA. 
Pamplona-
Zomenhan et al., 
2011 
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Malta and 
the island of 
Gozo 
Maltese propolis displayed no activity against Gram-
negative E.coli. All samples displayed good activity 
against S. aureus MICs 15 ± 1 mm to 27 ± 1 mm. Only 
six samples reported to display antifungal activity 
against C. albicans MICs 12 ± 0 mm to 16 ± 0 mm. 
Popova et al., 
2011 
Brazil (red 
propolis) 
Propolis extracts inhibited the growth of all 
microorganisms tested against with MICs as low as 256 
µg/ml against P. aeruginosa, B. subtilis and C. albicans. 
Righi et al.,2011 
Chile 
Tested the effects of commercial EEP samples against 
L. fermentum. All samples were found to inhibited 
growth of L. fermentum with the greatest inhibition 
being dilution 1/32. 
Saavedra et al., 
2011 
Turkey 
Study tested the inhibitory activity of EEP against 
foodborne pathogens; S. enteriditis and L. 
monocytogenes. Samples were tested as dilutions of 
1:10 and 1:100 v/v with sterile distilled water. Reported 
that the higher concentration 1:10 v/v strongly inhibited 
the growth of both microorganisms, whilst the 1:100 v/v 
concentration had a minimal effect on tested pathogens. 
Temiz et al., 
2011 
Iran 
The effects of propolis and nanopropolis were tested 
against S. aureus and C. albicans. Study reported ZOIs 
of 16-18 mm against C. albicans and 11-13 mm against 
S. aureus with propolis with larger particle size, study 
furthermore found that nanopropolis (propolis milled to 
form nanoparticles) produced greater ZOIs ranging 18-
21 mm and 24-26 mm against C. albicans and S. aureus 
respectively. 
Afrouzan et al., 
2012 
India 
Potent antimicrobial activity was observed against 
Gram-positive and Gram-negative bacteria as well as 
yeast species. MICs ranged between 1.21 - 9.75 µg/ml, 
furthermore no strains were found to be resistant to 
EEP. 
Choudhari et al., 
2012 
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Portugal  
Samples exhibited antimicrobial activity, however, the 
effect was dependant on the dose and origin of propolis. 
MIC's ranged from 0.24 ± 0.17 mg/ml to 1.43 ± 0.32 
mg/ml against Methicillin resistant S. aureus. 
Dias et al., 2012 
Iran 
Study tested the activity of EEP in comparison to 
calcium hydroxide against Lactobacillus, C. albicans, 
E. faecalis and Peptostreptococcus. In comparison to 
calcium hydroxide EEP was found to display larger 
ZOIs of 8.7 mm compared to the ZOI of calcium 
hydroxide at 7.1 mm. 
Kousedghi et al., 
2012 
Turkey 
Tested the effects of EEP against S. aureus, E. faecalis 
and C. albicans. Study found that EEP the greatest 
inhibition was against E. faecalis with a ZOI of 15.8 
mm. 
Mattigatti et al., 
2012 
Slovenia 
Tested two samples PEE70 and PEE96. All extracts 
showed to be more effective against Gram-positive 
bacteria with MICs 0.15 - 1.2 mg Chlorogenic acid 
equivalents(CAE)/ml. Against Gram-negative bacteria, 
yeasts and moulds MICs 0.17 - 1.4 mg CAE/ml. 
Mavri et al., 
2012 
Cuba 
Antibacterial, antifungal and antiprotozoal activities of 
red, brown and yellow Cuban EEP tested against S. 
aureus, E. coli, T. rubrum, C. albicans, Plasmodium 
falciparum and Leishmania. Study reported S. aureus as 
being the most sensitive microorganism MIC 4.4±1.3 
µg/ml, E. coli and C. albicans displayed the least 
sensitivity to all Cuban EEP samples with MIC >64 
µg/ml. Yellow Cuban EEP reported as having good 
antiprotozoal activity, particularly against Plasmodium 
spp. with an MIC of 0.2±0 µg/ml. 
Monzote et al., 
2012 
Brazil and 
Bulgaria 
Brazilian propolis inhibited the growth of S. 
typhimurium with an MIC of 9.9% v/v, and the MIC of 
Bulgarian propolis was 10.0% v/v. 
Orsi et al., 2012 
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Brazil 
Using the microdilution assay, tested EEP against three 
strains of S. aureus causing mastitis in cows. Propolis 
was found to display antimicrobial activity of 0.292 and 
0.586 mg/ml against all strains tested. 
Santana et al., 
2012 
Portugal  
Antimicrobial activity found to be dependent on origin 
of propolis. S. aureus reported as the most sensitive 
with MIC values 0.59 ± 0.30; 1.36 ± 0.79 and 1.72 ± 
0.87 mg/ml. C. albicans found to be the most resistant 
MIC values 13.19 ± 7.21; 13.44 ± 8.23 and 13.90 ± 
7.512 mg/ml. 
Silva et al., 2012 
India 
Investigated the effects of propolis produced by Apis 
mellifera and Trigona spp. against various pathogens 
including B. cereus, Burkholderia glumae, 
Xanthomonas campestris. The greatest inhibition was 
noted against B. glumae for A. mellifera with a ZOI of 
17.52±2.04 mm and for Trigona sp. with a ZOI of20.0± 
0.63 mm. 
Surendra et al., 
2012 
Iraq 
EEP 50 mg/ml and 100mg/ml produces ZOIs of 30 and 
40 mm against S. typhimurium, respectively. 
Al-safi, 2013 
Czech 
Republic 
Antimicrobial (MIC) and the minimum microbicidal 
concentration (MMC) of EEP was tested against various 
pathogens including vancomycin resistant Enterococcus 
faecium, MRSA, S. pyogenes and various Candida spp. 
Study reported S. pyogenes as being the most sensitive 
pathogen tested with MICs of 0.03-0.13 mg/ml and 
MBCs of 0.06-0.25 mg/ml; MRSA and E. faecium were 
reported as the least susceptible with MICs and MBCs 
of 0.13->4 mg/ml and 0.5->4 mg/ml, respectively. 
MICs and fungicidal concentrations (MFC) against the 
various Candida spp. ranged from 0.15-1.2 mg/ml, and 
MFCs of 0.6-2.4 mg/ml. 
Astani et al., 
2013 
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Chile 
Two samples from central Chile displayed the lowest 
activity with MICs 6.67 and 8.22 µg/ml against S. 
mutans and S. sobrinus respectively. Another 2 samples 
from southern Chile displayed the highest antimicrobial 
activity with MICs 1.94 and 0.90 µg/ml against S. 
mutans and S. sobrinus respectively. 
Barrientos et al., 
2013 
Brazil 
Using the microdilution assay the study tested propolis 
produced by honeybees, Melipona scutellaris, against S. 
mutans, S. aureus, MRSA, E. faecalis, Actinomyces 
naeslundii and P. aeruginosa. Reported geopropolis as 
being able to inhibit the growth of s. mutans, S. aureus 
and MRSA with MICs <50 µg/ml and MBCs 25 - 50 
µg/ml. No activity was noted against P. aeruginosa. 
Against E. faecalis and A. naeslundii MICs ranged from 
800 to 1600 µg/ml. 
da Cunha et al., 
2013 
Brazil 
EEP tested against a variety of rumen bacteria. 
Ruminococcus  flavefaciens and Fibrobacter 
succinogenes were reported as the most sensitive 
microorganisms inhabited at an EEP concentration of 
500 µg/ml, all other microorganisms tested were less 
susceptible and all inhabited at an EEP concentration of 
1000 µg/ml. 
de Aguiar et al., 
2013 
Poland 
Mean MICs of EEP against various S. mutans spp. 
ranged 0.78-1.56 mg/ml and against Lactobacillus spp. 
ranged 0.20-1.56 mg/ml. Study also tested the MBC of 
EEP and found that against S. mutans spp. mean MBCs 
ranged 3.13-12.5 mg/ml and 0.39-12.5 mg/ml against 
Lactobacillus spp. 
Dziedzic et al., 
2013 
Portugal  
EEP was tested against S. aureus and C. albicans, study 
reported ZOI of 24.6±3.8 mm and 32.0±3.2 mm against 
S. aureus and C. albicans, respectively. 
Falcão et al., 
2013 
India Antimicrobial activity of EEP was tested against S. Kalia et al., 2013 
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typhimurium in varying concentrations, the MIC of EEP 
was reported as 200 mg/ml and its MBC as 250mg/ml. 
Iran 
EEP was tested against 128 various pathogens causing 
onychomycosis including C. albicans. The MIC  for 
various strains of Candida spp. ranged from 2-20 
µg/ml. 
Khosravi et al., 
2013 
Oman 
MICs ranged 42 - 169 µg/ml against S. aureus and 169 - 
365 µg/ml against E. coli. 
Popova et al., 
2013 
Northern 
Thailand 
30%, 40% and 50% EEP's showed inhibitory zones 
between 4.11-4.44 mm against Gram-positive bacteria. 
Siripatrawan et 
al., 2013 
Poland  
The MIC and MBC of Polish EEP samples were tested 
against MSSA and MRSA. Study reported MICs and 
MBCs against MSSA of 0.39-0.78 mg/ml and 1.56-3.13 
mg/ml, respectively, and against MRSA of 0.39-0.78 
mg/ml and 0.78-3.13 mg/ml, respectively.  
Wojtyczka et al., 
2013a 
Poland  
Antimicrobial activity of EEP tested against S. 
epidermidis. Study reported all strains as susceptible 
and inhibited at MICs 0.78-1.56 mg/ml. 
Wojtyczka et al., 
2013b 
Argentina 
Activity of propolis was tested against various Candida 
spp. as well as dermatophytes such as Trichophyton 
mentagrophytes and T. rubrum. Study reported that a 
majority of Candidal and dermatophyte spp. were 
inhibited by EEP with MICs  ranging 31.25-125 µg/ml.  
Agüero et al., 
2014 
Brazil 
Propolis was obtained from bee species Melipona 
orbignyi. MICs ranged 3.1 - 50 mg/ml against S. aureus 
and C. albicans. 
Campos et al., 
2014 
Brazil 
Antibacterial activity tested against S. aureus, reported 
ZOIs 2.6-14.3 mm.  
de Souza et al., 
2014 
Egypt 
EEP was tested against bacterial pathogens causing 
mastitis including E. coli, S. aureus, E. faecalis and P. 
aeruginosa. S. aureus and E. faecalis were reported as 
being the most sensitive approximately 41% of all 
Hegazi et al., 
2014 
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bacterial strains implicated in mastitis in this study were 
found to be inhibited by EEP. 
Iraq 
EEP samples tested against various pathogens causing 
keratitis in lab animals such as E. coli and P. 
aeruginosa. P. aeruginosa found to be the most 
sensitive with ZOI range 44-58 mm and E. coli less 
sensitive with ZOI 23-32 mm. 
Kadhim and 
Kadhim, 2014 
India 
Ultrasonicated EEP samples were tested against various 
Gram-positive and Gram-negative pathogens including 
S. aureus and E. coli, study reported ZOIs of 1+0.03 
mm, 4 +0.07 mm and 6+0.2 mm against S. aureus and 4 
+0.05 mm, 5+0.01 mm and 7 +0.4 mm against E. coli. 
These results were found at propolis concentrations of 
500, 750 and 1000µg/ml of EEP respectively. 
Kothai and 
Jayanthi, 2014 
Australia 
Propolis obtained from bee species Tetragona 
carbonaria. Propolis tested against S. aureus and P. 
aeruginosa. S. aureus displayed MIC 6.94 µg/ml. 
Massaro et al., 
2014 
Romania 
Inhibitory activity of propolis was tested against 
organisms known to cause severe infections in animals 
such as; S. aureus, E. coli, P. aeruginosa, Salmonella 
spp., Streptococcus suis and Pasteurella haemolytica. S. 
aureus was found to be the most sensitive pathogen 
with a ZOI of 27 mm and P. haemolytica was noted as 
the least sensitive pathogen with a ZOI of 15 mm. 
Moţ et al., 2014 
Cameroon 
Methanolic extracts of propolis (PME) were tested 
against Salmonella spp., E.coli and P. aeruginosa. PME 
displayed no antimicrobial activity against Salmonella 
spp., however antimicrobial activity was noted against 
E. coli and  P. aeruginosa, ZOIs of 26 mm and 32.5 mm 
, respectively, were reported with corresponding MICs 
of 0.2 mg/ml. 
Sakava et al., 
2014 
Brazil EEP tested against S. aureus, E. faecalis and Schmidt et al., 
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Micrococcus luteus; MICs ranged 340-1300 µg/ml, 
760-2730 µg/ml and 340-680 µg/ml, respectively. 
MBCs reported ranged 380-2600 µg/ml, 1500-5480 
µg/ml and 380-1560 µg/ml against respective pathogens 
tested. 
2014 
Brazil 
Antimicrobial properties of geopropolis extracts tested 
against S. aureus and E. coli. Reported that only high 
concentrations of geopropolis extracts inhibited growth 
with MICs of 1788 µg/ml and 1997 µg/ml against S. 
aureus and E. coli, respectively. 
Araújo et al., 
2015 
Brazil 
EEP was tested against clinical strains of Candida spp. 
in varying concentrations. EEP samples with a 
concentration of 25% were reported as displaying a ZOI 
of 26.40±18.00  
Bezerra et al., 
2015 
France 
Antifungal and antibacterial activity of EEP was tested 
against various strains of Candida spp. and bacteria 
including S. aureus, P. aeruginosa, E.coli and E. 
faecalis. Study found that for all extracts of propolis 
antifungal activity ranged 15.63- >250 µg/ml, MIC 
against Gram-positive bacteria ranged 57-> 100 µg/ml. 
Gram-negative bacteria were found to be less 
susceptible to antimicrobial activity. 
Boisard et al., 
2015 
Brazil  
The antimicrobial activity of EEP samples were tested 
against various pathogens including S. aureus, E. 
faecalis, K. Pneumonia, P. aeruginosa and C. albicans. 
MICs against Gram-positive bacteria ranged 0.55-1.02 
mg/ml, against Gram-negative bacteria ranged 2.25-
7.91 mg/ml and against yeast species ranged 7-9.25 
mg/ml.  
Campos et al., 
2015 
Brazil 
Antifungal activity of propolis tested against C. 
albicans. Study reported that all strains were inhibited 
with MICs 68.35-546.87 µg/ml. 
Capoci et al., 
2015 
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Lebanon 
EEP was tested against extended spectrum -β 
lacatamase Klebsiella (ESBL-Klebsiella pneumonia), 
methicillin resistant S. aureus (MRSA) and Candida 
albicans. All samples were found to display 
antimicrobial activity with the most active sample being 
from Saffareh-Jezzine, this sample displayed MICs of 
6.25 mg/ml against MRSA, 12.5 mg/ml against ESBL 
K. pneumonia and 12.5 mg/ml against C. albicans. 
Chamandi et al., 
2015 
Lithuania  
Water, oil and ethanolic extracts of propolis were tested 
against S. aureus, B. cereus, K. pneumoniae, P. 
aeruginosa, E. coli and C. albicans. Study reported that 
some water and oil extracts displayed good 
antimicrobial activity with ZOIs ranging 16.0-20.5 mm 
for water and oil extracts against all microorganisms 
tested. ZOIs for EEP ranged 14.8-17.2 mm against all 
microorganisms tested. 
Kubiliene et al., 
2015 
Brazil 
The activity of brown EEP samples was tested against 
E. faecalis. Study reported a percentage inhibition of 
36% for samples containing a 40% concentration of 
Brazilian brown EEP. 
Pimenta et al., 
2015 
India 
Olive oil and virgin coconut oil (VCO) extracted 
samples of propolis were tested against S. aureus, E. 
coli and S. typhimurium in comparison to EEP extracts. 
Study reported that oil extracts displayed better 
antimicrobial activity than all other extracts and an 
increase in Gram-negative inhibition was also noted. 
Reported ZOIs of 22 mm and 9 mm against S. aureus 
and E. coli, respectively. 
Pujirahayu et al., 
2015 
Thailand 
Stingless bee (i.e. Tetragonula laeviceps and Tetrigona 
melanoleuca) EEP tested against various 
microorganisms including S. typhimurium, B. cereus, E. 
coli, S. aureus, P. aeruginosa and S. epidermidis. 
Sanpa et al., 
2015 
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Reported MICs of 0.13-16 mg/ml and MBCs of 1-128 
mg/ml against all microorganisms tested. 
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Appendix H: Compounds identified in propolis 
worldwide. 
 
Origin  Compounds identified References 
south 
Bulgaria 
Caffeic acid esters and ferulic acid esters. Bankova et al., 
1989 
Spain 
Benzoic acid, 1,2,3-propanetriol, butanedioic acid, 
glycerol monoacetate, 2-hydroxybutanedioic acid, 
guaiol, sesquiterpene alcohol, α-glucopyranose, 
trans-3(3,4-dimethoxyphenyl)propenoic acid, 
hexadecanoic acid, flenicosane, 3-methyl-3-butenyl 
trans-4-coumarate, trans-3(3,4-
dihydroxyphenyl)propenoic acid, octadecenoic acid, 
2-methylpropyl trans-caffeate,  tricosane, 2-methyl-2-
butenyl trans-isoferulate, 2',6'-dihydroxy-4'-
methoxydihydrochalcone, 2-methyl-2-butenyl trans-
caffeate, 3-methyl-2-butenyl trans-caffeate, 2',4',6'-
trihydroxydihydrochalcone, pinostrobin, 2',6'-
dihydroxy-4'-methoxychalcone, pinocembrin, 
pentacosane, dihydroxymonomethoxyflavanone, 
pinobanksin, pinobanksin-3-methyl ether, 
pinobanksin-3-acetate, benzyl trans-caffeate, 
heptacosane, glyceryl trans-caffeate, galangin-7-
methyl ether, chrysin, pinobanksin-3-propanoate, 
galangin-3-methyl ether, sucrose, galangin, 
nonacosane, trans-cinnamyl-trans-caffeate, 
hexacosanoic acid, henitriacontane and octacosanoic 
acid. 
García-Viguera et 
al., 1992 
Albania, 
Bulgaria 
and 
Ketones, alcohols, phenols: methoxyacetophenone,  
4-phenyl-3-buten-2-one, 
methoxyacetophenone(isomer), 2-phenylethanol, 
Bankova et al., 
1994 
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Mongolia isoeugenol. Esters: Unidentified ester of 2-
phenylethanol, benzyl acetate, benzyl benzoate. 
Terpenoids: δ-cadinen, guaiol, α-copaen, 
caryophylen, β-selinen, α-elemen, calamenen, α-
muurolen, ƴ-muurolen, cadinen (isomer), β-
eudesmol, bulnesol. Hydrocarbons: 3-methylinden, 
alkylbenzol, heneicosane (C-21), tricosane (C-23), 
pentacosane (C-25), heptacosane (C-27), nonacosane 
(C-29) and hentriacontane (C-31). 
New 
Zealand 
Dihydroflavonoids: Pinocembrin, pinobanksin and 
pinobanksin 3-acetate; cinnamic acid and their esters, 
including the rare 5-phenyl-trans-trans-2,4-
pentadienoic acid and a  new natural product; 5-
phenyl-trans-3-pentenoic acid. 
Markham et al., 
1996 
Canary 
Islands 
Palmitic acid, erytriol, stearic acid, xylitol, oleic acid, 
inositol, methylmalonic acid, myo-inositol, lactic 
acid, erytraric acid, malic acid, deoxyerytropentaric 
acid, dimethyoxybenzoic acid, tetronic acid, 
phosphoric acid, glucuronic acid, ᴅ-ribofuranose, 
isosesamin, ᴅ-xylopiranose, methyl xantoxylol, ᴅ-
mannopyranose, ᴅ-sorbopyranose, ᴅ-galactose, ᴅ-
fructose, β-ᴅ-glucopyranose, sucrose, lactose, 
maltose, melibiose and diterpene acid, myristic acid, 
aromadendrene, cinnamic acid, ledol, methyl 
palmitate, spatulenol, ethyl palmitate, isospatulenol, 
ethyl oleate, palustrol, benzyl benzoate, β-
cayophillene, ethyl dihydrocinnamate, α-humulene, 
benzaldehyde, nonane, piperonal, decane, linalyl 
propionate, undecane, geraniol, dodecane, nerolidol, 
tridecane, δ-cadinene, tetradecane, α-muurolene, 
hexadecane, α-calakorene, heptadecane, T-muurolol, 
β-selinene, octadecane, germacrene, nonadecane, α-
Bankova et al., 
1998 
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copaene, henicosane, ledene, docosane, tricosane, 2-
methylnaphthalene, m-methylstirol, vanquard BT 
(pesticide) and dodecaniene-1-ol. 
Brazil 
Quercetin, kaempferol, isosakuranetin, sakuranetin, 
kaempferide, acacetin, isorhamnetin and 
pinocembrin. 
Park and Ikegaki, 
1998 
Brazil 
p-Coumaric acid, dihydrocinnamic acid, prenyl-p-
coumaric acid, diprenyl-p-coumaric acid, 
aromadendrine-4'-methyl ether, kaempferide, β-
amyrine and cycloartenol.  
Bankova et al., 
1999 
Canary 
Islands 
Sesamin, aschantin, sesartemin and yangambin. Christov et al., 
1999 
Chile 
Viscidone, trementone, 14-hydroxytrementone, 2,2-
dimethyl-6-acetyl-2H-chromen, coniferyl-9-O-
acetate, ferulic acid ethyl ester, coniferyl aldehyde, 
vanillin, dihydrobenzofuran lignan aldehyde, 9,9'-
bisacetyl-olivil, diastereomers of a dimeric coniferyl 
alcohol and trimeric coniferyl acetate. 
Valcic et al., 1999 
Uruguay 
and China 
Caffeic acid, vanillin, pinocembrin, ferulic acid, 
naringin, sinapic acid, m-coumaric acid, rutin, 4-
hydroxybenzoic, o-cinnamic acid, pinobanksin, 
quercetin, hesperitin, kaempherol, galangin, apigenin, 
isorhamnetin, chrysin, acacetin, pinostrobin, 
tectochrysin and rhamnetin.  
Bonvehí and Coll, 
2000 
Brazil 
Benzoic acids, dihydrocinnamic acids, cinnamic 
acids, long chain caffeates, prenyl caffeates, benzyl 
and phenethyl caffeates, C-prenylated coumaric 
acids, diterpenic acids, triterpenic alcohols and 
sugars. 
Velikova et al., 
2000 
Turkey 
3-Methyl-2-butenol, ethyl decanoate, ethyl benzoate, 
diethyl succinate, ethyl decanoate, calamenene, ethyl-
3-phenyl propionate, phenylethyl alcohol, (E)-ethyl 
Keskin et al., 2001 
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cinnamate, ƴ-eudesmol, α-eudesmol, β-eudesmol, 
ethyl hexadecanoate, decanoic acid and ethyl oleate. 
Brazil 
3-prenyl-4-hydroxycinnamic acid, 2,2-dimethyl-6-
carboxyethenyl-2H-1-benzopyrane, 3,5-diprenyl-4-
hydroxycinnamic acid and 2,2-dimethyl-6-
carboxyethenyl-8-prenyl-2H-1-benzopyran. 
Marcucci et al., 
2001 
Brazil 
Gallic acid, diterpines, chlorogenic acid, 3,4-di-O-
caffeoylquinic acid, 3,5-di-O-caffeoylquinic 
acid, p-coumaric acid, caffeic acid and flavonoids. 
Midorikawa et al., 
2001 
El Salvador 
Chalcones: 2',3'-dihydroxy-4,4'-dimethoxychalcone 
and 2',3',4-trihydroxy-4'-methoxychalcone. 
Popova et al., 2001 
Turkey 
Alcohols, aliphatic acids, amino acids, aromatic acid 
esters, aromatic acids, aromatic aldehydes, 
flavonoids, ketones and terpenoids. 
Sorkun et al., 2001 
Egypt 
Aliphatic acids: Lactic acid, hydroxyacetic acid, 5-
hydroxy-n-valeric acid, 2,3-dihydroxypropanoic acid, 
pentonic acid- 2-deoxy-3,5-dihydroxy-γ-lactone, 
pentonic acid- 2-deoxy-3,5-dihydroxy-γ-lactone 
(isomer), malic acid, succinic acid, 2,3,4,5-
tetrahydroxypentanoic acid-1,4-lactone, 2,3,4,5-
tetrahydroxypentanoic acid-1,4-lactone (isomer), 
nonanoic acid, decanoic acid, dodecanoic acid, 
tetradecanoic acid, palmitic acid, heptadecanoic acid, 
linoleic acid, oleic acid, eicosanoic acid, 
tetracosanoic acid, hexacosanoic acid and 2- hydroxy 
hexacosanoic acid and stearic acid. Aromatic acids: 
Benzoic acid, 2-phenyl- 2-hydroxy acrylic acid, 4-
hydroxy benzoic acid, dihydrocinnamic acid, 
cinnamic acid, 4-methoxy-cinnamic acid, cis-p-
coumaric acid, trans-p-coumaric acid, 3,4-
dimethoxy-cinnamic acid, isoferulic acid, ferulic acid 
and caffeic acid. Esters: Methyl palmitate, ethyl 
Abd El Hady and 
Hegazi, 2002 
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palmitate, stearic acid methyl ester, phthalate ester, 
benzyl benzoate, benzyl-trans-4- coumarate, 
cinnamyl-trans-4- coumarate, 3-methyl-3-butenyl 
isoferulate, 3-methyl-2-butenyl isoferulate, 3-methyl-
3-butenyl caffeate, 2-methyl-2-butenyl caffeate, 3-
methyl-2-butenyl caffeate, benzyl caffeate, 
phenylethyl caffeate, cinnamyl caffeate, tetradecyl 
caffeate, tetradecenyl caffeate, tetradecenyl caffeate 
(isomer), tetradecanyl caffeate and hexadecyl 
caffeate. Di and Triterpenes: Pimaric acid, 
dehydroabietic acid, abietic acid, lupeol, cycloartinol, 
lanosterol, lanosterol with another double bond, α-
amyrin,  β-amyrin, triterpene of β-amyrin and 3-oxo-
triterpenic acid methyl ester (oleanane type). 
Flavonoids: 2’,6’-Dihydroxy-4’-methoxychalcone 
(Pinostrobin chalcone), hexamethoxyflavone, 
pinostrobin, pinocembrin, pinobanksin, pinobanksin-
3-acetate, chrysin, galangin and 5,7- dihydroxy-3-
butanoyloxyflavanone. 
Italy, 
Switzerland 
and 
Bulgaria 
Pinocembrin, pinobanksin, pinobanksin-3-O-acetate, 
chrysin, galangin, pentenyl caffeates, benzyl caffeate, 
phenethyl caffeate, phenolic glycerides, ferulic acid 
and diterpenic acids. 
Bankova et al., 
2002 
Uruguay 
Pinobanksin 3-hexanoate, pinobanksin 3-butanoate, 
pinobanksin 3-propanoate, pinobanksin 3-acetate, 
pinobanksin 3-acetoxy-7-methyl ether (3-
acetylalpinone), pinobanksin 5-methyl ether, 
pinobanksin, pinostrobin, pinocembrin, chrysin, 
tectochrysin, chrysin 5-methyl ether, galangin, 
izalpinin, kaempferol , quercetin 3-methyl ether, p-
coumaric acid, caffeic acid, 3,4-dimethoxycinnamic 
acid, cinnamylidene acetic acid, 2-methyl-2-butenyl 
Kumazawa et al., 
2002 
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p-coumarate, 3-methyl-3-butenyl ferulate, benzyl p-
coumarate, benzyl ferulate, phenethyl caffeate, 
cinnamyl cinnamate, cinnamyl p-coumarate, 
cinnamyl caffeate, cinnamyl isoferulate and cinnamyl 
3,4-dimethoxycinnamate. 
Croatia 
Galangin, naringenin, chrysin, pinocembrin and 
caffeic acid. 
Kosalec et al., 
2003 
Brazil 
Chlorogenic acid, caffeic acid, p-coumaric acid, 4,5-
dicaffeoylquinic acid, 3,4-dicaffeoylquinic acid, 4,5-
dicaffeoylquinic acid methyl ester, 3,4,5-
tricaffeoylquinic acid, dihydrokaempferide, 6-
methoxykaempferol, drupanin, dihydroconiferyl p-
coumarate, capillartemisin A, (E)-3-[2,3-dihydro-2-
(1-hydroxy-1-methylethyl)-7-prenyl-5-
benzofuranyl]-2-propenoic acid, (E)-3-[2,3-dihydro-
2-(1-methylethyl)-7-prenyl-5-benzofuranyl]-2-
propenoic acid, (E)-3-(2,2-dimethyl-3,4-dihydro-3-
hydroxy-8-prenyl-2H-1-benzopyran-6-yl)-2-
propenoic acid, artepillin C, (E)-3-prenyl-4-(2-
methylpropionyloxy)-cinnamic acid, (E)-3-prenyl-4-
(dihydrocinnamoyloxy)-cinnamic acid. 
Kumazawa et al., 
2003 
Brazil 
Caffeic acid, p-coumaric acid, ferulic acid, 
dicaffeoylquinic acid isomer, 3,5-diprenyl-4-
hydroxycinnamic acid derivative, pinobanksin, 
dicaffeoylquinic acid isomer, 3-prenyl-4-
hydroxycinnamic acid, 2,2-dimethyl-6-
carboxyethenyl-2H-1-benzopyran, kaempferol 
derivative, cinnamic acid derivative, 3-prenyl-4-
dihydrocinnamoyloxycinnamic acid, 2,2-dimethyl-8-
prenyl-2H-1-benzopyran-6-propenoic acid 
Cunha et al., 2004 
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Origin  Compounds identified References 
South 
America, 
North 
America,  
Australia, 
Europe, 
Asia and 
Africa. 
Flavonoids including p-coumaric acid, flavonoids 
absent in European propolis samples tested.  
Kumazawa et al., 
2004 
Greece 
CC: diterpenic and phenolic compounds such as; 7-
O-prenylstrobopinin, 7-O-prenylpinocembrin, 
pinostrobin, copalol, 13-epi-torulosal, pinocembrin, 
pinobanksin, isoagatholal, sakuranetin, chrysin, 
pinobanksin 5-methyl ether, 13-epi-cupressic acid, 
benzoic acid, p-coumaric acid, isocupressic acid, 
agathodiol, and caffeic acid.  GC-MS: cinnamyl 
cinnamate, feruginol, benzyl cinnamate, benzyl 
benzoate, butyl cinnamate and butyl vanillate. 
Melliou and 
Chinou, 2004 
Bulgaria, 
Italy and 
Swiss 
Caffeic acid, p-Coumaric acid, Ferulic acid, 
Kaempferol, Pinocembrin, Phenethyl caffeate , 
Isopentyl caffeate,  Chrysin, Galangin, Pinostrobin 
and Benzyl caffeate. 
Popova et al., 2004 
Bulgaria 
Ethyl hydrocinnamate, hydrocinnamic acid, ethyl 
indolacetate, 2-indolcarboxylic acid, mannose, 
inositol, cinnamic acid, hexadecanoic acid, ferulic 
acid, caffeic acid, oleic acid, 3-ketoadipic acid, 
acetobutyric acid, pentanedioc acid, pentenoic acid, 
linoleic acid, pinostrobin, diethyl 2-methylsuccinate, 
isobutylquinoline, geranyl acetal, patchouli alcohol, 
menthol, 2-hydroximethyl-3-indolacetic acid, 
undecanoic acid, glicyrrizic acid, α-amyrin, β-
amyrin, 3-methoxy-b-amyrin, β-amyrin acetate and 
2-ethylhexanoic acid. 
Salomão et al., 
2004 
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Brazil 
2,2-dimethyl-6-carboxyethenyl-2H-1-benzopyran, 6-
propenoic-2,2-dimethyl-8-prenyl-2H-1-benzopyranic 
acid, 3,5-diprenyl-4-hydroxycinnamic acid and 
kaempferol. 
Sawaya et al., 
2004 
Brazil, 
Bulgaria, 
Mozambiqu
e, England, 
Finland and 
North 
America 
para-coumaric acid, 3-methoxy-4-
hydroxycinnamaldehyde, 2-2-dimethyl-6-
carboxyethenyl-2H-1-benzopyran, 3-prenyl-4-
hydroxycinnamic acid, chrysin, pinocembrin, 3,5-
diprenyl-4-hydroxycinnamic acid and 
dicaffeoylquinic acid. 
Sawaya et al., 
2004 
Nepal 
Neoflavonoids, chalcone,  (+)-vesticarpan, cearoin, 
9-hydroxy-6,7-
dimethoxydalbergiquinol,obtusaquinol, , medicarpin, 
4-hydroxymedicarpin and 2',4,4'-trihydroxychalcone, 
(S)-4-methoxydalbergione.  
Awale et al., 2005 
Cuba 
Propolone, nemorosone, guttiferone and 
xanthochymol, garcinielliptone I, hyperibone B, 
propolone B and propolone D. 
Hernández et al., 
2005 
Turkey 
Fatty and aromatic acids: 9-ocadecenoic acid, 2-
propenoic acid and caffeic acid. Alcohol, ketone, 
and terpenes: 2-naphtalenemethanol, 2-propen-1-
one, 4H-1-benzopyran-4-one, coumaran-5,6-diol-3-
one and benzofran-3-one. Flavonoids: chrysin. 
Esters: cinnamyl cinnmate. Others: 1-
phenathrenecarboxaldehyde, benzeneamine, 
eicosane, heptacosane and cyclotrisiloxane. 
Koc et al., 2005 
Turkey 
Pinocembrin,  pinobanksin, pinobanksin 3-O-acetate, 
chrysin, galangin, p-coumaric acid, ferulic acid, 
caffeic aid, pentenyl caffeates, benzyl and phenethyl 
esters of caffeic, ferulic and p-coumaric acid, 
cinnamic acid, glucose, benzyl cinnamate, oleic acid, 
Popova et al., 2005 
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dimethylallyl caffeate, dehydroabietic acid, cinnamyl 
cinnamate, cynnamil caffeate, benzoic acid, vanillin, 
benzyl p-coumarate, benzyl ferulate, coumaroyl 
glycerol, coumaroyl glycerol (isomer), coumaroyl 
acetyl glycerol, dicoumarouyl acetyl glycerol, 
diferuloyl acetyl glycerol, coumaroyl caffeoyl acetyl 
glycerol, phenylethyl caffeate, dihydroabietic, 
abietic, isopimaric, hydroxy fatty acids 
(hydroxypalmitic, hydroxystearic), 
and triterpenic alcohols. 
Turkey 
Naringenin, Chrysin, Acacetin, 9-Octadecanoic acid, 
Hexadecanoic acid, Decanoic acid, Benzoic acid, 
Ferulic acid, 3,4-Dimethoxycinnamic acid, 3-
Hydroxy-4-methoxycinnamic acid, 4-Pentenoic acid, 
1,3-Benzenedicarboxylic acid, 2-Propenoic acid, 3-
Hydroxy-4-niethoxycinnamic acid, Benzene acetic 
acid, 1,3-Benzenedicarboxylic acid, Ethyl acetate, 
Benzyl benzoate, Benzyl cinnamate, Benzene 
ethanol, Benzyl alcohol, 4-Vinylphenol, 
Chrysophanol, 4,5-Dimethoxy-2-phenol, α-
Eudesmol, 4-Vinyl-2-methoxy-phenol, α-Cadinol, β-
Eudesmol, α-Bisabolol, 2-Naphtalenemethanol,  
Glycerine, 2-Methoxy-4-vinyphenol, 2-
Nonadeeanone, 2-Nonadecanone, 2-Propen-1-one, 
4H-1-Benzopyran-4-one, 1-Methyl-4-azailuorenone, 
Propanal, 2,4-Cycloheptadien-l-one, >Nonadecane, 
2,3-Dihydro-benzofuran, Heneicosane, 4-Hydroxy-2-
methoxycinnamaldehyde, Benzaldehyde, Eicosane, 
Octadecane, Docosane, Nonadecane, Heneicosane, 
2,5-Diethyl-3,6-dimethylpyrazine, Vanillin, Benzene 
and β-Cadinene. 
Silici and Kutluca, 
2005 
Canada Aromatic acids: benzoic acid, dihydroxycinnamic Christov et al., 
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Origin  Compounds identified References 
acid, Z-cinnamic acid, E-cinnamic acid, 3-phenyl-3-
hydroxypropanoic acid, methoxyphenylpropanoic 
acid, 4-hydroxybenzoic acid, Z-p-coumaric acid, E-p-
coumaric acid, ferulic acid and caffeic acid. Other 
aromatics: benzyl alcohol, 4-hydroxybenzaldehyde, 
hydroquinone, cinnamyl alcohol and 
hydroxyacetophenone. Fatty acids: oleic acid, 
stearic acid, palmitic acid. Esters: benzyl benzoate, 
benzyl methoxybenzoate, benzyl hydroxybenzoate, 
benzyl dihydroxybenzoate, benzyl Z-p-coumarate, 
benzyl E-p-coumarate, phenethyl p-coumarate, 
benzyl ferulate, benzyl caffeate, phenethyl caffeate, 
cinnamyl caffeate, pinostrobin chalcone, 
pinocembrin, pinobanksin, sakuranetin, 
isosakuranetin, alpinone, pinobanksin 3-O-acetate 
and galangin. Dihydrochalcones: 2’ ,6’ -dihydroxy-
4'methoxydihydrochalcone,  2’ ,4’ ,6’ –
trihydroxydihydrochalcone, 2’ ,6’ -dihydroxy-4',4-
dimethoxydihydrochalcone, 2’ ,4’ ,6’ -trihydroxy-4-
methoxydihydrochalcone and 2’ ,6’ ,4-trihydroxy-4'-
methoxydihydrochalcone. Others: glycerol, hexoses 
and sesquiterpenes. 
2006 
Brazil 
Phenolic and flavonoid compounds da Silva et al., 
2006 
Turkey 
Chrysin, apigenin, flavonoids, flavanones, 
naringenin, ethyl oleate, 3-4-dimethoxy-cinnamic 
acid and 9-octadecenoic acid.  
Mercan et al., 2006 
Argentina, 
Italy, Spain, 
China, 
Azerbaijan 
and 
Pinocembrin, naringenin, genistein, apigenin, 
kaempferol, acacetin, galangin and chrysin. 
Volpi and 
Bergonzini, 2006 
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Ethiopia 
Brazil 
Butanedioic acid, dimethyl ester, hydroxy-
butanedioic acid, dimethyl ester, m-guaiacol, 1-
methoxy-4-(1-propenyl)-benzene, methyleugenol, 
methyl o-orsellinate, 1,2,3-trimethoxy-5-(2-
propenyl)-benzene, methoxyeugenol, hexadecanoic 
acid, methyl ester, 10-octadecenoic acid, methyl 
ester, methyl abietate, benzoic acid, 
homopterocarpin, medicarpin, 2,4,6-trimethylphenol, 
4’7-dimethoxy-2’-isoflavonol, 7,4’-
dihydroxyisoflavone, 2H-1-benzopyran-7-ol, 2,2,6-
beta-trimethyl-bicyclo(4.3.0)non-9(1)-en-7.alpha.-ol, 
1,1,2-trimethyl-3,5-bis(1-methylethenyl)-,(2.alpha., 
3.alpha., 5.beta.)-cyclohexane. 
Alencar et al., 
2007 
Cuba 
Nemorosone, scrobiculatones A and B, 
isoliquiritigenin, liquiritigenin, formononetin, 
biochanin A, vestitol, neovestitol, 7-O-metilvestitol, 
medicarpin, homopterocarpin, vesticarpan, 3,8-
dihydroxy-9-methoxypterocarpan and 3-hydroxy-8,9-
dimethoxypterocarpan. 
Cuesta-Rubio et 
al., 2007 
Various 
regions of 
Asia, South 
and North 
America 
and Europe 
Phenolic acids, flavanones, flavones, flavonols, 
balsams and dihydroflavonols. 
Popova et al., 2007 
Brazil 
Ferulic acid, chrysin, quercetin, medicarpin and 3-
Hydroxy-8,9-dimethoxypterocarpan. 
Silva et al., 2008 
Mexico 
Flavones, flavonols, flavanones, dihydroflavonols 
and phenolic compounds. 
Velazquez et al., 
2007 
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Brazil 
(6aS,11aS)-6a-ethoxymedicarpan, 2-(2’,4’-
dihydroxyphenyl)-3-methyl-6-methoxybenzofuran, 
2,6-dihydroxy-2-[(4-hydroxyphenyl)methyl]-3-
benzofuranone, (2R,3R)-3,7-dihydroxy-6-
methoxyflavanone, alnusin, alnustinol, (+)-
pinoresinol dimethyl ether, (2S)-dihydrooroxylin A, 
(6aS,11aS)-medicarpan, (6aR,11aR)-3,4-dihydroxy-
9-methoxypterocarpan, (2S)-dihydrobaicalein, 
(6aR,11aR)-4-methoxymedicarpin, (7S)-
dalbergiphenol, (2S)-7-hydroxy-6-
methoxyflavanone, (6aR,11aR)-3-hydroxy-8,9-
dimethoxypterocarpan, 2’,4’-dihydroxychalcone, 
(3S)-7-O-methylvestitol, (6aS,11aS)-3,10-dihydroxy-
9-methoxypterocarpan, (2S)-7-hydroxyflavanone, 
(+)-pinoresinol, (6aR,11aR)-3,8-dihydroxy-9-
methoxypterocarpan, (3S)-Mucronulatol, (2R,3R)-
3,7-dihydroxyflavanone, biochanin A, formononetin, 
(3S)-ferreirin, 2’-hydroxybiochanin A, (3S)-
violanone, pratensein, xenognosin B, (+)-
syringaresinol, (3S)-vestitol, Isoliquiritigenin, (3S)-
vestitone, (3R)-4’-methoxy-2’,3,7-
trihydroxyisoflavanone, (2S)-liquiritigenin, 
calycosin, (2S)-naringenin, garbanzol, 4,4’-
dihydroxy-2’-methoxychalcone, (3S)-isovestitol, 
2’,4,4’-tetrahydroxydihydrochalcone, daidzein. 
Awale et al., 2008 
Romania  
Caffeic acid, rutin, quercetin, apigenin, kaempferol 
and chrysin. 
Coneac et al., 2008 
Brazil 
Pinocembrin, rutin, liquiritigenin, daidzein, 
pinobanksin, pinobanksin-3-acetate, quercetin, 
luteolin, dalbergin, isoliquiritigenin, formononetin 
and biochanin A. 
Daugsch et al., 
2008 
Turkey Fatty and aliphatic acids: butanedioic acid, Vardar-Ünlü et al., 
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propanoic acid, decanoic acid, malic acid, ᴅ-
arabinoic acid, tartaric acid, gluconic acid, α-ᴅ-
glucopyranuronic acid, octadecanoic acid, 
hexadecanoic acid, β-ᴅ-glucopyranuronic acid, 9,12-
octadecadienoic acid, tetradecanoic acid, 
hexadecanoic acid, octadecanoic acid, pentanedioic 
acid, glutamic acid, 2,3,4-trihydroxy butyric acid and 
phosphoric acid. Aromatic acids: benzoic acid, 
caffeic acid, ferulic acid and cinnamic acid. 
Alcohols: glycerol, erythritol, α-cedrol, xylitol, 
germanicol and stigmast-22-en-3-ol. Sugars: ᴅ-
erythrotetrofuranose, ᴅ-altrose, arabinopyranose, d-
arabinose, sorbopyranose, α-ᴅ-galactopyranose, 
maltose, α-ᴅ-glucopyranoside, ᴅ-fructose and ᴅ-
glucose. Flavonoids: pinobanksin. Esters: 4,3-
acetyloxycaffeate, cinnamic acid 3,4 dimethoxy-
trimethylsilyl ester, 3-methoxy-4-cinnamate and 
cinnamic acid 4 methoxy 3 TMS ester. Terpene, 
sesquiterpene alcohols: farnesol. Others: butane, 
2(3H)-furanone, ʟ-proline, furan, butane, 2-
furanacetaldehyde, 2,5-is-3-phenyl-7-
pyrazolopyrimidine, cliogoinol methyl derivative, 
fluphenazine, 4,8-propanoborepinoxadiborole, 1,3,8-
trihydroxy-6-methylanthraquinone, 1-5-oxo-4,4-
diphenyl-2-imidazolin-2-yl guanidine, 3,1,2-
azaazoniaboratine/piperonal, 3-cyclohexene, 1H-
indole, 1H-indole-3-one, 4,8 diphenyl -1-thieno-2-
benzazol-1,3-dione, 2-furanacetaldehyde, guanidine, 
2(3H)furanone and 1,3,8-trihydroxy-6-
meyhylanthraquinone. 
2008 
China 
Flavonoids, lipids, amino acids and long chain alkyl 
compounds 
Wu et al., 2008 
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China 
Rutin, pinocembrin, kaempferol, myricetin, 
quercetin, apigenin, galangin and chrysin. 
Zhou et al., 2008 
Brazil Hyperibone A. Castro et al., 2009 
Argentina 
Quercetin, gallic acid, chlorogenic acid, pinocembrin 
and kaempferol. 
Chaillou and 
Nazareno, 2009 
Brazil 
Coumaric acid, artepillin C, kaempferide, cinnamic 
acid, galangin, quercetin, kaempferol, isorhamnetin, 
sakuranetin, chrysin and pinobanksin-3-acetate. 
de Paula et al., 
2009 
South 
Africa 
Galangin, quercetin and luteolin. 
du Toit et al., 2009 
Myanmar 
(22Z,24E)-3-oxocycloart-22,24-dien-26-oic acid, 
(24E)-3-oxo-27,28-dihydroxycycloart-24-en-26-oic 
acid, cycloartanes and prenylated flavanones. 
Li et al., 2009 
Chania - 
Crete 
trans-communal, totarol, 13-epi-manool, copalol, 
trans-communic acid, pimaric acid, 13-epi-torulosal, 
totarolone (3-oxototarol), isoagatholal, 
acetylisocupressic acid, mixture of 15-oxolabda-
8(17),13E-dien-19-oic acid and 15-oxolabda-
8(17),13Z-dien-19-oic acid, 13-epi-cupressic acid, 
13-epi-torulosol, junicedric acid, isocupressic acid, 
agathadiol, isorhamnetin-3-O-rutinoside, 14,15-
dinor-13-oxo-8(17)-labden-19-oic acid and a mixture 
of labda-8(17),13E-dien-19-carboxy-15-yl oleate and 
palmitate, 3,4-seco-cycloart-12-hydroxy-4(28),24-
dien-3-oic acid and cycloart-3,7-dihydroxy-24-en-28-
oic acid. 
Popova et al., 2009 
Jordan 
Pinocembrin, chrysin and pinobanksin-3-O-acetate. Darwish et al., 
2010 
Portugal 
Phenolic acids: caffeic acid cinnamyl ester, caffeic 
acid phenylethyl ester, CAPE, caffeic acid benzyl 
ester, caffeic acid isoprenyl ester, p-coumaric acid 
isoprenyl ester, p-coumaric acid methyl ester, 3,4-
Falcão et al., 2010 
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dimethyl-caffeic acid, isoferulic acid, ferulic acid, p-
coumaric acid and caffeic acid. Flavones and 
flavonols: chrysin-6-methyl-ether, kaempferol-5-
methyl-ether, chrysin-5-methyl-ether and chrysin. 
Flavanones and dihydroflavonols: 5-methoxy-3-
hidroxy-flavanone, pinobanksin-3-O-pentanoate or 2-
methylbutyrate, pinobanksin-3-O-butyrate or 
isobutyrate, pinobanksin-5-methyl-ether-3-O-
pentanoate, pinobanksin-3-O-propionate, 
pinobanksin-3-O-acetate, pinobanksin-5-methyl-
ether, pinobanksin, hesperitin-5,7-dimethyl-ether, 
pinocembrin and pinocembrin-5-methyl-ether. 
Chile 
Caffeic acid, myricetin, quercetin, kaempferol, 
apigenin, pinocembrin, galangin and caffeic acid 
phenyl ester (CAPE). 
Herrera et al., 2010 
India Polyphenols and flavonoids Laskar et al., 2010 
Mexico 
1-(3',4'-dihydroxy-2'-methoxyphenyl)-3-
(phenyl)propane, (Z)-1-(2'-methoxy-4',5'-
dihydroxyphenyl)-2-(3-phenyl)propene and 3-
hydroxy-5,6-dimethoxyflavan as well as other known 
isoflavans, pterocarpens and flavonones such as 
pinocembrin and vestitol. 
Lotti et al., 2010 
Turkey 
Aromatic alcohol, alcohols, acids, aromatic acid 
esters, aromatic esters, aromatic acids, flavanones, 
hydrocarbons, aliphatic esters, aliphatic acid esters 
and aromatic hydrocarbons 
Özen et al., 2010 
Kenya 
Arylnaphtalene lignans namely; tetrahydrojusticidin, 
6-methoxydiphyllin and phyllamyricin. A 
geranylated flavonol, macarangin and a geranylated 
stilbene, schweinfurthin. 
Petrova et al., 2010 
The 
Solomon 
prenyl flavanones - propolin H, propolin G, propolin 
D and propolin C. 
Raghukumar et al., 
2010 
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Islands 
Various 
regions of 
South 
America, 
North 
America, 
Europe, 
Asia and 
Oceania. 
Dihydroxyflavone, chrysin, pinobanksin, 
pinocembrin, apigenin/galangin, pinobanksin acetate, 
caffeic acid phenylethyl ester (CAPE) and two 
prenylated benzophenones identified as markers of 
Brazilian red propolis tested. 
Sawaya et al., 
2010 
Brazil 
Simple phenylpropanoids: dihydrocinnamic acid 
methyl ester, dihydrocinnamic acid, p-
hydroxydihydrocinnamic acid, p-coumaric acid, p-
methoxycinnamic acid, cis--3-methoxy-4-hydroxy-
cinnamic acid, trans-3-methoxy-4-hydroxy-cinnamic 
acid, trans-3,4-dimethoxycinnamic acid, and 
dihydrocinnamic acid ethyl ester. Prenylated 
phenylpropanoids: allyl-3-prenylcinnamate, 4-
hydroxy-3-prenylcinnamic acid, artepillin C, 4-
dihydrocinnamoiloxy-3-prenylcinnamic acid, 2,2-
dimethylchromene-6-propenoic acid, 2,2-dimethyl-8-
prenylchromene-6-propenoic acid, 8-(methyl-
butanechromane)-6-propenoic acid and 3-hydroxy-
2,2-dimethyl-8-prenylchromane-6-propenoic acid. 
Sesqui and diterpenoids: (-) caryophyllene oxide, 
farnesol, farnesyl acetate, spathulenol, viridiflorol, 
dehydrocostus lactone and isocupressic acid 
derivative. Triterpenoids and steroids: squalene, 
obtusifoliol, bauer-7-en-3b-yl acetate, α-amyrin, α-
amyrin acetate, β-amyrin acetate, lupeyl acetate, 
olean-18-en-3b-yl acetate, taraxer-14-en-3b-yl 
acetate, urs-18-en-3b-yl acetate and friedooleanan-
Teixeira et al., 
2010 
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7,12-dien-3b-yl acetate. Constituents from other 
classes: p-vinylphenol, p-vinyl-o-prenylphenol, 
quinic acid, 2-hydroxy-7,12-dimethyl-
benzanthracene and isomaturnin. 
Iran 
Prenylated coumarin: Suberosin. Terpene esters: 
tschimgin, tschimganin, ferutinin and teferin. 
Trusheva et al., 
2010 
Iran 
Aldehydes: 2-hydroxy-5-methylbenzaldehyde; 
Flavonoids: 5-hydroxy-7-methoxy flavanone 
(pinostrobin), 5,7,40-trihydroxy flavanone 
(naringenin), 5,7-dihydroxy flavone (chrysin), 
dihydrochrysin; Aromatic acids: 3(3,4-
dihydroxyphenyl)-2-propenoic acid (caffeic acid); 
Sesquiterpenes: cis-lanceol, caryophyllene oxide, 
eudesmol, 6-hydroxy-1-oxogermacr-4,10(15),11(13)-
trien-12,8-olide; Triterpenes: 3,12-oleandione; 
Alcohol: 1-heptatriacotanol; Aliphatic 
hydrocarbons: 1,5,5-trimethyl-6-methylene-
cyclohexene, alfaxalone; Aromatic hydrocarbons: 
2-amino-1-(3-hydroxy-4-methoxyphenyl) ethanone, 
1,3,8-trihydroxy-6-methylanthracene-9,10-dione.  
Tukmechi et al., 
2010 
Argentina 
3'Methyl-nordihydroguaiaretic acid, 
nordihydroguaiaretic acid, 2-heptanone, tricyclene, 
camphene, terpinene, o-cymene, limonene, m-cresol, 
actophenone, terpinolene, 2-nonanone, p-cymenene, 
linanool, N-nonanal, benzyl acetate, borneol, 4-
terpineol, terpineol, N-decanal, (E)-caryophyllene, 
cis-bergamotene, humulene, AR-curcumene, 
hexadecane, cis-guaiene, eudesmol, nonadecane and 
eicosane. 
Agüero et al., 2011 
Brazil 
Gambogenone, aristophenone A, 7-epi-clusianone, 7-
epi-nemorosone, dimethyl weddellianone derivative, 
propolone derivative, xanthochymol, 18-ethyloxy-17-
de Castro Ishida et 
al., 2011 
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hydroxy-17 and 18-dihydroscrobiculatone B 
Turkey 
Alcohols: 3-methyl-3-buten-1-ol. Aromatic 
alcohols: phenylethyl alcohol, (E)-11-hexadecen-1-
ol, 2-propen-1-ol, 2-naphthalene-methanol, 13-
Tetradecy-11-yn-1-ol, olean-12-en-3-ol and 
benzenemethanol. Aromatic acids: 5-phenyl-4-
pentenoic acid, benzoic acid, benzenepropanoic acid, 
3-phenyl-2-propenoic acid, decanoic acid, 9-
octadecenoic acid and octadecanoic acid. Aromatic 
acid esters: benzene acetic acid, 4-hydroxy-3-
methoxymethyl ester, octadecanoic acid-methyl ester, 
1,2-benzenedicarboxylic acid, bis(8-methyl nonyl) 
ester,  1,2-benzenedicarboxylic acid, bis(8-methyl 
propyl) ester, 1,2-benzenedicarboxylic acid, butyl 8-
methylonyl ester, benzyl cinnamate and 1,2-
benzenedicarboxylic acid diisodecyl ester. 
Aldehydes: benzaldehyde. Straight-chain acids: 
tetradecanoic acid, heptadecanoic acid and n-
hexadecanoic acid. Straight-chain acids esters: 
tetradecanoic acid ethyl ester, hexadecanoic acid 
ethyl ester, and heptadecanoic acid 15-methyl-ethyl 
ester. Flavonols: 4H-1-benzopyran-4-one, 5-
hydroxy-7-methoxy-2-phenyl, 4H-1-benzopyran-4-
one, 2,3-dihydro-5, 7-dihydroxy-2-phenyl, 4H-1-
benzopyran-4-one, 3,5,7-trihydroxy-2-phenyl, 
chrysin, 5,7-dihydroxy-6-methoxy-3(4’-
methoxyphenyl) and 5-hydroxy-6,7-dimethoxy-3(4’ -
methoxyphenyl). Hydrocarbons: cyclotetradecane, 
heptadecane, 1-heptadecane, 1-nonadecene, 9-
tricosene, delta-cadinene, bicyclo(4.4.0) dec-1-ene, 
6(Z) 9(E)-heptadecane. Aromatic esters: 2-propen-
Duran et al., 2011 
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1-one. Fatty acid ester: ethyl oleate, cinnamic acid 
esters, cinnamyl cinnamate and 3-hydroxy-4-
methoxycinnamic acid. Ketones: 2(5H)-furanone, 
5,5-diphenyl, 2-phenyl-2-tipyl-acenapthenone, 1-(2-
vinyl phenyl)ethanone, otarolone, hinokione and 2-
heptadecanoate. 
China 
Epicatechin, p-coumaric acid, morin, 3,4-
dimethoxycinnamic acid, naringenin, ferulic acid, 
cinnamic acid, pinocembrin and chrysin. 
Guo et al., 2011 
Brazil 
α-Pinene, β-pinene, sulcatone, myrcene, careen, 
limonene, eucalyptol, α-ocimene, β-ocimene, 
acetophenone, linalool, nonanal (E)-4,8-dimethyl-
1,3,7-nonatriene,  methyl hydrocinnamate, α-
cubeben, α-copaene, γ -caryophyllene, 
aromadendrene, γ -muurolene, viridiflorene, 
germacrene D, δ-cadinene, β-farnesol, spathulenol, 
artepillin C, 4-hydroxy-3(E)-(4-hydroxy-3-methyl-2-
buthenyl)-5-prenyl cinnamic acid, betuletol, 
caffeoylquinic acid, 3-prenyl-4-
dihydrocinnamoyloxycinnamic acid and 
dicaffeoylquinic acid. 
Nunes and 
Guerreiro, 2011 
Brazil Vestitol, neovestitol and isoliquiritigenin. Oldoni et al., 2011 
Brazil 
3-[4-hydroxy-3-(oxobutyl)-phenylacrylic acid, 3-
prenyl-3(E)-(4-hydroxy-3-methyl-2-butenol)-5- 
prenylcinnamic acid, 3-prenyl-4-(2-
methylpropionyloxi)cinnamic acid, 3-prenyl-4-
dihydrocynamoiloxicinnamic acid, 
dihydrokaemferide, 3-prenyl-4-hydroxycinnamic 
acid, caffeic acid, caffeoylquinic acid 1, 
caffeoylquinic acid 2, caffeoylquinic acid 3, 
caffeoylquinic acid 4, caffeoylquinic acid 5, cinnamic 
acid, p-coumaric acid, kaempferide, kaempferol, 
Pamplona-
Zomenhan et al., 
2011 
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betuletol, 2.2-dimethyl-6-carboxyethenyl-2H-1-
benzopirane, 2.2-dimethyl-8-prenyl-2H-1-
benzopirano-6-propenoic acid, (E)-3-{4-hydroxy-3-
[(E)-4-(2.3)-dihydrocynamoiloxi-3-methyl-2-
butenyl]-5-prenylphenyl-2-propenoic acid, 3.4-
dihydroxy-5-prenylcinnamic acid and 3,5-diprenyl-4-
hydroxycinnamic acid 
Malta 
Diterpene acids - isocupressic, communic, pimaric 
and imbricatoloic acid as well as totarol and 13- epi-
torulosal. Neoabietic acid and manool oxide:  Abietic 
acid, acetyl isocupressic acid, 1 agathadiol, 1 
communal, copalol,1 13-epi-cupressic acid, 1 
dehydroabietic acid,1 13,14-dehydrojunicedric acid, 
14,15-dinor-13-oxo- 8(17)-labden-19-oic acid, 1 
ferruginol, 1 ferruginolon, hydroxydehydroabietic 
acid, 2-hydroxyferruginol, 1 6/7-hydroxyferruginol, 
isoagatholal, 1 junicedric acid, 1 labda-8(17),12,13-
triene,13-epi-manool, 1 sempervirol and totarolon. 
Popova et al., 2011 
Chile 
Caffeic acid, myricetin, quercetin, kaempherol, 
apigenin, pinocembrin, galangin and CAPE. 
Saavedra et al., 
2011 
Iraq 
Caffeic acid, vanillin,  coumaric acid, methyl 
caffeate, ferulic acid, luteolin, quercetin, sakuranetin, 
methyl quercetin, cinnamic acid, tectochrysin, 
apigenin, naringenin, pinobanksin, kaempferol, 
kaempferide, Bis-methylated quercetin, acacetin, 
hesperetin, prenyl caffeate, benzyl caffeate, chrysin, 
pinocembrin, galangin, caffeic acid, phenethyl ester, 
pinobanksin-3-acetate, isopentyl caffeate, isoprenyl 
coumarate, isoprenyl ferulate, pinobanksin-3-
propionate, clerodane diterpenoid I, clerodane 
diterpenoid II, pinostrobin, clerodane diterpenoid 
dihydro, clerodane diterpenoid dehydrated and 
Sulaiman et al., 
2011 
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palmitic acid. 
Kangaroo 
Island 
Prenylated cinnamic acid, prenylated 
tetrahydroxystilbenes, stilbenes and flavanones 
Abu-Mellal et al., 
2012 
Portugal 
Caffeic acid, , p-coumaric acid, ferulic acid, 
isoferulic acid, benzoic acid, 3,4-dimethyl-caffeic 
acid, pinobanksin-5-methyl ether, quercetin, luteolin, 
cinnamic acid, , p-coumaric acid methyl ester, 
pinobanksin, pinocembrin-5-methyl ether, apigenin, 
chrysin-5-methyl ether, kaempferol, isorhamnetin,  
pinobanksin-5-methyl ether-3-O-acetate, 
cinnamyliden acetic acid, galangin-5-methyl ether 
(isomer),  rhamnetin,  pinocembrin, chrysin, 
pinobanksin-3-O-acetate, galangin, acacetin, 
kaempferide, 6-methoxychrysin, pinobanksin-3-O-
acetate-5-O-phydroxyphenylpropionate, 
pinocembrin-5-O-3-hydroxy-4-
methoxyphenylpropionate, pinobanksin-3-O-
propionate, ferulic acid derivative, pinobanksin-3-O-
pentanoate or 2-methylbutyrate, and pinobanksin-O-
hexenoate. 
Falcão et al., 2012 
Solomon 
Islands 
Solophenol B, solophenol C, solophenol D, 
solomonin, prokinawan, nymphaenol A, bonannione 
A, 6’-geranylpinocembrin, propolin I, 
sophoraflavanone A,  (2S)-5,7-dihydroxy-4’-
methoxy-8-prenylflavanone, puyanin, propolin A, 
nymphaeol B, nymphaeol C,  solophenol A, propolin 
B, propolin E, isonymphaeol B, 3’-geranylnaringenin  
and gallic acid. 
Inui et al., 2012 
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Honduras 
(E,Z)-cinnamyl cinnamate, cinnamic ester 
derivatives, flavanones, chalcone, triterpenes and 
aromatic acids. 
Lotti et al., 2012 
Brazil 
Phenolic acids - Gallic acid, caffeic acid, t-cinnamic 
acid and hydrocinnamic acid and the flavone - 
apigenin. 
Maraschin et al., 
2012 
Cuba 
Brown Cuban propolis: Nemorosone, hyperibone, 
garcinielliptone I, propolone A, propolone B, 
propolone C and propolone D. Red Cuban propolis: 
Isoliquiritigenin, liquiritigenin, biochanin A, 
formononetin, vestitol, neovestitol, isosativan, 
medicarpin, homopterocarpin, vesticarpan, 3,8-
dihydroxy-9-methoxy pterocarpan and  3-hydroxy-
8,9-dimethoxy pterocarpan and 3,4-dihydroxy-9-
methoxy pterocarpan. Yellow Cuban propolis: 24-
methylene-9,19-ciclolanostan-3β-ol, α-amyrin, α-
amyrone, β-amyrin, β-amyrin acetate, β-amyrone, 
cycloartenol, germanicol, germanicol acetate, 
lanosterol, lanosterol acetate, lupeol and lupeol 
acetate. 
Monzote et al., 
2012 
China 
Caffeic acid, p-coumaric acid, ferulic acid, isoferulic 
acid, 3,4-dimethylcaffeic acid, quercetin, 
pinobanksin-5-methyl ether, quercetin-3-methyl 
ether, apigenin, pinobanksin, isorhamnetin, 
pinocembrin-5-methyl ether, luteolin-5-methyl ether, 
quercetin-5,7-dimethyl ether, galangin-5-methyl 
ether, quercetin-X-methyl ether, quercetin-7-methyl-
X-methyl-ether, chrysin, pinobanksin-7-methyl-ether, 
pinocembrin, caffeic acid isoprenyl ester, galangin, 
pinobanksin-3-O-acetate, caffeic acid phenylethyl 
ester, hydroxy-cinnamic acid benzyl ester, p-
coumaric acid benzyl ester, caffeic acid cinnamyl 
Shi et al., 2012 
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ester, pinobanksin-3-O-propionate, chrysin-7-methyl 
ether, pinocembrin-7-methyl ether, pinobanksin-3-O-
(pentanoate or 2-methylbutyrate), methoxycinnamic 
acid and cinnamyl ester 
Korea 
(SS)-(+)-laserpitin, (SS)-(-)-isolaserpitin, (S)-(-)-
selidin, 4-hydroxyderricin, xanthoangelol and 
xanthoangelol F 
Shimomura et al., 
2012 
India 
Fatty acids - 9-octadecenoic acid, decanoic acid, 9,12 
hexadecanoic acid and octadecadeinoic acid methyl 
ester. Alcohols - 1-tetradecanol, octadecanol, 1-
dotricontanol and 2,3 epoxy-5,8-hectadecadien-1-ol. 
Trace amount of quercetin and cyclopentadiene 
Thirugnanasampan
dan et al., 2012 
Australia 
2',3',4'-trimethoxychalcone, 2'-hydroxy-3',4'-
dimethoxychalcone, 2',4'-dihydroxy-3'-
methoxychalcone, 5,7-dihydroxy-2,3-
dihydroflavonol 3-acetate (pinobanksin 3-acetate) 
and 5,7-dihydroxy-6-methoxy-2,3-dihydroflavonol 3-
acetate. 
Tran et al., 2012 
Mexico 
Pinocembrin, pinobanksin 3-acetate, chrysin, CAPE, 
acacetin and galangin. 
Valencia et al., 
2012 
Thailand 
(7″S)-8-[1-(4′-hydroxy-3′-methoxyphenyl)prop-2-en-
1-yl]-(2S)-pinocembrin and (E)-cinnamyl-(E)-
cinnamylidenate. 
Athikomkulchai et 
al., 2013 
Chile 
Quercetin, myricetin, kaempferol, rutin, pinocembrin, 
coumaric acid, caffeic acid and caffeic acid phenethyl 
ester 
Barrientos et al., 
2013 
Brazil 
Neovestitol and vestitol Bueno-Silva et al., 
2013 
Brazil 
6-Acetyl-2,2-dimethyl-3-hydroxychroman, 2-
hydroxy-4-methoxychalcon, liquiritigenin, 
formononetin, medicarpin, biochanin A, 
retusapurpurin B and hesperetin 7-rhamnoglucoside. 
da Silva Frozza et 
al., 2013 
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Brazil 
Artepillin C, CAPE, chrysin, p-coumaric acid, caffeic 
acid, apigenin and naringenin. 
de Aguiar et al., 
2013 
India 
Terpenoids, flavonoids, alkaloids, phenols, tannins 
and saponins. 
Kalia et al., 2013 
East 
Andalusia 
Caffeic acid, p-coumaric acid, ferulic acid, 
pinobanksin, cinnamylden acetic acid, chrysin, 
pinocembrin, galangin, pinobanksin 3-acetate, 
cinnamyl caffeate and caffeic acid 
phenethyl ester (CAPE). 
Kumazawa et al., 
2013 
Croatia 
Caffeic acid, chrysin, p-coumaric acid, ferulic acid, 
isoferulic acid, kaempferol, apigenin, galangin, 
naringenin rhamnetin, sakuranetin, tectochrysin, 
pinocembrin and pinocembrin-7-methyl ether. 
Medić-Šarić et al., 
2013 
Portugal 
2-Acetyl furan, benzaldehyde, verbenene, 2,6,6-
trimethyl cyclohexanone, acetophenone, γ-terpinene, 
n-nonanal, hotrienol, α-campholenal, trans-
pinocarveol, trans-verbenol, pinocarvone, nerol 
oxide, p-mentha-1,5-dien-8-ol, borneol, terpinen-4-
ol, octanoic acid, myrtenal, α-terpineol, myrtenol, 
pinocampheol, cis-7-decenal, n-decanal, trans-
carveol, cis-ocimenone, carvone, trans-ocimenone, 
nonanoic acid, bornyl acetate, thymol, carvacrol, 
decanoic acid,  aromadendrene, allo-aromadendrene, 
eremophilene, 1,1,5,6-tetramethyl-1,2-
dihydronaphtalene, viridiflorene, 1,1,5,6-tetramethyl-
1,2,3,4-tetrahydronaphtalene, trans-calamenene, δ-
cadinene, α-calacorene, β-caryophyllene alcohol, 
guaiol, ledol, 1-epi-cubenol, δ-cadinol, β-eudesmol, 
cadalene, n-tetradecanol, n-heptadecane, benzyl 
benzoate, ambroxide, 6-acetoxy-11-nor-drim-7-en-9-
one, n-octadecane,  n-nonadecane, palmitic acid, n-
eicosane, n-heneicosane, linoleic acid ethyl ester, 
Miguel et al., 2013 
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ladenol, n-docosane, n-eicosanol, n-tricosane, n-
tetracosane, n-pentacosane and fatty acids. 
Italy 
Caffeic acid, p-coumaric acid, ferulic acid, isoferulic, 
3,4-dimethyl-caffeic acid (DMCA), quercetin, 
cinnamic acid, pinobanksin-5-methyl-ether,  
quercetin-3-methyl-ether, apigenin, pinobanksin, 
kaempferol , isorhamnetin, pinobanksin-5-methyl-
ether-3-O-acetate, quercetin-7-methyl-ether, 
quercetin-dimethyl-ether, caffeic acid prenyl ester, 
chrysin, caffeic acid prenyl ester , caffeic acid benzyl 
ester , pinocembrin, galangin, pinobanksin-3-O-
acetate, caffeic acid phenylethyl ester (CAPE), 
methoxy-chrysin, p-coumaric benzyl ester, caffeic 
acid cinnamyl ester, pinobanksin-3-O-propionate, 
pinobanksin-3-O-butyrate, p-coumaric cinnamyl 
ester, pinobanksin-3-O-pentanoate, pinobanksin-3-O-
hexanoate, p-methoxy cinnamic acid and cinnamyl 
ester. 
Pellati et al., 2013 
Oman 
Sugars, polyols, hydroxy acids, fatty acids, cardanols 
and cardols, anacardic acids, flavan derivatives, 
triterpenes, prenylated flavanones and chalcones. 
Popova et al., 2013 
Brazil 
Taraxerone, oleanene,  caffeic acid 4-O-glucoside, 
quinic acid, dihydroquercetin, caffeoylquinic acid, 
caffeic acid 4-O-arabinoside, caffeic acid 4-O-
xyloside, caffeoylquinic acid, feruloyl-caffeoylquinic 
acid, caffeoylquinic acid, caffeoylquinic acid, 
feruloyl-caffeoylquinic acid, feruloyl-caffeoylquinic 
acid, methylkaempferol-O-rutinoside, naringenin-C-
glucoside, apigenin-O-rutinoside, feruloylquinic acid, 
caffeic acid, delphinidin arabinoside, caffeoylquinic 
acid, catechin arabinoside, apigenin-di-C-glucosyl 
rhamnoside, apigenin-C-rhamnoside, isoschaftoside, 
Righi et al., 2013a 
 166 
 
Origin  Compounds identified References 
dicaffeoylquinic acid, caffeic acid-dihydroxy phenyl 
ethyl ester, dicaffeoylquinic acid, dicaffeoylquinic 
acid, schaftoside, quercetin-O-arabinoside, quercetin-
O-rhamnoside, dicaffeoylquinic acid, isorhamnetin-
glucoside, tricaffeoylquinic acid, tricaffeoylquinic 
acid, apigenin-O-glucuronide, diprenyl chrysin, 
quercetin, cinnamoyl hexoside, isorhamnetin, 
rhamnetin, artepillin C, quercetin-dimethyl ether, 
pentamethoxy flavonol, nobiletin, chrysin 
rhamnoside, prenyl-trimethoxyluteolin and prenyl-
trimethoxykaempferol. 
Brazil 
Flavanones, glycosyl flavones, prenylated 
phenylpropanoids, caffeoylquinic acids, prenylated 
flavonoids and schaftoside (apigenin-8-C-glucosyl-6-
C-arabinose). 
Righi et al., 2013b 
Algeria 
Pectolinarigenin, pilosin, ladanein, chrysin, and 
apigenin. 
Segueni et al., 
2013 
Korea 
Various chalcones and coumarins. Shimomura et al., 
2013 
Poland 
Cinnamic acid, p-coumaric acid, ferulic acid, gallic 
acid, caffeic acid, caffeic acid phenethyl ester, 
pinobanksin, kaempferol, apigenin, pinocembrin, 
quercetin, chrysin, galangin, acecetin and 
kampferide. 
Wojtyczka et al., 
2013a 
Argentina 
Pinocembrin, galangin, chrysin, 3 -methyl-
nordihydroguaiaretic acid (MNDGA) and 
nordihydroguaiaretic acid (NDGA). 
Agüero et al., 2014 
China 
Caffeic acid, p-coumaric acid, ferulic acid, isoferulic 
acid, 3,4-dimethoxycinnamic acid, cinnamic acid, 
pinobanksin, naringenin, quercetin, kaempferol, 
apigenin, pinocembrin, 3-O-acetyl pinobanksin, 
chrysin, CAPE and galangin. 
Cui-ping et al., 
2014 
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Brazil 
Guttiferone E, oblongifolin A, xanthochymol, 
pinocembrin, formononetin, biochanin A, daidzein. 
Giménez-Cassina 
López et al., 2014 
Brazil 
(3S)-vestitol, (3S)-neovestitol, isoliquiritigenin, 
(6aS,11aS)-medicarpin 2-(2′,4′-dihydroxyphenyl), 3-
methyl-6-methoxybenzofuran, liquiritigenin, 
naringenin, (2S)-7-hydroxyflavanone, biochain A, 
daidzein, formononetin and retusapurpurin A. 
Inui et al., 2014 
Australia 
Gallic acid, abietic acid, abietane and flavonoids. Massaro et al., 
2014 
Germany 
Apigenin, ellagic acid, chrysin, pinocembrin, 
pinobanksin, galangin, kaempferol, quercetin, 
naringenin and caffeic acid. 
Morlock et al., 
2014 
Algeria 
Flavonoids and polyphenols. Nedji and Loucif-
Ayad, 2014 
Ethiopia 
Triterpenoids: β-amyrone, α-amyrone, β-amyrin, α-
amyrin, β-amyryl acetate, α-amyryl acetate, lupeol, 
moretenol and moretenyl acetate. n-Alkanes: 
heneicosane, docosane, tricosane, tetracosane, 
pentacosane, hexacosane, heptacosane, octacosane, 
nonacosane, triacontane and hentriacontane. n-
Alkenes: pentacosene, hexacosene, heptacosene, 
octacosene, nonacosene, triacontene, hentriacontene, 
dotriacontene, tritriacontene, tetratriacontene and 
pentatriacontene. Methyl n-Alkanoates: methyl 
dodenoate, methyl tridecanoate, methyl 
tetradecanoate, methyl pentadecanoate, methyl 
hexadecenoate, methyl hexadecanoate, methyl 
heptadecenoate, methyl octadecenoate, methyl 
octadecanoate, methyl nonadecanoate, methyl 
eicosanoate, methyl heneicosanoate, methyl 
docosanoate, methyl tricosanoate, methyl 
tetracosanoate, methyl pentacosanoate, methyl 
Rushdi et al., 2014 
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hexacosanoate, methyl heptacosanoate and methyl 
octacosanoate. Wax esters: docosyl hexadecanoate, 
tetracosyl hexadecanoate, hexacosyl hexadecanoate 
and octacosyl hexadecanoate. 
Cameroon 
Alkaloids, anthraquinones, phenolic compounds, 
reducing compounds, coumarins, saponins,  steroids,  
triterpenes (25-cyclopropyl-3β-hydroxyurs-12-ene; 
cycloart-3β-hydroxy-12, 25(26)-diene; lup-20(29)-
en-3-one; olean-12-en-3β, 28-diol; lup-20(29)-en-3β-
oate and 3β-hydroxylup-20(29)-ene.), tannins and 
volatile oils. 
Sakava et al., 2014 
Sub-
saharan 
region of 
Africa 
Prenylated flavonoids, flavonoids, diterpinoids, 
diprenylated flavonoids, geranylated flavonoids, 
hydroxyl acid, chlorogenic acid, cinnamic esters, 
triterpenes, triterpenoids, diterpenes, sesquiterpenes, 
and sesquiterpinoids. 
Zhang et al., 2014 
Brazil 
Triterpines, carbohydrates and derivatives thereof, 
anacardic acid, sugar alcohols and alkylresorcinols. 
Araújo et al., 2015 
France 
Pinobanksin-3-acetate, pinocembrin, chrysin, 
galangin and prenyl caffeate 
Boisard et al., 
2015 
Brazil 
Benzoic acid, cinnamyl caffeate, benzyl, caffeate, 
hydrocinnamic acid, hydrocinnamic acid ethyl ester, 
p-coumaric acid, 3-phenyl-p-coumaric acid, fructose, 
glucose, kaurenoic acid, 4-methoxybenzoic acid, 
retinol, cholesterol and tocopherol. 
Campos et al., 
2015 
Lebanon  
Alkaloids, flavonoids, phenols, saponins, steroids, 
tanins, and terepenoids 
Chamandi et al., 
2015 
Brazil 
Ferulic acid, caffeic acid, cinnamic acid, coumaric 
acid and 3,4-dihydroxybenzoic acid. 
de Lima Silva et 
al., 2015 
Sudan 
Gallic, b-oh benzoic, caffeic acid, phenol, p-
coumaric, salicylic acid, ferulic acid, cinnamic acid, 
quercetin, euganol, chrysin, galangin, pinostrobin, 
Elsayed and El-
Sarrag, 2015 
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vanillin, 3,5 di methoxy benzyl, pyro gallic, 
kaempherol, catechine, dadzin, genstin, dadazien and 
genstein. 
Lithuania 
Caffeic acid, naringenin, kaempferol, galangin, trans 
p-coumaric acid and ferulic acid. 
Kubiliene et al., 
2015 
Thailand 
α-Mangostin, mangostanin, 8-deoxygartanin, 
gartanin, dipterocarpolde, γ-mangostin, garcinone, 
dipterocarpol, methylpinoresinole, 3-O-acetyl ursolic 
acid, ocotillone, mixtures of ursolic and oleanolic 
aldehydes and cabralealactones. 
Sanpa et al., 2015 
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